Psychedelics Today

In this episode, Joe interviews Joanna Kempner, Ph.D.: associate professor in the Department of Sociology at Rutgers University and author of the recently released, Psychedelic Outlaws: The Movement Revolutionizing Modern Medicine.

The book profiles the history and groundbreaking work of ClusterBusters, a nonprofit researching and spreading awareness about what someone named Flash discovered decades ago: that for some people, psilocybin and LSD could stop cluster headaches from coming on. Through early internet message board posts and email exchanges between Bob Wold, Rick Doblin, and others, Kempner pieced together their story. And through attending ClusterBusters meetings, she discovered that a lot of the true healing lies in the bonds formed and the hope people find when seeing something new work for a pain for which science has no answer.

She discusses:

• The lack of political will behind something so debilitating: Why is there no funding for this?
• The importance of patient advocacy and the role of the internet in sharing novel information
• The difficulty in studying a disease so unpredictable: How do you run a randomized trial when you don’t know when a cluster is going to happen?
• Why the headache community clashes with psychology
• Concerns over how to ethically combine underground and Indigenous knowledge with above-ground University research

and more! 

For links, head to the show notes page.

In this episode, Kyle interviews Mustapha Khan: Emmy Award-winning director with over 100 film and television credits, who has worked with clients such as Coca-Cola and Honda, and celebrities ranging from Maya Angelou to Snoop Dogg.

Khan is finalizing a film about Lenny and Elizabeth Gibson and their ongoing work at Dreamshadow – the people and community responsible for Joe and Kyle meeting and the creation of Psychedelics Today. He talks about meeting the Gibsons, being welcomed into their community (instead of his proposed “fly on the wall” role), how centered and happy he felt after his first breathwork session, and what he has learned through the process: that breathwork can be an incredibly healing modality, but the magic he has found has been more in the community surrounding it, and the responsibility (and honor) of being a sitter for someone else.

He discusses:

• The first time his breathwork went psychedelic, and speaking with his recently deceased Mothe
• How he got into filmmaking and why he wants to tell stories about people like the Gibson
• The beauty of breathwork not having a dogma or doctrine attached to it
• The power in holding space for someone else, even if it’s just being presen
• The importance of taking action that aligns with psychedelic ethos: What can you do to contribute to your community?

and more! 

Khan is hoping to release the documentary, “Life and Breath,” in October. In addition to a screening at Dreamshadow, PT will likely do a virtual one as well, so stay tuned for updates!

For links, head to the show notes page.

In this episode, Joe interviews Danielle Nova: founder of Psychedelic Recovery, founding team member of Decriminalize Nature Oakland, and Executive Director of the San Francisco Psychedelic Society.

As a recovering addict, Nova discusses how working with psychedelics helped her find her way to recovery, and how she's spreading that knowledge to others through her Psychedelic Recovery program, which focuses more on 'targeted abstinence,' instead of the total abstinence model of Psychedelics In Recovery (which works alongside AA's 12-step program). She believes that it's extremely important to reframe addiction as a life process or temporary state of consciousness (rather than a life sentence you can't escape), and that beating addiction is not about constantly being afraid of a relapse, but about evolving to a state of empowerment: that you can overcome it, and that actually, a horrific addiction may have saved you and brought you to where you're supposed to be.

She discusses: 

• The complications of Western medicine and the impact of conflicting medications that are nearly impossible to stop taking
• How self-regulation of tough emotions with outside stimuli (be it drugs, pornography, or even video games) trains people to rely on external forces rather than themselves
• How addicts end up programing themselves with 'addict consciousness,' and the power of changing one's mind state to view suffering as the fuel for a new purpose
• How, over time, we will likely start viewing microdosing as a regular dose, and the large doses we're used to will be seen as overdosing
• How being part of her ayahuasca experience (and having one himself) completely changed her father's perspective on drugs and addiction

and more!

She has co-created Microdosing Facilitator Training with Adam Bramlage of Flow State Micro: a first-of-its-kind 4-month program teaching clinicians, facilitators, and coaches about microdosing and how to safely guide others through the practice. The next cohort launches in January 2025.

For links, head to the show notes page. 

In this episode of Vital Psychedelic Conversations, David interviews Deanna Rogers: Registered Clinical Counselor and Vital instructor.

She discusses how trauma grows in our bodies, and the importance of practitioners and facilitators becoming trauma-informed before working with clients. She stresses the need to create the right conditions for clients to be able to work with trauma – to bring compassion to the different parts of their self and build a relationship with the uncomfortable ones, to interrupt negative narratives, and to learn how to exist in a place where they can embrace their window of tolerance and explore discomfort in a safe way. What is the specific container and pace each client needs? How flexible is their nervous system to be able to work with these states? What can be done to bring out the empathetic witness in themselves? And most importantly, how can their sense of agency be improved so that they feel like they’re fully in control of how deep things go?

She discusses:

• Her early ayahuasca experiences, and her path toward working with others, including working with Gabor Maté and Peter Levine
• How psychedelics allow us to access our irrational, animal parts, and how this work is often a combination of sacred and messy
• The need for facilitators to have a basic understanding of the nervous system and fight or flight reactions
• Moving away from the idea of: “There’s something wrong with me.” What do these chronic narratives do to our bodies?
• Working with clients to build out the capacity of their nervous system first, before working with any trauma

and more!

Rogers is one of our Vital instructors, featured in one of Vital 4’s new Specializations: Somatics & Trauma. This cohort begins on September 17, and the application deadline is next week, September 3, so apply today before it’s too late! For links, head to the show notes page.

In this episode, Joe interviews Jean Lacy: Executive Director of the Illinois Psychedelic Society; and La Shawn K. Ford: 17-year member of the Illinois House of Representatives, representing the 8th District.

Together, they are working on the CURE (Compassionate Use and Research of Entheogens) Act, which aims to decriminalize plant medicines and bring a state-regulated model for psychedelic use to Illinois. Similar to Oregon's model, but with hopefully a more cohesive ecosystem, it would include service centers, different license types, the removal of psilocybin and psilocin from the controlled substances list, and a percentage of taxes allocated to education of first responders and law enforcement. Guided by the mistakes of cannabis legalization, they're putting a lot of focus on accessibility – not just for consumers, but for people trying to get licenses and open businesses. What does equity and inclusion look like in a psychedelic service model?

They discuss: 

• The need to educate lawmakers about psychedelics and shine a light on the myths and lies of the Drug War 
• The importance of understanding the process and doing the work when working with lawmakers: When it's done right, democracy can actually happen
• Why conversations about accessibility and certain provisions need to happen up front, as bills are being written
• The impact of bipartisan support, and how bipartisan psychedelics are starting to become
• The overwhelming support for the CURE Act that Rep. Ford has seen, from people of all walks of life

and more!

If you want to help, please sign their petition and/or make a donation. And if you want to help on a larger scale, get out there and have those conversations: Tell your story, and tell it to lawmakers. Your voice can make a bigger difference than you realize.  For links, head to the show notes page. 

In this episode of Vital Psychedelic Conversations, David interviews Rachelle Sampson, Ph.D.: researcher and founder of Blue Prism Coaching; and Bennet Zelner, Ph.D.: researcher, speaker, and creator of the Pollination Approach. They are both Vital instructors and Associate Professors at the Robert H. Smith School of Business, University of Maryland.

Based on a passion for regenerative economics (how we might be able to apply patterns of nature to socioeconomic systems), they are co-leading the Connected Leadership Study, a research project tracking how psychedelic experiences can facilitate change in people in leadership positions. They believe that a shift from a mechanistic attunement to a more synergistic recognition of our interconnectedness should lead to new ways of thinking, resulting in more creative leaders with better decision-making and team-building skills, and corporate culture caring more about values, regenerative models, equity, and sustainability – all while still being successful. They wonder: Can psychedelic experiences create better leaders? Can capitalism become more conscious?

They discuss:

• The structure of the study, what they learned in the first cohort, and why they track participants for a yea
• How change happens over time, and why they believe it to needs to happen from the bottom u
• The concept of emergence and emergent change illustrated by the shifts in movement of a flock of bird
• How synergistic attunement can be traced back to the cellular level
• The challenge of balancing the therapeutic aspect of psychedelics with the more corporate strategy/professional side

and more!

The study’s next cohort begins in October, so if you’re a business leader interested in being a participant, head to Leaders.study for more info. And if you’d like to learn more about these concepts, the new Regenerative Business and Leadership specialization path in this year’s cohort of Vital digs deep into this world. And we’ve just extended the applications to Sept. 2, so you still have time to apply! For links, head to the show notes page.

As the psychedelic renaissance continues to spread throughout the West, we learn more about these substances and experiences every day. But are we losing the important ancestral teachings and Indigenous knowledge that got us here?

In this episode, Kyle interviews Alonso Del Río: author, musician, filmmaker, founder of the Center for Healing and Consciousness Studies (Ayahuasca Ayllu), and facilitator with 45 years of experience largely under the framework of the Shipibo tradition.

Together with translator, Francisco Rivarola, they have developed a course called “Ancestral Teachings for the Psychedelic Renaissance,” which aims to be both an honoring of knowledge that has safeguarded these traditions, and a bridge between that wisdom and our Western frameworks, teaching ancestral traditions (largely Shipibo and Incan-Peruvian), the roles and function of dietas, the less talked-about dangers of brujeria (witchcraft), holistic frameworks for dealing with mystical experiences, and the connection between spirituality and responsibility towards nature. The course features 20 hours of Del Río’s teachings (with subtitles) and is the first time they’ve been made available to the general public.

He talks about:

• The importance of following guidelines when working with ayahuasca, and how Westerners often don’t respect the rigor required to do it right
• The different types of healers in the Shipibo tradition, from good and bad to the “Ascended Master,” who transcends physical limits and is incapable of causing harm
• The potential for ayahuasca to be weaponized, how often this happens, and the risks for Westerners who aren’t aware
• How the consciousness level of a person can be related to the emotions that that person allows themselves to have
• How the expansion of consciousness is healing in itself

and more!

Ancestral Teachings for the Psychedelic Renaissance is a self-paced course that can be taken at any time, so if you’re interested, take advantage of early bird pricing and check it out in the Psychedelic Education Center now! For links, head to the show notes page.

In this episode of VItal Psychedelic Conversations, Vital instructor, Diego Pinzon hosts his first podcast, interviewing Vital graduate and clinically-trained psychologist, “The Kinki Buddhist”: Kate Amy.

As Amy’s interest in psychedelics grew, she began to see a clear intersection between psychedelic states and the non-ordinary states she’d reached through years of meditation practice, as well as lessons from Buddhism that could help in better understanding psychedelic journeys. She talks about the importance of really understanding what it is one is seeking when looking to have a psychedelic experience, and the significance of integration – no matter how long it takes. While she has tips that have worked for clients, she feels that the psychedelic space has a long way to go in establishing best practices for the most effective integration.

She discusses:

• Why she uses the name, “The Kinki Buddhist”
• How she frames the psychedelic experience as taking an evolutionary substance (and/or receiving a software upgrade)
• The necessity of having a positive relationship with the self before a big trip
• The continuous process of patients and facilitators both engaging in shadow work, and ways of discovering our different hidden parts
• The rigidity many of us prescribe to certain healing frameworks, and how beneficial it can be to view strict rules as guidelines for exploration instead

and of course, her experience with Vital!

The deadline for submitting your application is next week, August 23, so make sure to get your application in today. For links, head to the show notes page. 

In this episode, Chris Koddermann interviews two members of the Center for the Neuroscience of Psychedelics at Mass General Hospital: founding director, author, and co-founder of three drug development companies, Dr. Jerry Rosenbaum; and psychiatrist and associate director and director of cognitive neuroscience, Sharmin Ghaznavi, MD, Ph.D.

Rosenbaum and Ghaznavi bonded over an interest in rumination, and wondered: How could the plasticity-inducing effects of psychedelics change these negative loops people find themselves in? How important is the ability to break out of those loops – and learn new patterns – when our concept of self is so central to who we are? Ghaznavi is studying the effects of psilocybin on rumination and scanning patients at multiple times throughout the process to track data we still don’t really have: how psychedelic-induced neuroplasticity changes over time, and why.

They discuss:

• How much of a role the default mode network takes in the therapeutic benefits of psychedelics: Is it overblown?
• Hyperscanning, which involves scanning two individuals at the same time, looking for potential concordance in signal and/or an increased alliance between the therapist and patient
• The Schultes Legacy Project and the work of Stephen Haggarty to explore the potential of largely unstudied psychoactive plants
• Critiques of the recent ruling on Lykos and MDMA-assisted therapy and the clash between the FDA and the advisory committee: Were they really on the same page?
• The false dichotomy of neuroscience vs. patient experience: Does the subjective experience actually increase plasticity and other measurable benefits?

and more!

For links, head to the show notes page.

In this episode of Vital Psychedelic Conversations, David interviews Tiffany Hurd: microdosing coach, speaker, business leadership advisor, and student in our current cohort of Vital.

After 15 years in the corporate healthcare industry and several years on antidepressants, she started microdosing psilocybin and saw an immediate change in her life, tapering off antidepressants within a few months. She realized that she could blend her background in business development and strategy with microdosing, helping companies (and specifically company leadership) become more vulnerable, heart-centered, and innovative. She has found that the changes in people have (not surprisingly) led to improved employee mental health, better team relationships, and more open-mindedness and authenticity, and likely, a large reason for that is not the microdosing itself, but the increased attention to preparation and integration – two huge factors often not discussed with microdosing.

She talks about:

• Why mentorship/coaching has not been seen as an integral part of a microdosing practice, and why it should be
• Her drive to normalize the use of low-dose psychedelics, especially in our Western ‘go all in’ culture
• The benefits of pairing microdosing with other healing modalities, and how microdosing can help you embrace more of them
• Why she signed up for vital and how she feels about the course half way through
• How she deals with the illegality of substances in the corporate world

and more!

Microdosing is one of the new specialization tracks featured in our next cohort of Vital, beginning September 16. If you want to know more, send us an email or attend one of the next Vital Q+As!

For links, head to the show notes page.

The path of the psychedelic renaissance has largely touched on the aspects of therapy, personal growth, and initiation rites, but now, the relationship between psychedelics and creativity is being studied more and more. Can psychedelics really increase intellect, novelty, and problem solving?

In this episode, Joe interviews Dr. Bruce Damer: astrobiologist with a long history of work at NASA, and now the president and co-founder of the Center for MINDS, a new nonprofit researching the best ways to improve creativity and problem solving.

He talks about how we’re losing our best creative minds to hyper-specialization, and while there is lots of research pointing to psychedelics as creativity-enhancers, we need to develop frameworks and protocols to be able to measure exactly how that works, and the best ways to encourage better results. The Center for MINDS is sponsoring research while running its own three year project studying creativity in a naturalistic setting, and aims to answer: How do we unlock more genius? What’s the main driver for novel thinking?

He discusses:

• His path to psychedelics, including his time with ‘endo-tripping’: training his mind to trip without any external substances
• The importance of adding ‘set up’ to set and setting, representing one’s intentions and preparatory work up until that point
• The tale of his extraordinary ayahuasca experience where he journeyed together with Mama Ayahuasca all the way to the beginning of life on earth
• His theory on the real origin of life, and why the ‘survival of the fittest’ framework shouldn’t be our North Star
• The absolute necessity of mentorship from elders

and more!

The steps the Center for MINDS will take in studying psychedelics and creativity will largely be steered by people’s personal stories, so please share yours with them by filling out their survey. What has worked for you? What is your personal protocol? For links, head to the show notes page. 

Jungian psychology takes a fascinating look at the relationship between the conscious and unconscious parts of our minds. How is this framework brought more to the forefront through psychedelics and an understanding of our many parts?

In this episode of Vital Psychedelic Conversations, Johanna interviews Jung experts and Vital instructors: Maria Papaspyrou, psychotherapist and co-founder and director of the Institute of Psychedelic Therapy (IPT); and Dr. Ido Cohen, clinical psychologist and founder of The Integration Circle.

They talk about the experiences that helped them first understand the concept of multiple different parts making up their being, and dive into what it is about psychedelics that allows us to discover and work with these different parts: how the protector parts of our psyche work overtime to keep parts away from us, and how psychedelics can dissolve them, leading to a better understanding of ourselves. How much of our persona is based on who we feel we’re supposed to be? What shadow parts are stopping us from being our true selves? And what amazing parts of ourselves have yet to be discovered?

They discuss:

• The idea of self as a unified entity: Does this concept make sense anymore?
• Risks in understanding how different parts work together, from justifying behaviors to inflating defensive structures
• The need to move away from solution-based to more process-focused frameworks, and the power in treating healing and growth as an ongoing process
• The rejection of the shadow and the archetypal (and impossible) wish to extinguish all suffering
• The large discrepancy between what people think being a psychedelic facilitator is vs. the reality

and more!

If you really want to dig into Jungian ideas, Jungian psychology is one of the new specialization tracks featured in the next cohort of Vital, beginning September 16. If you want to know more, send us an email or attend one of the next Vital Q+As. For links, head to the show notes page. 

As many mushroom enthusiasts will attest: the more you learn about the fungal kingdom, the more you see how important mushrooms are to every ecosystem they’re a part of – and how life-changing a relationship with them can be.

In this episode, Joe interviews Jasper Degenaars: mycologist, educator, and the Hyphae Headmaster at Fungi Academy, offering retreats, communal living, and online courses to teach people how to grow mushrooms and form a deeper connection with them.

Degenaars tells of his path to Guatemala and the Fungi Academy, from foraging to cultivation, to the impact psychedelic experiences have had on his life. He believes that mushrooms show up where people like to live; that they are integral to ecosystems, and that they are the masters of death and life – and of ego death and rebirth. The Fungi Academy has several several in-person events for which they just opened up registration, self-paced courses you can enroll in now, and their next Sacred Mycology Summit takes place Feb. 23 – 25, 2025.

He discusses:

• The importance in studying the entire organism rather than just specific compounds
• The stoned ape theory and possible new evidence
• Why he prefers the term ‘magic mushrooms’ to the reductionist way of only talking about psilocybin
• The clash between clinical Western approaches and Indigenous tradition
• The Iron law of prohibition and how MDMA has gotten stronger and stronger
• His desire to move more into permaculture, including courses teaching it alongside the fundamentals of psychedelics: How can they work in tandem?

and more! For links, head to the show notes page. 

Psychedelics in palliative care has become an exciting new framework for people looking to ease anxiety and embrace spirituality, but the concept is not as simple as just providing a substance.

In this episode, Joe interviews Livi Joy: Director of Health and Safety, Existential Palliative Ministry Lead Facilitator, and more at Sacred Garden Community (SGC).

As she screens applicants for SGC (and Beckley Retreats), she talks a lot about the process and the safety measures that are absolutely necessary when using psychedelics in palliative care – especially under the framework of the Religious Freedom Restoration Act. Does the patient have at least one strong support person? Do they need to start or increase therapy? Does their home need to be rearranged due to possible fall risks? How will certain medications muffle their experience? Are they truly physically healthy enough to be able to handle a powerful journey? And also, is the sacrament always necessary?

She discusses:

• How preparation questions for a journey are often in line with preparation for death
• Why it’s important to provide these experiences for people far from the dying process itself
• What Sacred Garden’s core tenant of faith that everyone can have a direct experience of the divine in this lifetime means to her
• Atheism and the complications that arise when discussing spirituality and consciousness: Who’s really in charge?
• How psychedelics can help with understanding and preparing for death, but our culture is too death-phobic too embrace it

and more! For links, head to the show notes page: 

In this episode, Joe interviews Erica Rex, MA: award-winning journalist, past guest, thought leader on psychedelic medicine, and participant in one of the first clinical trials using psilocybin to treat cancer-related depression.

She tells the story of her recent harrowing experience, brought on by 6 times the amount of Syrian rue that was recommended: from entities threatening her, to a sense of terror she was going to die, to finding her way out of it with time, and most importantly, context to process and a strong support system. She and Joe emphasize the reality that bad trips can happen at any time, with any dose, for any reason, and that – if you can make your way through the experience without being traumatized – you can learn a lot about yourself during those states.

She discusses:

• Methods to help others having a bad experience
• Her skepticism about psychedelic therapy being in a medical context at all
• Her thoughts on the recent ICER recommendation against approving MDMA and the multiple topics not addressed
• Possible complications from MDMA use nobody talks about, from cytotoxic effects to even sudden-onset psychosis
• The pathologizing of anything outside the ordinary, to the point that we’re trying to suppress natural human emotions and reactions

and more! 

Rex's book, “The Heroine’s Journey: A Woman’s Quest for Sanity in the Psychedelic Age” will be published by She Writes Press in the spring of 2026. For links, head to the show notes page.

In this episode of Vital Psychedelic Conversations, Johanna interviews Monica Nieto: Vital graduate, psychedelic facilitator and integration coach, and founder of Holistic TherapeutiX, a retreat center offering cannabis and breathwork retreats; and Jordana Ma: past Vital instructor and psychological counselor who runs retreats in Peru following the Asháninkan tradition of traditional Amazonian medicine.

They discuss their similar paths to psychedelics and healing, the power of plant dietas and fully immersing yourself into nature, and learning to hear your true teacher: the inner healer. They highlight how we’ve lost the connection to the ecological consciousness within our bodies, and how the plants – perhaps in a self-serving way – have become allies, trying to teach us to heal the web we’re a part of and reconnect to nature and ourselves.

They discuss:

• The importance of combining traditional perspectives and Western psychotherapy into a spiritual practice
• The similarities between yoga and traditional Amazonian medicine
• Singing as a somatic (and breathwork) practice
• How things are meant to work in synergy, and the problem with science trying to extract compounds rather than respecting the power of the whole plant
• Their role models who have inspired them and informed their work

and more! The Vital Early Bird discount ($2000 off!) ends on July 22, so make sure to apply today! For links, head to the show notes page. 

In this episode, Joe interviews Jon Reiss: critically acclaimed filmmaker, author, and host of the Plantscendence podcast, which tells people’s psychedelic stories and is beginning its second season soon.

He talks about his early days of directing Nine Inch Nails and Type O Negative videos, and how Plantscendence was born after he realized that the conversations he was having with people about their most transformative experiences were perfect for a podcast. He discusses his first psychedelic experience with ayahuasca, how microdosing is helping him today, and his realization that people can get to these big experiences in many different ways.

He discusses:

• The two episodes of Plantscendence that stand out the most to him
• Using the term, ‘plant medicine’
• His 30 years of meditation practice and how it likely helped him to integrate his first psychedelic experiences
• The concept of plant intelligence and how plants can stop you from being a “consciousness tourist”
• Kabbalah, Kashmir Shaivism, non-duality, and his Shaktipat experience

and more! For links, head to the show notes page. 

In this episode of Vital Psychedelic Conversations, David interviews Sara Reed: Vital instructor, lecturer, and lead psychedelic research therapist at Imperial College London; and Alex H. Robinson: Vital student, integration coach and psilocybin facilitator for Heroic Hearts Project, and distinguished Army SOF combat Veteran with a decade of active duty service.

Reed has worked with MAPS to make clinical trial populations more diverse and is creating culturally sensitive Clinical Research Forms for future research trials, and Robinson spearheaded her unit’s Cultural Support Team program and contributed to policy changes to help place women into traditionally male-centric Special Operations roles. Representing marginalized groups themselves, they’re both passionate about making psychedelic therapy more inclusive and representative of the general population, and getting more practitioners up to speed to be able to deliver culturally competent care.

They discuss:

• The importance of having difficult conversations and calling out bad behavior
• The fallacy of zero-sum thinking: Doing something special for a smaller community doesn’t take away from the main goal; it adds to it
• The benefit of being able to self-reflect and personalize content when most psychedelic education consists of one-sided lectures
• The challenge of getting people who don’t feel represented to enroll in clinical trials, and how personal stories go a long way

and more! For links, head to the show notes page.  Vitalpsychedelictraining.com

In this episode, Joe and REMAP Therapeutics Founder, Court Wing, host Lynn Watkins: medically retired USAF JAG & Ops Resource Mgmt Specialist; and C.J. Spotswood, PMHNP: principle psychiatric clinician at REMAP Therapeutics, and author of The Microdosing Guidebook: A Step-by-Step Manual to Improve Your Physical and Mental Health through Psychedelic Medicine.

Watkins tells her story of 20+ years of chronic pain: from Complex Regional Pain Syndrome brought on by a severed nerve to multiple foot surgeries, chest pains, cognitive issues, the inability to move her toes, burning mouth syndrome, and more, which unsurprisingly resulted in depression, anxiety, and being unable to work. Wing and Spotswood talk about their initial assessment, how they figured out how to work with her and her multitude of medications, and the incredible success they saw when combining practiced techniques, neuromodulation, and regular assessments with neuroplastic windows brought on by psilocybin.

They discuss:

• How much preparation was done before introducing psychedelics, and the importance of realizing that they were dealing with PTSD
• How often a history of chronic pain is related to a history of trauma, whether the patient realizes it or not
• Consequences and complications of medications, specifically Clonazepam in Watkins’ case
• The cascade of ailments and side effects that can happen from just one injury

and more! For links, head to the show notes page. 

In this episode of Vital Psychedelic Conversations, David interviews Casey Paleos, MD: Vital instructor, researcher, psychiatrist with a private practice offering ketamine infusion therapy and KAP, and co-founder of Nautilus Sanctuary, a non-profit psychedelic research, education, and advocacy organization. 

Paleos talks about how stress creates trauma, and how the symptoms Western medicine tries to silence are actually signals – a quality assurance mechanism sending an alert that something is wrong, and that when symptoms are labeled as ‘treatment-resistant,’ is it actually a case of one’s own inner healing intelligence outsmarting a medication to make sure that that message is delivered?  

He discusses:

• MAPS’ recent advisory board ruling, past ethical violations, and how training should be done
• How consent in a therapeutic relationship is an ongoing process of checking in
• How psychedelic-assisted therapy (and maybe all therapy) is simply removing obstacles so one’s own inner healing intelligence can do its job
• The importance of a culture (and training) that celebrates all therapeutic modalities as complementary: There’s a lot of uniqueness in this world, so we should embrace that  

and more!

For links, head to the show notes page. 

In this episode, Kyle interviews Peter A. Levine, Ph.D.: developer of Somatic Experiencing®, educator, and author of several best-selling books on trauma.

His most recent book, An Autobiography of Trauma: A Healing Journey, is exactly that: a change from more scholarly writing into an extremely vulnerable telling of his early childhood trauma and how he has healed over the years. He talks about how his unconscious convinced him to write the book, how trauma can move into the body, and how he needed a student to identify how his trauma was affecting him. He believes that we all have wounding, but it's how we carry these wounds and tell our truth that matters. 

He discusses: 

• The need to allow space for both Indigenous traditions and evidence-based Western frameworks
• The power of having even just one distinct moment of feeling cared for and loved
• How Colin Turnbull saw healing differently after living with an African tribe for three years
• Why he suggests 15-20 sober experiences with non-ordinary states for each drug experience
• Why not having a community or empathetic other makes us more vulnerable to trauma

and more!

For links, head to the show notes page. 

In this episode of Vital Psychedelic Conversations, Johanna interviews Erika Dyck: author, professor, historian, Vital instructor, and research chair in the History of Health & Social Justice at the University of Saskatchewan.

Dyck talks about the book she co-edited: Women and Psychedelics: Uncovering Invisible Voices, which was released in March as a Chacruna anthology, and collects pieces from several different authors highlighting the untold or lesser known stories from women throughout psychedelic history. Albert Hofmann was the first person to intentionally ingest LSD, but who was the first woman to do so? Who were the women assisting in research or sitting with experiencers in the early days who never got the credit for their contributions? Who were the women supporting some of the biggest psychedelic names in history?

She talks about:

• The contrast in societal attitudes towards psychedelic exploration based on stereotypical gender roles
• Some of her favorite stories from the book, including a woman diagnosed with manic depression becoming one of the first guides in LSD trials
• The use of psychedelics in pregnancy and birthing practices across other cultures
• Traditional gender attributes: Are women more wired to care for others? Is there something about the psychedelic experience that’s inherently feminine?
• The importance of moving past the gender binary and implementing more diversity in research – with the challenge of needing to universalize medicine at the same time

and more! For links, head to the show notes page.

In this episode, Joe interviews Lia Mix, LMFT, CPTR: founder and CEO of Delphi, a consulting firm dedicated to the healthy growth of the psychedelic movement.

After many years of working in community mental health and 15 years in the commercial health insurance industry (where she helped to establish coverage for autism), Mix was one of the first graduates of CIIS’s training program, and after a very distinct MDMA-assisted therapy session, she wondered: “How can I be of service?” She’s since helped to launch The Board of Psychedelic Medicines and Therapies, the American Psychedelic Practitioners Association, and Enthea, and is working every day toward a more unified and uniform psychedelic space, with healthcare frameworks, official boards and certifications, consumer protections, and a general consensus that this is our responsibility to manage – not some outside regulator’s. So how can we, as a scattered psychedelic community, come together?

She discusses:

• Her path to psychedelics and how nobody was talking about how to bring psychedelics into healthcare
• The need for a unified code of ethics for any practitioner of psychedelic therapy
• The FDA, Lykos Therapeutics, and how the recent advisory committee’s recommendations on MDMA-assisted psychotherapy were largely based on fear
• How there actually is a lot of financial possibility if we can all agree on what is absolutely essential right now

and more! For links, head to the show notes page.

In this episode of Vital Psychedelic Conversations, David interviews Kaitlin Roberson: Vital graduate and co-founder and CEO of Cacti Therapeutics, a psychedelic biotech company developing novel therapies for chronic pain; and Dr. Michele Cox, DO: current Vital student, veteran, physician, and co-founder of LifeBloom, a brand new company focusing on bringing community and connection into women’s healthcare.

They talk about their work: Roberson’s research on trauma and chronic pain, and why she feels that working in the pharma industry is a calling; and Cox’s framework as an osteopath, the value she’s found in touch and connection, and how she explains to clients what to expect when undergoing ketamine treatment.

They discuss:

• Why psychedelics are such useful interventions
• The body’s ability to tell us what’s wrong, as long we’re listening
• The destabilization that can occur after a big experience: If you don’t have a good support system, is it really the right time?
• Self-care and our tendency to never feel like we’re good enough
• How there is energy in everything and we should all recognize that more

And, as Vital students, they talk about what they hoped to get out of Vital and how it delivered more than expected. If you’re just discovering Vital, be sure to check out the website and fill out an application. Secure your spot and take advantage of the Early Bird discount! For links, head to teh show notes page. 

In this episode, Joe interviews Dr. Amanda Holley: pharmacologist and regulatory consultant in nonclinical drug development, and previously a nonclinical pharmacology/toxicology reviewer at the FDA.

With Lykos Therapeutics working towards FDA approval of MDMA-assisted psychotherapy for PTSD, ICER (Institute for Clinical and Economic Review) recently published its draft evidence report, concluding that they couldn't endorse this modality. While disappointing to the psychedelic space, this report doesn't determine the FDA's official stance, and also really highlights a lot about how the FDA works, the knowledge gap between consumers and regulators, and how clinical studies should be designed in the future. Holley talks about the FDA's dedication to safety and data, and how, essentially, drug development comes down to a risk/benefit analysis. 

She discusses: 

• Misconceptions about the FDA, especially related to psychedelics
• The path of a substance in early drug development and how breakthrough status works
• The complications with blinding psychedelics, the placebo effect, and how much therapy is a factor
• The contrast between productization and harm reduction: Should we be concerned with creating products, or understanding these substances better?
• How changing one molecule really does create a different drug

and much more! For links, head to the show notes page. 

In this episode of Vital Psychedelic Conversations, Kyle interviews two Vital graduates: Alice Dommert: certified breathwork facilitator and co-founder of retreat company, The Infinite Center; and Kara Tremain, ACC: somatic practitioner and growth and development coach.

A huge part of Vital is the experiential aspect of attending a retreat. Students report that being part of a group process, feeling the power of the proper set and setting, taking a journey as both a sitter and experiencer, and separating from the world and connecting with each other has been one of the best parts of the program – even life-changing. With Dommert behind 13 Vital retreats to date, she and Kyle dive into what they’ve learned in how to run a successful retreat.

They discuss:

• Facilitator humility and how important it is for everyone to be on the same page
• How much additional activities can add to the experience (tea ceremonies, CrossFit, chanting, fireside chats)
• The importance of allowing enough time and space for everything, from personal time with facilitators to possible issues
• Co-creation and openness: What can facilitators and people coming to the retreat build together? How do we create the most meaningful time together?

If you’re interested in Vital, applications are now open with an Early Bird discount! And if you want to attend a Vital retreat, we have a few spots left in two: a transpersonal breathwork retreat in Pennsylvania, July 9-14, and a cannabis + breathwork retreat in Agoura Hills, CA in October. Head to the Infinite Center’s website for details. For links, head to the show notes page. 

In this episode, Joe interviews Charles Stang: Professor of Early Christian Thought and the Director of the Center for the Study of World Religions at Harvard Divinity School.

The Center was created to gain a better understanding of world religions by bringing scholars from their respective countries to study and live alongside Divinity School students. As students and Stang started to become interested in psychedelics, a zoom series, "Psychedelics and the Future of Religion," began, and the school just hosted their second conference, "Psychedelic Intersections: Cross Cultural Manifestations of the Sacred." Next year's Psychedelics and Spirituality conference will take place February 15, 2025. 

He discusses: 

• Harvard's psychedelic history, and why it's important to not erase the past out of the interest of presumed legitimacy
• How people are consistently having extraordinary experiences with psychedelics, but not always with religion: Are people becoming less (or more) religious?
• The Immortality Key, the Eleusinian mysteries, and psychedelic enthusiasts' need to connect Christianity with psychedelics
• Psychedelics and other mystery religions, like Hermeticism and Mithraism
• Why religion is important to so many people, and how it helps us understand the "more-than-human" 

and much more. For links, head to the show notes page.

In this episode – the first in the 2024 series of Vital Psychedelic Conversations – David interviews Pierre Bouchard, LPC: Vital instructor and lead trainer for the Congregation for Sacred Practices; and Kara Tremain, ACC: recent Vital graduate-turned-instructor, somatic practitioner, and growth and development coach. 

In this series, we pair up a Vital instructor with a current or previous student as a way of showcasing different (and aligned) perspectives on what they feel is most vital for the psychedelic space to be discussing, while also highlighting their experiences with Vital, our 12-month training program. The next cohort begins September 17 and we're accepting applications now.  

As they are both are passionate about somatic work, they discuss: 

• The power of somatics in showing people how much our bodies and nervous systems matter, and how our thoughts are often not the main driver
• How ketamine or MDMA can help with somatic work
• How somatic sound can be, through music for journeys, sound bowls, or tuning forks: Can just the right frequency create magic?
• How somatic work is not solely about resolving trauma, but also about learning to conduct energy and use one's body as a tuning apparatus

and more!

For links, head to the show notes page. 

In this episode, Kyle interviews Alex Belser, Ph.D. and Bill Brennan, Ph.D.: psychologists, psychedelic researchers, authors, and co-creators of the EMBARK model, a framework for psychedelic therapy. 

When Belser and Brennan worked together at Cybin, they canvassed the field of psychedelic research and saw very little reporting (if any) of the manuals researchers were using, so they created the EMBARK model as a "big tent" framework – a way to understand what patients were going through from the perspective of six different clinical domains, where the clinician can go deeper into whichever domain is needed based on their specific skill sets. The EMBARK model has been used in two randomized controlled trials to date, and its corresponding book, EMBARK Psychedelic Therapy for Depression: A New Approach for the Whole Person (co-authored by Belser and Brennan), was released in April. 

They discuss: 

• The six domains and four ethical care cornerstones that make up EMBARK, as well as the many proposed change mechanisms that come into play
• Concerns over facilitators stepping aside and letting the medicine do the work: How much of a factor is someone's presence in the room?
• How much smaller, "little t" traumas can affect people – trauma doesn't always come from a single hallmark event
• The need for facilitators to be trained well (and trauma-informed), as it's nearly impossible to tell when an adverse outcome is coming

and more! For links, head to the show notes page.

In this episode, special guest host Court Wing interviews Monica Verduzco-Gutierrez, MD: professor and chair of rehabilitation medicine at UT Health San Antonio; Joel Castellanos, MD: co-founder and associate medical director of the Center for Psychedelic Research at UC San Diego; and MaryAnn Welke Lesage: a long COVID survivor who reports experiencing drastic improvement in symptoms after MDMA and psilocybin therapy.

As the world slowly recovers from COVID, many people are seeing continued or new symptoms, and while much is still not understood, these symptoms are being categorized as long COVID: essentially a persistent viral inflammation causing brain fog, headaches, depression, and other hard-to-diagnose symptoms. With estimations of as many as 18% of people in the U.S. experiencing this at one point and 6.8% currently dealing with it, could psychedelics – which can decrease inflammation and reset neural networks – help alleviate these symptoms? 

They discuss: 

• How long COVID fits into what we already know about psychedelics, pain, and inflammatory medicine
• Why MDMA or psilocybin therapy, specifically, can help
• The importance of physical medicine and rehabilitation (PM&R) and the myriad of tools these physicians have learned to work with
• Why anecdotal evidence matters towards future research

and more! 

For more info, read Lesage's article, "How Psychedelics Became Key to My Long COVID Recovery," as well as the official paper: "Long-COVID symptoms improved after MDMA and psilocybin therapy: A case report." For more links, head to the show notes page.

In this episode, Joe interviews Sean Lawlor: writer and therapist specializing in ketamine-assisted therapy at Reflective Healing in Fort Collins, CO.

His first book, Psychedelic Revival: Toward a New Paradigm of Healing, will be released on June 4. Written as somewhat of a primer for psychedelics and psychedelic therapy, he talks about how he decided to write the book, how Michael Pollan was an influence, and the importance of making psychedelic literature not boring: Research and statistics are important, but how does one relate to data points when trying to understand something so rich and weird?

He discusses:

• Studying philosophy, from Nietzsche and Freud to Jung and William James
• When a clinical frame or license is important (but can you always trust a license?)
• How context and interwoven culture matter when differentiating between plant medicines and man-made psychedelics
• Brian Muraresku’s The Immortality Key and research into ancient Greeks using psychedelics: Why do we place so much importance on proving this?
• The importance of community, rituals, shared meanings, mythology, and rites of passage and more!

For links, head to the show notes page. 

In this episode, Joe interviews Elliot Marseille, DrPH, MPP: founding director of UC Berkeley’s Collaborative for the Economics of Psychedelics (CEP), a network of health economists and researchers analyzing the economics behind emerging psychedelic-assisted therapies.

In the early days of drug research, efficacy was the leading factor in decision making, but as time has gone on, people are looking much more into the economics of everything: If a government is granted X amount of money, what should they spend it on that will be the most beneficial to the most people? How do you create models for future research and regulations based on the data we have now? Can there be a time in the near future when someone sits before Congress and says, “This is the exact societal cost of not making psychedelic therapy accessible”?

He discusses:

• His early work with the SEVA Foundation, studying at the economics behind HIV/AIDS treatments in developing countries
• His experiences working with Ram Dass and having a big psychedelic journey with Leo Zeff
• His issues with the recent ICER (Institute for Clinical and Economic Review) report which said they couldn’t endorse MDMA-assisted psychotherapy
• Why we need more studies tracking people for long periods after psychedelic therapy, specifically analyzing their healthcare utilization over time

and more!

For links, head to the show notes page. 

In this episode, Joe interviews two members of The Daschle Group: Founder and CEO, Senator Tom Daschle; and Public Policy Advisor, Charlie Panfil.

As Senator Daschle served in the House of Representatives for eight years (starting in 1978) and the Senate for 21, he was deep in the War on Drugs at its peak, and thankfully, as seen with so many of his constituents in recent years, the data and personal stories of so many healed people has broken through the propaganda and made him a strong advocate for psychedelic-assisted therapy. While minds are changing and progress is happening before our eyes (the majority of substances the FDA is currently researching for psychiatric indications contain some form of psychedelic ingredient), government bureaucracy, a severe lack of communication between the FDA and DEA, and decades of lies are still massive roadblocks. How do we address all of this while advancing research?

They discuss:

• The need to develop a partnership between the public and private sectors, mostly for the cost of treatments
• The DEA’s place in all of this: If they’re essentially a law enforcement agency, why are they involved in the safety and efficacy of medical treatments?
• The STATES Act, the Breakthrough Therapies Act, and how they can affect research
• Why we need to move past relying on opioids, and instead, embrace a science-based drug policy

and more! For links, head to the show notes page. 

In this episode, Kyle interviews Simon Yugler: psychedelic-assisted therapist, educator, and author of the book, Psychedelics & the Soul: A Mythic Guide to Psychedelic Healing, Depth Psychology, and Cultural Repair, which comes out this fall.

He digs into depth psychology and why it’s a beneficial framework for navigating non-ordinary experiences – a practice he believes will be the next focus in psychedelic education and understanding, alongside more analysis into the archetypes and myths that reside within (and all around) us. In an age of hyper-individualism and isolation, the stories and archetypal energies we share (which can be brought more to the forefront with psychedelics) can be incredibly healing and connecting.

He discusses:

• The challenges of reintegrating to reality after the classic Hero’s Journey, and how some people don’t want to
• The time he ate 7 grams of strong mushrooms and nothing happened, confirming to him the omnipresence of trickster energies
• Jung’s theory on individuation, and how true individuation actually creates deeper engagement with the world
• How myths offer windows into deeper realms, and a breakdown of his Mythopoetic Integration Method
• How psychedelics show us our souls, and how so much of the chaos in the world can be related to a denial of the soul

and more! For links, head to the show notes page. 

In this episode, David interviews Sami Awad: Palestinian peace and nonviolent activist and founder of Holy Land Trust in Bethlehem; and Leor Roseman, Ph.D.: Israeli neuroscientist, researcher, and senior lecturer at the University of Exeter.  

They talk about Roseman's 2021 paper, "Relational Processes in Ayahuasca Groups of Palestinians and Israelis," which looked at what happened when people with fiercely different opinions moved beyond fear, anger, and othering, and sat together in a safe container and drank ayahuasca with the purpose of healing collective trauma. When the focus of the participants moved toward understanding each other, Roseman and Awad saw a unity that gave them a lot of hope, leading to the creation of their nonprofit, RIPPLES, which is focused on using psychedelics for peacebuilding – first in the Middle East, and hopefully soon, everywhere. As Awad says, "If it can happen here, it can happen almost anywhere."

They discuss: 

• The efficacy of psychedelics as a tool for nonviolent activism, building peace, and recognizing – and healing – collective trauma
• The balance between the idealistic and the practical, or 'the irony of harmony' – if you focus too much on the connectivity of psychedelics, do you actually exclude voices?
• The concept of "my liberation depends on your healing and your liberation depends on mine"
• The challenge in doing something with the hope and enthusiasm that comes after a powerful experience: How do you make sure that wave of hope continues rippling through choppy waters? 

Click here to head to the show notes page.

In this episode, Joe interviews two members of the Heroic Hearts Project team: Director of Donor Development and founder of The Hope Project, Allison Wilson; and Director of Research and founder of Hystelica, Dr. Grace Blest-Hopley.

They discuss how The Hope Project – a nonprofit that supports spouses of veterans, Gold Star Wives, and female veterans with scholarships to psychedelic healing retreats, integration, community, etc. – merged with Heroic Hearts Project, and why this is such a necessary part of the veteran healing story: How does a family hold space for a vet returning to a suddenly alien civilian life (especially after a psychedelic journey)? How does a spouse deal with their own trauma from constant worry and isolation? Wilson and Blest-Hopley are learning that, for many spouses, having their own experience (and with other spouses) has been incredibly beneficial.

They talk about:

• The concept of secondary PTSD (often referred to as ‘compassion fatigue’) and the many ways it can manifest
• How Heroic Hearts is working with Imperial College London to use veteran retreats as real-world observational research
• The importance of involving family in the healing process, and how positive outcomes can trickle down to children
• The need for more research into how PTSD and the effects of psychedelics are different in women based on their unique physiology (as most studies have focused on men)

and more! For links, head to the show notes page. 

In this episode, Joe and Kyle interview William Richards, STM, Ph.D.: senior advisor at Sunstone Therapies, psychologist at the Center for Psychedelic and Consciousness Research at the Johns Hopkins School of Medicine, contributor to Vital, and author of Sacred Knowledge: Psychedelics & Religious Experiences.

He talks about the first time he experienced psilocybin in a research study in 1963, his early studies on the psychology of religion, working with Abraham Maslow, how he became one of the early psychedelic therapists, and what it was like for all of that to disappear when Nixon came into office and shut everything down. He discusses his move into psychedelics and end-of-life care after seeing patients’ fear of death completely disappear, and contemplates whether psychedelics could help people prepare for death – how would we live if we no longer feared death?

He also discusses:

• How the integration of psychedelics into palliative care should be a huge step in cultural acceptance
• How psychedelics could be used for education and boosting creativity, problem solving, and even new perspectives on history and classic works
• The study of comparative religion and the potential for psychedelics to find the connections and commonality between seemingly disparate religions
• The impact of psychedelic experiences on the perception of the sacred
• How fascinating it is that the same substance, dose, and set and setting can create such incredibly different experiences

and more! For links, head to the show notes page. 

In this episode, Joe interviews Shahar Amit: psytrance musician who has created what may be the world's first modular album for psychedelic exploration under his project, Held By Sound. 

He talks about his background in the rave and festival scene, the moment he realized he wanted to make music, and the realization that he could create soundscapes specifically for journeys into non-ordinary states. And he digs into the 'choose your own adventure' framework of the free album: how he actually recorded 3 different albums and figured out how to transition into different moods based on which direction the listener wants to go – from more still to more expansive, to darker or more bittersweet. He has also created music for DMT trials in the UK, and talks a lot about the potential in extended-state DMT experiences.

He also discusses: 

• How he came up with the flow of the album related to phases of the trip
• How much of a catalyst and safe container music can be, with or without a complimentary substance
• How psychedelics in a fun, festival experience with lots of laughter can be extremely beneficial – you don't need to do them the 'correct' way
• Graham Hancock, Donald Hoffman, and the concept of consciousness as the building block of all reality
• Psytrance, classical music, traditional Bwiti music, Lady Gaga, and what music he feels is best for exploration 

and more! For links, head to the show notes page. 

In this episode, Joe and special guest, Court Wing, interview Tommy Aceto: former Navy Seal and trauma medic, NCAA athlete, Michigan State Champion Wrestler, and now, psychedelic advocate and ambassador for the Veteran Mental Health Leadership Coalition.

He discusses his journey from childhood to wanting to become a SEAL, and the toll that military life and its programming can take on a person: how a life built on high levels of endurance, deprivation, and constantly surviving in a fight-or-flight mindset often manifests in Operator Syndrome, chronic pain, depression, and addiction. Veterans are seeing the potential of psychedelics to rewire their brains and allow them to process pain differently, by allowing them to feel emotions they were trained to turn off: “You’ve got to feel to heal.”

Aceto discusses:

• The affirmation and approval many who join the military seek, and how that often translates into needing to stay at certain levels of risk to truly feel alive
• The similarities between soldiers and professional athletes and high performers
• Dealing with chronic pain, and how forcing movement is often the best tactic
• The Controlled Substances Act and how opioids became a business
• Why the most important thing vets can do today is to tell their healing stories

and more! For links, head to the show notes page. 

In this episode, Kyle and Johanna catch up, interviewing each other about psychedelic education and what they’ve learned, the biggest challenges, and what advice they would give to anyone looking to get involved in the psychedelic field.

They discuss:

• How sometimes it’s not about the substance: If you want to be a psychedelic therapist, do you see yourself doing therapy without the psychedelics?
• How no part of education is exempt, and becoming truly psychedelically-competent can involve studying psychology, neuroscience, somatics, religion, history, etc.
• How people’s experiences are evidence – it doesn’t have to come from a research study to be valid
• The importance of figuring out what your gifts are and how you could best contribute to progress, and then finding the job that matches it

and more!

The next round of our year-long training program, Vital, begins in September, but for those who feel that that may be too much of a commitment, our most popular course – the 9-week Navigating Psychedelics for Clinicians and Wellness Practitioners, LIVE – begins on May 8. Head to the Psychedelic Education Center for more details! Click here to head to the show notes page.

In this episode, Joe interviews Philip Wolf: writer, member of Rolling Stone's Culture Council, founder of Cultivating Spirits (the first company in the U.S. to offer legal culinary cannabis experiences), and founder of CashoM, an education company offering a certificate in cannabis stewardship.

He discusses his recent Rolling Stone article about the need to divorce ourselves from the colonial mindset that pervades the psychedelic movement, and he talks about the difficult conversation that came about when he asked a very critical group of psychedelic leaders how they felt about the article, and how it taught him just how powerful having these difficult conversations can be. 

He also discusses: 

• The importance of asking questions and not making assumptions
• Why we may need to abandon the "no justice, no peace" attitude if we ever want to move forward
• The idea that instead of endlessly battling the establishment, maybe it makes more sense to change our consumer mindset and allow capitalism to do its thing
• The importance of reaching out to local Indigenous tribes and allocating resources to go to them, not make them come to you
• The challenge of merging spirituality and science, especially for a regulatory model focused on profit

and more! For links, head to the show notes page. 

In this episode, Joe and Kyle interview Lenny Gibson, Ph.D.: philosopher, Grof-certified Holotropic Breathwork® facilitator, 20-year professor of transpersonal psychology at Burlington College, and the reason Joe and Kyle met many years ago.

He talks about his early LSD experiences and how his interest in the philosophy of Plato and Alfred North Whitehead provided a framework and language for understanding a new mystical world where time and space were abstractions. He believes that while culture sees the benefits of psychedelics in economic terms, the biggest takeaway from non-ordinary states is learning that value is the essence of everything. And as this is being released on Bicycle Day, he discusses Albert Hofmann’s discovery and whether or not it’s fair to say that Hofmann intentionally had the experience he did on that fateful day.

He also discusses:

• The end of Cartesian thinking and the need for a new understanding of reality that incorporates the insights of quantum mechanics
• How philosophy has been taught as an intellectual endeavor, and how we need to embrace the practical and conceptual side of life
• John Dewey and quantitative thinking, William James and pragmatism, and was Aristotle a Platonist?
• The novelty of the creation of LSD, and how it gave us a path to a mystical experience that wasn’t culturally bound

and more! For links, head to the show notes page. 

In this episode, Joe interviews Joey Lichter, Ph.D.: professor in the Chemistry & Biochemistry department at Miami’s Florida International University, and one of the few professors in the U.S. teaching a course about psychedelics at the collegiate level.

He talks about his path towards the course, the challenge of creating a curriculum that covers everything in a few months, and the importance of teaching young minds about psychedelics the right away; shifting drug education from the “Just say no!” D.A.R.E. model to a more balanced, honest, and evidence-based approach. He aims for his students to think critically, ignore the hype, and see all possible angles with a fairly simple approach: Present the full story.

He discusses:

• The importance of teaching history, from Stan Grof to MKUltra
• The work of David Nichols, David Nutt’s drug harm scale, and the greatest lesson William Leonard Pickard took from LSD
• The representation of Spravato as a new drug, and his concerns with the over-medicalization of psychedelics
• Teaching about the complexities of Timothy Leary: Was he a positive or negative force?
• Decriminalization, legalization, and how he gets students to think about drug policy

and more! For links and more, head to the show notes page. 

In this episode, Joe interviews Devon Phillips: community & partnerships officer for the Multidisciplinary Association for Psychedelic Studies (MAPS).

Phillips works on strategies to tackle the questions: How do we responsibly mainstream psychedelics? And how do we get culture engaged? He's focusing on being the bridge to psychedelics outside of research, facilitating workshops and psychedelic coming-out stories at music festivals and conferences. He talks about harm reduction and drug checking at festivals, the concept of training big names to become trustworthy resources, the differences found in a hop hop crowd compared to EDM, and the power in using psychedelics for pleasure and celebration – not just healing and growth. 

He also discusses: 

• MAPS' involvement with the NFL for their 'My Cause, My Cleats' campaign, and how the San Francisco 49ers' Jon Feliciano is bringing awareness to psychedelic healing
• Details about MAPS' first responders training, fiscal sponsorship program, international therapist education program, and upcoming membership program (launching in June)
• The success of MAPS' Psychedelic Science and his hopes for the 2025 edition, taking place June 16 - 20 at the Denver Convention Center
• Dr. Carl Hart, drug exceptionalism, and the importance of creating safe containers and inclusive drug policy 

and more! For links and more, head to the show notes page.

In this episode, Joe interviews Keeper Trout: archivist, author, photographer, co-founder of the Cactus Conservation Institute, and creator of Trout’s Notes, a website compiling personal research and collected data to help ethnobotanical researchers.

From an interest in cactus taxonomy, Sasha Shulgin urged Trout to go through his files, resulting in a friendship, and eventually, an 8-year project of digitizing all of these files into the ever-evolving Shulgin Archive.

Trout discusses:

• His relationship with Sasha and The Shulgin Farm project, which aims to make the farm a community resource for therapy, research, events, and more
• The messiness of cactus taxonomy, and how he believes we’re nearing the end of being able to properly identify cacti
• The perception of LSD as unnatural and why the natural vs. synthetic argument is largely political
• Why repealing the Controlled Substances Act is the path we should take over decriminalization or legalization

and more!

For links and more, head to the show notes page. 

In this episode, Alexa interviews April Pride: creative entrepreneur, veteran of the cannabis space, and now, founder of SetSet, an educational platform and podcast (picking up where The High Guide left off) for women curious about psychedelics.

With Alexa about to embark on the journey of motherhood, she asks many of the questions parents working with psychedelics have to consider: How do you overcome the stigmas of being a psychedelic parent? How do you talk to your children about drugs? How do you know if a substance is ok to use during pregnancy?

Pride discusses:

• Being dubbed “the weed mom” and why she embraced the nickname
• Parenting children around drug use and how parents lose credibility when they lie (the kids are going to know)
• The need for more research into how substances interact with women’s cycles and changing hormones
• Knowing when to trust your doctor and how more conversations lead to more knowledgeable doctors
• Microdosing psilocybin and the developing SetSet protocol

and more! For links and more, head to the show notes page. 

In this episode, Joe interviews Paul F. Daley, Ph.D., who worked with Sasha Shulgin in his lab for the last seven years of his life, helping him finish (and co-authoring) "The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds."

He is now the co-founder, Chief Science Officer, and Director of Analytical Science at the Alexander Shulgin Research Institute (ASRI), focusing on the discovery and development of novel psychedelic compounds. While Sasha was passionate about self-experimentation, the Institute is aiming for the next step for these drugs: FDA approval.  

He discusses: 

• Meeting Sasha at the 2nd international conference on hallucinogenic mushrooms in Washington D.C.
• Bonding with Sasha while reviewing the autopsy of researcher Robert van den Bosch for possible foul play
• The two compounds ASRI is closest to being able to test in clinical trials
• The 5-HT2B receptor, risk of valvular disease, and why we will likely be hearing more about this going forward
• How AI and new technology can lead to better safety science  

and more! Click here to head to the show notes page.

In this episode, David interviews Osiris González Romero: philosopher and Postdoctoral researcher on cognitive freedom and psychedelic humanities at the University of Saskatchewan.

Romero believes that our weakest point of research is our knowledge of Indigenous languages, and is focused on highlighting different cultural uses of psychedelics to better inform future drug policy. He’s currently studying more than 100 documents (including one over 400 years old) to establish an honest understanding of why peyote was ever banned.

He discusses:

• Mesoamerican psychedelics and their relevance to cognitive liberty and decolonization
• How the War on Drugs is our main colonial legacy
• The concepts of an ontological turn and ontological pluralism
• The neocolonial, biomedical, and spiritual paradoxes found inside the ‘psychedelic renaissance’
• How imagination is often viewed through a lens of illusion rather than problem solving or creativity

and more!

Click here to head to the show notes page. 

In this episode, Joe interviews Maria Mangini, Ph.D., FNP: researcher, educator, and midwife who has worked closely with many psychedelic innovators and was part of the original social network at Shulgin Farm – where this episode was recorded. She traces her journey from the influence of pioneers like the Wassons, Shulgins, and Grofs, and historic places like Esalen and Millbrook.

She discusses:

• Her early experiences with the Grofs at Esalen and how she met the Shulgins
• Gregory Bateson guiding her to become a midwife
• The similarities between midwifery and psychedelic facilitation
• The unsung work of Denis Berry in saving the Timothy Leary archives
• How the working relationship of the Shulgins is a perfect example of the coequality society should strive for

and more! Click here to head to the show notes page.

In this episode, released on Ann Shulgin’s birthday, Joe interviews Wendy Tucker: daughter of Ann and stepdaughter to Alexander “Sasha” Shulgin.

Recorded in Sasha’s old office, she recounts her formative years, giving an insider’s look into her Mother’s openness about psychedelics, working with Sasha in the lab, how the Shulgins made a perfect team, and watching a close-knit circle of self-experimenters start to form at Shulgin Farm – and keep coming back over the years.

She talks about the energy infused into the property from the decades of research and gatherings, and how she is trying to preserve it – not just to capture its history and the pioneering research that happened there, but as a beacon for future generations. She imagines weddings, conferences, other communal gatherings, and more. Imagine taking a chemistry course in Sasha Shulgin’s lab?

To learn more about the project and to donate, head to Shulginfarm.org.

Click here to head to the show notes page and watch the video.

In this episode, Joe interviews Juan Pablo Cappello: co-founder and former CEO of Nue Life Health, whose assets were subsequently acquired by Beckley Waves.

Cappello digs into his recent article which has been making waves across the psychedelic community: “Profit Over Patients? A Critical Look at At-Home Ketamine Therapy.” He created Nue Life with the goal of helping a million people address the root cause of their anxiety, and while the company was successful, he began to see a problematic trend: that using ketamine while providing services of a mental health company is very expensive and resource-consuming, and as companies saw a large percentage of clients requiring maintenance doses, the most profitable business model became essentially slinging ketamine to patients without providing any real integration or aftercare. Are these companies promising healing but really only guaranteeing recurring revenue?

He talks about:

• How this emerging model makes it harder for ethical practitioners to be able to provide their services
• The tools they built at Nue Life for long-term benefit, and why these should be the main focus – not repeated ketamine
• Matthew Perry’s death and how the media was quick to place the blame on ketamine
• The need for companies and communities to come to gather and create ethical industry standards for the at-home ketamine model
• How cannabis was almost decriminalized under the Carter administration

and more!

Click here to head to the show notes page. 

In this episode, David interviews Dr. 1Drea Pennington Wasio: integrative physician, psychedelic-assisted therapy facilitator and psilocybin retreat leader, international speaker, podcaster, and author of several books, including "Sacred Medicine: Exploring The Psychedelic Hero’s Journey."

She discusses her personal metamorphosis and name change inspired by a powerful ayahuasca experience, and how that moved her into a life more inspired by authenticity and self-love. She gives the details of her retreats, explains her PRISM sessions, and talks in depth about the magic of resiliency: How can we not just return to baseline, but experience post-traumatic growth?

She talks about:

• The power of tuning into creativity in times of depression
• The efficacy of narrative therapy and writing in general
• The universal themes of ‘The Hero’s Journey’ and how much agency matters
• The importance of embracing nonfiction, and her upcoming book series, "The Dreamweaver’s Legacy"
• The potential of microdosing psilocybin for menopause and more!

Her new course on trauma-informed psychedelic therapy begins this month, and her next retreat begins May 10. Head to 1drea.com for details. Click here to head to the show notes page. 

In this episode, David interviews Itzhak Beery: author, shamanic teacher, speaker, trip leader, and founder of ShamanPortal.org, an online community and resource for people who want to learn, practice, and teach shamanic traditions.

Beery shares his transformational journey, starting from his upbringing on a kibbutz in Israel, to his disillusioned advertising days in Manhattan, to the life-altering sweat lodge experience in Hawaii that eventually led him to write the book, Shamanic Transformations: True Stories of the Moment of Awakening, and realize his true purpose. He discusses the two major sides of trust: how to know when a healing path has truly become your life purpose, and how to know who to trust as a good healer in a world of self-initiated shamans.

He and David dig into:

• How we all have the innate ability to be a shaman
• How Westerners are often seeking healing too young, before they have the capacity to truly understand lessons they may receive
• His upcoming book which attempts to teach practitioners how to create narratives out of symbols, The Language of Spirit
• The importance in not denying the experiencer’s truth

and more!

Click here to head to the show notes page.

In this episode, Johanna interviews Laura Reeves: Glastonbury-based facilitator and medicine woman trained in craniosacral therapy, somatic experiencing, breathwork, and more, who holds retreats at sacred sites in the U.K. and Peruvian Amazon.

She tells of her journey from serendipitously booking a trip to Ecuador just as she first heard about ayahuasca, to the early ayahuasca experiences that showed her our true interconnectedness, to a heroic dose of psilocybin and a trip to the hospital, to being accepted into training with an Indigenous shaman in the Amazon. With a lifelong love of nature, paganism, and ancient traditions, she stresses the importance of connecting to the natural rhythms of the Earth and harnessing its energy.

She talks about:

• Self-initiated shamans and the dangers that can come from bad actors operating out of integrity and respect for the lineage
• Ayahuasca as a purgative and the power of energetic clearings
• Her experience with shamans using Icaros to channel the sounds of plants
• Shadow work and its role in personal growth and healing
• The energy of Glastonbury, feeling deep connections to sacred places, and how ley lines inspire places of pilgrimage and more!

Click here to head to the show notes page. 

In this episode, Joe and guest co-host Erica Rex interview Elizabeth Anglin: spirit medium, animal communicator, intuitive healer, alien abductee, and author of Experience: Memoirs of an Abducted Childhood.

She talks about her early abduction experiences, the time when she and her father realized they were both being abducted at the same time (from different locations), and the horrifying experience of six beings entering her apartment and realizing she knew one of them. These experiences led her to Budd Hopkins, and eventually John Mack (who did regression work with her) and the John E. Mack Institute, where she became a peer mentor for abductees. She talks about the validity of alien abductions, the concept of spiritual ecology, and the importance of listening to people: There’s so much we don’t know, so is it fair to label experiencers as schizophrenic just because we can’t replicate the experience?

She discusses:

• The commonality of people from the same family being abducted and why some people are lifetime abductees while others are only taken once
• The differences in abductions and how some seem to only be mental while others are physical and extremely painful
• The story of Linda Napolitano and the famous Brooklyn Bridge abduction
• Regressive hypnotherapy work: Are the memories you’re recovering accurate?
• Quantum biology, the Penrose-Hameroff quantum theory of consciousness, parallel realities, time travel, and quantum jumping and so much more! As the X-Files made famous: The truth is out there. And this episode is definitely pretty out there! Click here to head to the show notes page.

In this episode, Christopher Koddermann interviews Dr. Sam Banister: co-founder and chief scientific officer of Psylo, an Australian biotech company developing next-generation psychedelics.

Banister discusses how he got involved in drug development, how Psylo came about, and the hallucinogenic and non-hallucinogenic 5-HT2A agonists Psylo is working on. He talks about the compromise between immediate need and ambition, and the ethical considerations and possibilities behind developing non-hallucinogenic compounds: What can we take from the psychedelic experience for people who aren’t ideal candidates for one? Is the psychedelic experience truly necessary? And for what indications will these new Gen 3 compounds be most useful?

He discusses:

• What we can infer about the volatility of biotech and the state of the psychedelic industry based on recent mergers and acquisitions
• The long-term challenges of drug development and the scalability of treatment options
• How the initial success of Spravato has played a role in allaying fears around new compounds
• Head twitch response and concerns it’s not as accurate of a metric as we’ve believed
• Australia’s decision to down-schedule psilocybin and MDMA, and the speed of implementation and licensing: How long will it be before people have easy access?
• What he sees for the future and why we need to be careful with language around expectations

and more! Click here to head to teh show notes page. 

In this episode, Joe interviews Dr. Robin Carhart-Harris: founder and head of the Centre for Psychedelic Research at Imperial College London, founding director of the Neuroscape Psychedelics Division at University of California, San Francisco (UCSF), and founder of the Carhart-Harris Lab.

A legendary researcher, he talks about his psychedelic origins: studying Freud, Jung, and eventually Stan Grof and depth psychology to try and better understand the unconscious. He discusses the growth of psychedelics and the cultural shifts he’s noticed (especially in the U.S.), as well as what he’s working on today: researching the influence of psychedelics on set and setting by studying experiences in both enriched and unenriched environments.

He also talks about:

• Plasticity: how he defines it, how it relates to critical reopening periods, and how it’s a fundamental thing that transcends the metrics we use to measure it
• Early LSD studies, the nervousness surrounding he and David Nutt dosing Ben Sessa, and the youthful energy that kept them going
• How plasticity could be exploited to help relieve chronic pain
• The potential of psychedelics to help with fibromyalgia and anorexia
• How psychedelic-assisted therapy brought care back to health care

and more!

UCSF is seeking survey volunteers, so if you’ve had more than three experiences with ketamine, MDMA, and psilocybin (must have experiences with all three) and want to contribute, do so here. Click here to head to the show notes page. 

In this episode, Joe interviews Alyssa Gursky, LPC: artist, research associate and study therapist at the Social Neuroscience and Psychotherapy (SNaP) lab, and founder of Psychedelic Art Therapy LLC, which pioneers ketamine-assisted art therapy.

She talks about her first mushroom experience and how her art and creative process instantly felt different – how the judgment and concern about where the art was going disappeared and was replaced by a freedom; a return to a more childlike way of being, where all that mattered was the fun of the creative process, and expressing her inner world in art. They realized how much the creative process related to true embodiment and the ability to be fully present, and how healing it can be to simply be with other people and create art. 

She talks about:

• The power of being seen in a group, and how the bravery of one person can completely shift the group dynamic
• The need for mentorship in the psychedelic space
• The comfort and freedom found in affinity groups
• The inspiring lives of Genesis P-Orridge and avant-garde filmmaker, Alejandro Jodorowsky
• Rick Rubin’s ability to treat creativity as a spiritual act
• and how attending a live wrestling event aligns with non-ordinary states.

Gursky is launching a virtual education and support group this March for anyone who wants to integrate art into client work or their own process. Visit her instagram for details. Click here to head to the show notes page. 

In this episode, Joe interviews Matthew ‘Whiz’ Buckley: former decorated US Navy F/A-18 Hornet fighter pilot and now, founder and CEO of No Fallen Heroes Foundation, a non-profit focused on healing veterans and first responders with psychedelic-assisted therapy.

Buckley met Joe in D.C. while they were both campaigning for psychedelic therapy to any lawmaker they could speak with. He talks about how the government is spending a fortune on the military, but not paying the total cost, since so much of that is externalized onto the soldiers themselves. He points out how many of them care more about making money than saving lives, and how we need “We the people” moments to wake them up or remove them from office.

He discusses:

• His time in the Navy and his transition back to civilian life, coming to terms with trauma and realizing how much was physical (including tinnitus)
• His life-changing experiences under ibogaine and 5-MeO-DMT with the Mission Within
• How we should be teaching veterans about various mental health options (including psychedelic-assisted therapy) as part of their transition process
• The signing of the National Defense Authorization Act and the disappointing amount of money reserved for psychedelic research: Was it all just lip service?
• The complications that arise when trying to get benefits from the VA while also trying to move on: When honesty about mental health isn’t incentivized, when do you tell the truth?
• His experience operating legally in Colorado and how he plans to stay on top of Governor Desantis to bring psychedelics to Florida

and more! Click here to head to the show notes page. 

In this episode, David interviews Saga Briggs: freelance journalist and author of "How to Change Your Body: The Science of Interoception and Healing Through Connection to Yourself and Others."

A collection of interviews, peer-reviewed research, and personal story; the book dives deep into the mind-body connection, how to become more embodied, and our need for social connection – which factors into mental and physical health far more than most of us realize. The nod to Michael Pollan’s book is also a challenge: Have we been focusing too much on our minds and now it’s time to pay more attention to our bodies? How much of the benefit of psychedelic experiences is related to truly experiencing our bodies?

She discusses:

• How neuroscience is starting to look more at brain-body interactions, and the psychedelic space’s growing interest in somatics
• The minimal and narrative selves: Do psychedelics make the minimal self traverse over the narrative self?
• Flexible switching and applying interoception to a social context
• Her concept of a ‘possibility space’ and new ways of perceiving
• The benefit of adding embodiment practices to psychedelic assisted therapy – especially during preparation and integration

and more! Click here to head to the show notes page. 

In this episode, Joe interviews Steve Rio: psychedelic guide, performance and transformation coach, musician, and co-founder of Enfold, a retreat center in BC, Canada.

While Enfold caters each experience to each client, they largely work with 5-MeO-DMT (which is unregulated in Canada); partly because of its power, and partly because Rio realized how much was missing in terms of safety and process when using the substance. They are trying to fill in the gaps, working with the University Health Network Centre for Mental Health to analyze measurements of mindfulness, DAS tests, the Brief Inventory of Thriving survey, and language used when describing experiences to collect as much qualitative data as possible. He discusses their screening process, why they work with synthetic 5-MeO-DMT, why they encourage everyone to go to a group session, and how 5-MeO seems to bypass psychological processes and largely be related to somatic release.

He talks about:

• The power of 5-MeO and being humble and honest with yourself: Are you stable enough to handle the dysregulation?
• 5-MeO bad actors and 'Drive-by 5' people who show up, do the drug, and leave
• The plight of Sonoran Dessert toads and the need for more data around their declining populations
• How 5-MeO seems to connect people with a higher power, and the need for the experiencer to find their own context for it
• The importance of creating a clean and open container for spirituality and meeting the client where they are

and more!

Click here to head to the show notes page.

In this episode, Joe interviews Ayize Jama-Everett: author, educator, filmmaker, and therapist with a long history of work in substance use and mental health services.

When Jama-Everett was last on the show, “A Table of Our Own” – a film focusing on healing, psychedelics, and bonds within the Black community – was still in its infancy. It’s now complete, and he and others behind the film are touring with it, with showings coming up in Detroit, LA, and Boston. A free follow-up discussion hosted by CIIS’ Center for Psychedelic Therapies and Research is happening Feb. 15, and, from February 15-16 only, the film is available to rent online.

He gives his full origin story: growing up around substance use, how he got into therapy and healing people through journeys, how “A Table of Our Own” came about, and how it was influenced by mushrooms. Then he discusses a lot more, with a much-needed critical eye:

• His experiences with some notorious bad actors in the facilitation space
• Decriminalization and how we celebrate small wins while ignoring steps back
• Drug exceptionalism, the Drug War, and the demonization of crack
• Power dynamics and the dangerous concept of letting go
• Why the Black community is so skeptical of psychedelics

And he talks about why it’s so important to meet people where they are – that what works for one person or one community won’t necessarily work for another, and the above-ground, corporatized, overly medicalized model will never work for everyone. Click here to head to the show notes page. 

In this episode, Joe interviews Dr. Peter Grinspoon: primary care physician and cannabis specialist at Massachusetts General Hospital, TedX speaker, certified physician life coach, and author of the new book, Seeing Through the Smoke: A Cannabis Expert Untangles the Truth about Marijuana.

He tells his story of growing up in a house where academics like John Mack and Carl Sagan regularly smoked cannabis, and being inspired by the groundbreaking books of his father, Lester Grinspoon. An outspoken advocate for drug policy reform and embracing different, non-AA paths to recovery, he talks about how he got there: his opiate addiction, fall from medicine, subsequent return, and learning just how deep the stigma against drugs goes, and how much the medical establishment is another arm of the Drug War. Seeing Through the Smoke aims to tell the truth about cannabis, especially on benefits and real and debunked harms. How can we get more physicians and lawmakers on our side if all they know is propaganda?

He discusses:

-The challenge in speaking honestly with physicians about drug use -Why physicians are in support of researching psychedelics but not cannabis -Stigmatized language and Drug War vibes in medical software -The truth about cannabis, schizophrenia, and the risk of drug-induced psychosis -Portugal and the ‘Rat Park’ model -The importance of listening to what patients are saying – especially when we don’t have enough good data

and more! Click here to head to the show notes page.

In this episode, Joe interviews Dr. Kate Pate: Ph.D. neurophysiologist; Founder and CEO of Coruna Medical; founding board member of the Psychedelic Medicine Association; and Founder of The Way Back, a company that will provide education and coaching services related to military, veteran, and first responder health – often in wilderness settings.

She talks about her introduction to psychedelics through the Heroic Hearts Project, where she later served as an integration coach and director of research, looking at psilocybin for traumatic brain injury symptoms, and how the gut microbiome changes after ingesting ayahuasca. She points out that gut health hasn’t been a focus of research, but it’s now emerging as a key indicator of physical and mental health. So, how do psychedelics, particularly plant-based ones, come into play? Are the long term shifts after an experience related to a change in the bacteria inside of us?

She breaks down what a microbiome is and how it changes based on diet; how inflammation is created and the inflammatory cascade that happens after a head injury; how toxins create a stress response similar to an allergic reaction; the frustrations of vets and the limited resources of the VA; the commonality of substance and alcohol use disorders in people coming home from service; the many nonprofits she’s worked with; and how important it is to increase science funding from the government. Click here to head to the show notes page. 

In this episode, Joe speaks with Paul F. Austin: Founder & CEO of Third Wave, Founder of Psychedelic Coaching Institute, and host of Third Wave's The Psychedelic Podcast.

Recorded in-person at this year's reMind conference, this episode – a shared release with Third Wave – is a rare glimpse into the inner workings of both Psychedelics Today and Third Wave, with Joe and Paul reconnecting after early podcast appearances and interviewing each other about where they've come from and where they're going now that they're so many years into this. Paul breaks down Third Wave's history and new coaching training program, and Joe discusses Vital: Why he invested in Vital over an investment raise, what we've learned from the first two cohorts, how we've handled scholarships, and why sometimes losing money can be worth it if it's for the greater good.

They talk about the challenge of keeping the lights on while trying to create something new; the balance of running a media company while building out an educational platform; the importance of staying focused and ignoring the noise; the relationship-building they've seen from their students; why we need to welcome the corporate types we may be inclined to dismiss; and why seeding good actors in as many roles and communities as possible is vital to the growth of psychedelics.  Click here to head to the show notes page. 

In this episode, Joe interviews Ryan Latreille: Founder of Hearthstone Collective, which sells functional mushrooms and low-dose kanna designed for microdosing; and Kanna Extract Co., which is focused on offering high-potency kanna extracts more for ceremonial and recreational use.

He talks about how he found his way to kanna; his first psychedelic experience (kanna mixed with MDMA); how he worked with a Koi tribal leader to find high-alkaloid kanna; how they created the strain they use; and why so many people are interested in kanna and more people should try it, as he believes it’s not only a natural alternative to other substances and alcohol, but also a great entry point for people looking to experiment with microdosing.

If you want to learn a lot about kanna, this is the episode for you, as it is all discussed: How dosing should be done depending on what you’re looking for; whether or not it’s fair to say kanna is ‘MDMA-lite’; Indigenous history of usage; drug interactions and safety; the journey from seed to harvest; a breakdown of different grades of kanna; how the ratio of different alkaloids creates different experiences; and what could be possible by combining different alkaloids, different strains, and by pairing with different substances.

Click here to head to the show notes page. 

In this episode, Kyle interviews Emma Knighton: Somatic trauma therapist, Vital instructor, and psychedelic integration therapist focusing on consciousness exploration, complex PTSD from childhood abuse, and queer identity development.

This episode is a bit of a masterclass on consent and boundaries within the client/practitioner relationship. She discusses power dynamics: how conflicts arise due to the breaking of established boundaries; safety, and embracing the idea of creating a container that is ‘safe enough’ to go into places that feel unsafe; and the importance of maintaining agreed-upon boundaries no matter how much the client may want to break them. They discuss ways to fulfill the need for touch when touch was not agreed upon, and the concept of practicing touch interactions before the experience – that playing out possible scenarios will create a somatic map so bodies remember what it feels like to be near each other while one body is deep in an experience.

And she talks about much more: What she’s learned from the kink and sex work community and their similarities with the psychedelic world; ways to handle consent in group settings; the clash between giving people agency but needing to step in and protect them; restorative justice models and how they could be used in a much-needed psychedelic practitioner accountability system; the need for practitioners to continue doing their own work; and how part of true consent is being honest about one’s own limitations or conflicts as a practitioner. Click here to head to the show notes page. 

In this episode, Joe interviews Erik Vaughan: Co-Founder and Manager of Epiphany mushrooms, a mushroom and mental health company based in Akron, Ohio.

Epiphany mushrooms will initially be selling Lion's Mane, Reishi, and Cordyceps, and they plan to expand into more functional mushrooms while also pursuing a license to operate healing centers in Colorado. Vaughan was involved in changing Colorado's psilocybin legislation after lobbying to add a section that allows product testing labs to register and charge for their services – while voluntary and complementary to required testing, it allows growers to have an unlimited amount of product for testing purposes; adds an extra step in keeping the grower and lab in compliance with state law; and, as more states work on their own legislation, highlights the need for potency testing to let customers know exactly what they're ingesting. 

He discusses changing attitudes and how Michigan can lead the way for the midwest; why he's excited about Colorado and what they got right; the enthusiasm of the mycology crowd; Rick Perry's speech at Psychedelic Science 2023; the iron law of prohibition and mushroom products sold in Ohio; and the incredible inefficiency of the drug war (when viewed like it was not designed to do exactly what it's doing). Click here to head to the show notes page.

In this episode, Joe interviews Christine Calvert: Licensed Chemical Dependency Counselor and certified Holotropic Breathwork® facilitator.

She talks about how addiction led her to breathwork, how breathwork has helped her over the years, how breathwork can be a compliment to other self-work, and how becoming comfortable with breathwork first could be a very important stepping stone towards better understanding the psychedelic experience. She talks about how years of breathwork helped her navigate complicated states of consciousness, and the incredible benefit of learning to trust our body's capacity to heal itself. 

She discusses using bodywork in sessions and the importance of having the experiencer be the one who requests it; how much a facilitator's past relationship with touch affects how they use touch; the risk in meditation vs. the safety of breathwork; the concept of learning self-awareness; how profound it is to be witnessed in breathwork's dyad model; and why researching and creating guidelines for this kind of work seems impossible. Click here to head to the show notes page. 

In this episode, recorded in-person at the recent reMind conference, Joe interviews Kaci Hohmann and Dave Kopilak: business attorneys at Emerge Law Group and co-chairs of Emerge’s psychedelics practice group. Hohmann also serves as Chair of the Oregon State Bar’s Cannabis and Psychedelics Law Section.

They were both drafters of Oregon Measure 109 (with Kopilak as the primary drafter), so this episode goes deep into the details, legalities, and possibilities behind Measure 109. What licenses are involved? What does a business heading to Oregon need to prepare for? What do they think the feds will do and how does that relate to cannabis’ Cole Memorandum? What is tax code 280E and how can its effects be minimized? What do they see the future looking like?

They discuss what they do for clients at Emerge Law Group; the differences between the cannabis and psychedelics industries; why service centers are likely more important than the products; and how the psilocybin service center experience is more like a relationship with clients than anything in the cannabis world, which makes everything much more complicated – but also much safer.

Joe also highlights some recent news, including MAPS PBC rebranding to Lykos Therapeutics, symptoms from traumatic brain injuries being improved by the combination of ibogaine and magnesium, and more! Click here to head to the show notes page. 

In this episode, Joe interviews Mike Margolies: community catalyst; conversation creator; Founder of Psychedelic Seminars; and Co-Founder and Co-Steward of the Global Psychedelic Society.

The Global Psychedelic Society was created for all of the different psychedelic societies that have sprung up over the world to connect, share resources and information with each other, and be housed in a central hub so people can find them more easily. He talks about Frederic Laloux’s book, "Reinventing Organizations," and modeling the GPS around the “Teal” concept of organization, where employees are encouraged to show up as their true, honest, and most powerful selves; where it’s more about relationships than hierarchy; and more about embracing a mycelial – and psychedelic – way of thinking and interacting with each other. He breaks down how this way of thinking has progressed from the earliest ways of organizing, and discusses its three main principles of self-governance, wholeness, and evolutionary purpose.

He then talks about the Boom Festival: its “Liminal Village,” its inventive Kosmicare harm reduction program, and how drugs are not as decriminalized as people think in Portugal; and Burning Man: how it all came together for him this year when he didn’t even want to go, his experiences with the rain and a friend’s dreams warning of floods, what he learned from the ghost of a lost friend, and how that resulted in the concept of Batman doing a striptease to Seal’s “Kiss From a Rose.” Is the Joker simply a manifestation of Batman’s shadow material and his desire to be a hero? Yea, this one gets weird… Click here to head to the show notes page. 

In this episode of Vital Psychedelic Conversations, David interviews Christine Caldwell: graduate of the first cohort of Vital and Founder of End of Life Psychedelic Care (EOLPC); and Mary Telliano: end-of-life coach, psychedelic facilitator, and Founder of The Anam Cara Academy, which trains people in the art of end-of-life coaching.

Whether we’re comfortable with it or not, we’re all going to die. And research shows that psychedelic experiences can help tremendously with the anxiety and depression that surround that inevitable transition between realms. Caldwell and Telliano discuss the role of a death doula; how they found their way into end-of-life care; why the West’s relationship with death changed during the Civil War; the role of families in the process; the legality of providing end-of-life psychedelics and the complications that arise when people are unable to leave their homes; and how different substances can be used based on each person’s abilities and comfort level. 

They talk about why the mystical experience of psychedelics can be so helpful during this process (and how the placebo effect can be a very real factor); tell a few stories of amazing things they’ve witnessed while doing this work; and drive the point home of how important it is for us to reintegrate death as a natural part of life – to have rites of passage around death, to learn from death, and, much like we need to remember our inner healing capacity, realize that we all have the capacity to play the role of a death doula for someone else. Click here to head to the show notes page.  Click here to apply to Vital! Applications close on January 14. 

In this episode, we toast to the beginning of an exciting and hopefully groundbreaking 2024 by switching things up a bit. Christopher Koddermann, Co-Founder and Chair of Board of the International Therapeutic Psilocybin Rescheduling Initiative (ITPRI) will be conducting some interviews for PT, and in this episode, he does his first – with our Co-Founders, Joe Moore and Kyle Buller.

Kyle tells the story of his fateful New Years Eve snowboarding trip that resulted in a near death experience and a complete change in his life’s trajectory, and Joe discusses his more academic roots and how he and Kyle were united through their shared passion for the work of Stan Grof, holotropic breathwork, and transpersonal psychology. Psychedelics Today was created largely with no aims other than to promote transpersonal psychology and archive the best insights from their mentors, but has obviously turned into so much more, mostly from the simple goal of trying to spread the word through interesting conversations.

They talk about the growth of PT; how they got involved in education; the harms of the drug war; why decriminalization isn’t enough; where they see ‘the psychedelic renaissance’ going; what has surprised them the most in the last few years; and what we’re most proud of: Vital – how it came to be created, what’s involved, the benefits of the retreats, the self-discovery they’ve witnessed, and what they’ve learned through two successful cohorts.

The next edition of Vital begins on January 23, and we’ve extended applications until January 14, so if you’ve been curious if Vital is the answer you’ve been looking for, now is the time to act! Click here to head to the show notes page.

In this episode, Kyle interviews Kayse Gehret, the Founder of Microdosing for Healing, an international virtual community and coaching program supporting microdosing practice.

She tells the story of embracing microdosing and her grand mal seizure disorder going away, and how the inability to touch people during the pandemic led to the creation of Microdosing for Healing. She breaks down the details of the program, challenges she's seen, and the importance of using every effective modality possible to align with each person's individual experience. The next 6-Week Immersion Group course begins January 26.

She talks about how accessing the body is usually the best entry point to healing; how effective journaling and other personal development practices are to recognize change (especially with how subtle microdosing can be); the efficacy of group process; how physicians are beginning to see the power in community and connection; concerns over the "jump in the deep end" attitude of many people leading to destabilizing experiences; how regular check-ins are important to keep people connected to their original intention; and the idea that people are striving for an unattainable state of perfection - that our goal should be a constant state of improvement and aligning ourselves to who we are meant to be - and microdosing until we don't need to microdose anymore.

Click here to head to the show notes page. 

In this episode, Joe interviews Mike Finoia: standup comedian, Producer for the hit show, “Impractical Jokers,” and co-host of the Comes a Time Podcast with Dead & Company bassist, Oteil Burbridge. His new Special, “Don’t Let Me Down,” is out now.

He talks about his early days of recreational drug use at jam band shows; a powerful psilocybin experience; passing out before his first ketamine experience and how his commitment has made subsequent experiences much smoother; and how his continued work has allowed him to focus on what’s truly important. He’s seen positive results from talking about his ketamine-assisted psychotherapy experiences on stage, and he’s working on new material that will be much more focused on not just psychedelics, but the therapy, self-work, and growth he’s gone through in his journey.

He also discusses the influence of other comedians; the bioavailability in different ketamine methods; how psychedelics are like a performance-enhancing drug; the importance of having a working, attainable idea of success and not getting caught up in other people’s lives; the benefit of asking people in the audience to raise their hands if they’ve done psychedelics; and the importance of recognizing that psychedelics are absolutely not for everyone – at least if they’re not ready. Click here to head to the show notes page. 

In this episode, Joe and Kyle are honored to welcome back Stanislav and Brigitte Grof: Stan being the person who kickstarted their interest in non-ordinary states of consciousness, breathwork, and this podcast; and Brigitte: his other half, co-creator of Grof® Legacy Training, and support system (and often, voice) since his stroke a few years back.

They discuss the recently released Stanislav Grof, LSD Pioneer: From Pharmacology to Archetypes, which Brigitte assembled in honor of Stan’s 90th birthday. It celebrates his life’s work in pioneering research into non-ordinary states of consciousness and transpersonal psychology, and features an extended interview with Stan; testimonials from a number of legends in the psychedelic and psychological fields like Jack Kornfield, Rupert Sheldrake, Richard Tarnas, and Fritjof Capra; and a large photo album of rarely seen pictures, including Stan doing his first experiments with LSD.

And they talk about so much more: The evolution of LSD psychotherapy as Stan realized people’s experiences were coming from the psyche rather than any pharmacology; why he started practicing and teaching breathwork; Stan’s love of treasure hunts; how the perinatal matrices were born and how each corresponds to astrology and religious archetypes; why experience in breathwork can be so beneficial to better psychedelic experiences and facilitation; why integration is equally as important as the experience; and an argument to take archetypal astrology more seriously – that there is often a synchronicity that can’t be denied between these archetypes, events, and experiences. Click here to head to the show notes page. 

In this episode of Vital Psychedelic Conversations, Johanna interviews Angie Leek, LMFT/LPC-S, SEP: Vital instructor, Founder of the Holos Foundation for Transpersonal Healing, and psychotherapist offering KAP through her private practice, Holos Counseling; and Justin LaPree: Vital graduate, decorated Marine, former firefighter, and Founder and President of Heroic Path to Light; a retreat center in Austin, Texas offering psychedelic-assisted therapy and community to veterans, first responders, and Gold/White Star families.

LaPree shares his personal journey of struggling to reintegrate into life after war and the daily traumas he lived as a firefighter leading to an eventual suicide attempt, and the healing he found when he rediscovered the community and purpose he had been longing for. And Leek tells her story of her spiritual emergency and the nonlinear path she found for coming to terms with her repressed trauma, further illustrating a common theme we see in this space of the wounded healer, and the challenge of taking care of yourself first in order to be able to heal others.

They discuss the importance of specialized communities for trauma healing; the need for a support system and the power of sharing experiences with others; how they both work with their clients, the idea of viewing preparation as “pre-integration”; why families and friends also need to be prepared; and how, if you feel like something needs to change or you’re in need of a community, maybe it all begins with you.

They also talk about how much they loved Vital and the impact it’s had on their life paths. The deadline for applications for the 2024 cohort of Vital is tomorrow, December 20, at midnight, so if you’re ready to take the leap, head to vitalpsychedelictraining.com to apply now! Click here to head to the show notes page. 

In this episode, Joe interviews Mason Marks, MD, JD: drug policy analyst, writer, Professor at the Florida State University College of Law, and senior fellow and project lead of the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics.

As somewhat of an expert on drug policy and FDA regulation, Marks discusses much of the current legal landscape: What was controversial and most interesting about the FDA’s recent guidance for researchers running clinical trials; how an amendment changed Colorado’s Natural Medicine Act and the odd vibe coming from the rule-making process (very private with canceled meetings and a notable lack of urgency); concerns over Oregon’s confusing program not being sustainable; and how Senate Bill 303 drastically changed confidentiality and how personal data would be collected in the state. 

He also discusses the complications and ethics of end-of-life care and psychedelics; the theoretical heart valve risk from chronic use and ways we could research this; the challenge of informed consent; the legal risk of transactions involving people gifting illegal substances; the Gracias Foundation’s recent $16 million grant to Harvard and how people at Harvard feel about psychedelics; and more. 

POPLAR, which was founded to essentially change laws around psychedelics, is hosting a conference on February 16 in Manhattan called “Drug Law for the 21st Century,” which will be looking back on 50 years of DEA drug policy and envisioning what could be different going forward.

Click here to head to the show notes page. 

In this episode, Joe interviews Flor Bollini. Named “The Corporate Shaman” by Forbes Magazine, she is an entrepreneur, medicine woman, and the Founder and CEO of NANA Health.

NANA Health is a platform that provides best practices, educational content, and peer to peer support around a framework that is fully personalized, using what they call “psychedelic-initiated transformative medicine.” Inspired by feminine energy, African tradition, and Ayurveda, their concept is that if you can’t afford a luxurious retreat, what can you do at home? What are the lifetime practices and biohacking techniques that can enable your self-healing capabilities to take over, with or without any psychedelics? Is your trajectory reversible?

She talks about accepting her healing destiny and what she learned from several ayahuasca experiences across different countries; contrast therapy and the use of sweat lodges throughout history; how so many of our struggles come from repressing sexual energy; why 5-MeO-DMT is the best tool to treat the most complex issues; the concept of using 5-MeO as a Eucharist in church; why we need to connect with the divine; and why we need more spirit in Western medicine.

Click here to head to the show notes page.

In this episode of Vital Psychedelic Conversations, Johanna interviews Daan Keiman, MA: Buddhist, Psychedelic Chaplain, and Co-Founder of the psychedelic think-and-practice tank, Communitas Collective Foundation; Aura Ahuvia: Rabbi who served five years as President of the ALEPH (Alliance for Jewish Renewal) Board and is now the Founder of Psychedelic Rabbi; and Josh Harper: Consciousness Medicine Guide who works with Ligare, a Christian Psychedelic Society.

They dig deep into the intersection of psychedelics and spirituality, focusing largely on the concept of psychedelic chaplaincy: how they each define it and how spiritual caregivers are uniquely positioned to be of service to those coming out of powerful and unexplainable mystical experiences (whether they be psychedelic or not). They discuss why being grounded in a spiritual tradition is important, but how it’s often more important to be open to mystery and exploring that which is complex and difficult, even if that means someone questioning if their religion is truly right for them anymore.

Each tell their stories of struggling with and eventually embracing their religion and how psychedelics and spirituality became part of their lives, and discuss much more: Psychedelics in religious history and the slow embrace of mysticism in today’s renaissance; the importance of truly listening to individuals’ experiences and not dismissing life-changing experiences as ‘drug-induced’; how practice (no matter what kind) is a huge benefit of religion; and the need to eventually de-center psychedelics from the narrative – that the shared experience of coming together in community and asking big questions is where the healing truly lies.  Click here to head to the show notes page. 

In this episode, Kyle interviews John H. Buchanan, Ph.D.: certified Holotropic Breathwork practitioner; contributing co-editor for Rethinking Consciousness: Extraordinary Challenges for Contemporary Science; and author of the new book, Processing Reality: Finding Meaning in Death, Psychedelics, and Sobriety.

Recorded shortly after a week-long philosophy and breathwork conference which they both attended, they mostly dig into the challenging philosophical concepts of Alfred North Whitehead: how everything is made up of a feeling; how everything is relational and we all feel each other’s experiences; how Whitehead defined occasions and how moments of experience are accessing the totality of the past; and how neurology and the mind-brain interaction impacts human experience. This analysis leads to a lot of questions: Is the past constantly present, in that it is an active influencer on all our actions? When we relive a past event, where does that live in our minds vs. bodies? Are we tapping into a universal storehouse of past events, or are we tapping into past lives (or into others past lives)? When we sense that someone is looking at us, what is that?

He also discusses his realization that the experiential element of non-ordinary states of consciousness was the most important; his entry point into breathwork; why breathwork creates a perfect atmosphere for conversation; reincarnation and the idea of being reincarnated into other dimensions; the concept of objective immortality and how ripple effects from a single moment continue onward; and the fallacy of misplaced concreteness and psychoid experiences: Are they real beyond our psyche?

Click here to head to the show notes page. 

In this episode, David interviews Shauheen Etminan, Ph.D. and Jonathan Lu: Co-Founders of Magi Ancestral Supplements.

Through studying ancient Zoroastrian writings and 2,000 year-old Chinese texts in search of compounds and formulations forgotten by history, Etminan and Lu co-founded drug discovery company VCENNA in 2019 to use extraction technology to isolate these compounds. This led to an understanding of the health properties behind beta-carbolines, which led to their nootropic company, Magi Ancestral Supplements. They talk about the early days and experimenting on themselves, how beta-carbolines create dream-like states, and how their research sent each of them further into their own heritage, and asking themselves: How do we remember what our ancestors knew? 

They discuss espand, haoma, Syrian rue, and how common Syrian rue is in both Iranian culture and psychedelic history; what is a drug vs. what is a supplement; common threads they’ve seen across different cultures and how we may be repeating some of their mistakes; Etminan’s recent ayahuasca experience with the Santo Daime church; and of course, some of Magi Ancestral Supplements’ products and their expected effects – from deep meditation to lucid dreaming to even mild hallucinations. You can get 10% off any product using code PT10 here.

Click here to head to the show notes page.

In this episode, Kyle interviews Bessel van der Kolk, MD: pioneer clinician, researcher, and educator on traumatic stress; Founder of the Trauma Research Foundation; Professor of Psychiatry at Boston University Medical School; Principal Investigator of the Boston site of MAPS’ MDMA-assisted psychotherapy study; and author of the #1 New York Times Science best seller, The Body Keeps the Score: Brain, Mind, and Body in the Treatment of Trauma.

As of this recording, van der Kolk was publishing his last paper and closing down his laboratory, so he looks back on his past: being part of the group who put together the first PTSD diagnosis in the 80s; the early days of psychedelic research and how he discouraged Rick Doblin and Michael Mithoefer from pursuing MDMA research; how the DSM has no scientific validity and was never meant for the diagnosing it’s being used for; how science wasn’t seeing the whole picture and pushing us mindlessly from medication to medication; and how trauma research has evolved over the years as society learned more about how the mind actually works. 

He discusses the struggle to validate “softer” sciences; the impracticality and price of the MAPS protocol and the need for more group and sitter/experiencer frameworks; the efficacy of psychodrama and how that plays out in group sessions; his interest in using the Rorschach test more; how rolfing helped him; the problem with diagnosis and people becoming their illnesses; bodywork, somatic literacy, and how disconnected most people are from their bodies; and how, in all the healing frameworks he’s explored, he has never seen anything work as profoundly as psychedelic-assisted therapy. Click here to head to the show notes page. 

In this episode, Joe interviews Dana Lerman, MD: a decade-long infectious disease consultant who has since been trained in psychedelic-assisted therapy, ecotherapy, and Internal Family Systems, and is the Co-Founder of Skylight Psychedelics, where she prescribes IM ketamine and trains therapists who work with it.

Lerman tells her story: how working with kids with cancer made her want to learn medicine, what it was like working as an infectious disease expert during COVID, and how fascinating it has been to start with modern medicine and then fully embrace the traditional frameworks of ayahuasca ceremonies. She has realized that part of her role is to bring that intention, ceremony, and inner healing intelligence to modern medicine – that that will greatly benefit patients as well as clinicians who naturally want to be healers but are burnt out by the bureaucracy and distractions of the faulty container they find themselves in. Skylight Psychedelics is working on opening a clinical research division, researching psychedelics for Long COVID, and bringing in-person psychedelic peer support services to emergency rooms.

She also discusses intergenerational trauma and how psychedelics have affected her parenting; the impossibility of informed consent in psychedelics and why there should be disclaimers as well as instructions; accessibility, the need for insurance to cover psychedelic-assisted therapy, and why the price of these expensive treatments actually makes sense; why we should be sharing stories of mistakes and things going wrong during ceremonies; and why one of the biggest things we can do to further the cause is to educate our children and parents about psychedelics.

Click here to head to the show notes page. 

In this episode, Joe interviews neuroscientist, board-certified psychiatrist, health tech entrepreneur, inventor, and Co-Founder & Chief Medical Officer at Apollo Neuro: Dr. David Rabin, MD, Ph.D.

He talks about his path to psychiatry; his realization that trauma and chronic stress were primary themes at the root of most mental illness; and the creation, research and implementation of the Apollo wearable: the first scientifically-validated wearable technology designed to improve energy, focus, and relaxation based on touch therapy. The idea was born from Rabin asking himself: If we're all starved for touch and constantly feeling unsafe, our bodies prefer a calm, soothed state, and MDMA seems to work by amplifying feelings of safety and essentially telling our brains, "you're safe enough to heal now," could a rhythmic vibration programmed to stimulate touch receptors and put our bodies into a meditative state fool our brains into the same perceived feeling of safety – especially if that stimulation is constant? Would our nervous systems be able to tell the difference? So far, the data seems to prove that this technology works. 

He discusses what they learned from initial research about how people were using their Apollo wearables; heart rate variability and what changes it; MAPS' Phase III MDMA-assisted psychotherapy results; the idea of the inner healer; using the Apollo in conjunction with ketamine and other psychedelics to ease pre-experience anxiety; and the concept of MDMA-assisted psychotherapy as reverse trauma, the reality that it could stop epigenetic memory, and the question of whether or not the Apollo can do this on its own.

Apollo Neuro is continuing their research by running 14 different trials right now, and if you ever participated in a MAPS trial, you're eligible for a free wearable. If you're just curious about trying the Apollo, you can receive $50 off using this link.  Click here to head to the show notes page.

In this episode of Vital Psychedelic Conversations, David speaks with two current Vital students: Certified Depth Hypnosis Practitioner and Founder and Executive Director of Zoo Labs, Vinitha Watson, CHT; and artist and outdoorsman with decades of experience in bodywork, structural integration, and Vipassana meditation: Judson Frost.

They talk about their personal paths: Watson’s work educating musicians about the music business and their value with Zoo Labs and Frost’s work as an artist; as well as how their experience as parents has grounded them, and how they found Vital. They discuss the importance of integration, having a process, and recognizing how long that can take; being adequately prepared and learning mindfulness skills ahead of a journey; and bringing courage to the space (and as the space-holder, encouragement). They talk about how they hold space, and how one needs to view integration from a spiritually-open perspective to enable people to find their own meanings behind what they experienced. 

They discuss how Watson uses a combination of hypnotherapy, transpersonal psychology, and buddhism to create a slowed down mystical experience; how hypnotherapy can benefit a psychedelic experience; bodywork and how we can’t view the mind and body separately; and more. And since they’re nearing the end of their Vital experience, they discuss what they’ve gotten out of it, and reflect on something they didn’t expect: a collective feeling of regenerative healing inside their Vital community. Click here to head to the show notes page.

In this episode, Joe interviews internationally renowned musician, comedian, writer, and actor, Reggie Watts. Watts starred on “Comedy Bang! Bang!,” most recently was the bandleader on CBS’s “The Late Late Show with James Corden” for the last 8 seasons, and just released his memoir, "Great Falls, MT."

Watts discusses his early days of LSD use and how he felt psychedelics and cannabis were useful (in contrast to alcohol); how movies and TV rarely get the psychedelic experience right (and is that because writers haven’t experienced it?); and how the Situationist Movement inspired his concept of being a “disinformationist,” which he uses to bring an instability and psychedelic nature to his shows. And he discusses ketamine: why he loves it (especially with other people), a party he recently attended where everyone was open to trying it together, and why the group collectively agreeing to go deeper is so important to the experience. 

He shares his thoughts on treating certain drugs as bases and others as modifiers, and how the wrong drugs are being treated as bases; the negative feedback loops some drugs (cocaine, nitrous oxide) send us into; psychedelic exceptionalism and the low quality, synthesized drugs created solely out of capitalistic greed; microdosing and the question of whether or not it’s become popular out of a fear of going deeper; what he wants to bring to to the psychedelic conversation; and why sometimes (in the right context), “going off the rails” can be a great thing. Click here to head to the show notes page.

In this episode, Kyle interviews Ted Riskin, LCSW: psychotherapist running group KAP sessions and certified in Core Energetics, Internal Family Systems, and Holotropic Breathwork, which he has taught in various forms for 26 years.

He discusses group ketamine-assisted psychotherapy: how he runs sessions, why being welcomed and loved in a group seems to be a bigger factor than the psychedelic, how he came to combine IFS with ketamine or breathwork, and why exploring the parts work of IFS seems to work so well with non-ordinary states of consciousness. And he talks about two complications we often don’t think about with Group KAP: the challenge of getting our different parts to all truly consent to an experience (and how do you get them to?), and how very safe spaces can inspire oversharing, and sadly, subsequent shame.

He discusses knowing when to use a non-directive approach vs. intervening; how people often learn more about themselves as a sitter; using core energetics before experiences to move energy we’re often afraid to work with; the importance of embracing anger (when necessary); memory reconsolidation and bringing exiles from the past into the present; the concept of double bookkeeping; and finding the magic in realizing that sometimes, just being there (“being a useless person” as he says) is all that’s needed. Click here to head to the show notes page. 

In this episode, Joe interviews Imran Khan: Executive Director of the UC Berkeley Center for the Science of Psychedelics.

Khan shares his journey into the world of science and policymaking, beginning with science journalism and inspired by David Nutt’s famous ‘Equicy’ paper and subsequent firing for telling the truth. Realizing how strong the disconnect was between political and science worlds, his goal became to represent science when it comes under attack; using campaigning, lobbying, advocacy work, etc., and essentially becoming a translator between science and society – bringing these overly complicated concepts down to a level every day culture can understand. At UC Berkeley, he’s focusing on research, training scientists to be better communicators, educating the public on the benefits of psychedelics, and trying to make research more trustworthy.

He discusses the word “science” and how it’s used to describe lots of things; the hard problem of consciousness; color constancy, perception, and the influence of priors; the risk of abuse in all therapies; trust and why people don’t always “trust the science”; the risks of putting too much faith in experience insights; the word “sacred”; and more. He concludes by discussing the findings of the first UC Berkeley psychedelic survey, which revealed public sentiments and attitudes towards psychedelics, and, while mostly positive, truly proved the need for people like Khan to be out there educating the public. Click here to head to the show notes page. 

In this episode of Vital Psychedelic Conversations, David interviews Erika Dyck: Vital instructor, historian, professor, author, and editor of the new book, Expanding Mindscapes: A Global History of Psychedelics; and Jono Remington-Hobbs: graduate of the first cohort of Vital, coach, facilitator, and now, Co-Founder of Kaizn, an experiential wellness company with a strong focus on community, creating a feeling of safety, and modern rites of passage. 

They talk a lot about rites of passage and how they create liminal spaces to reflect on the deeper questions we need to ponder but our culture doesn’t allow time for. They talk about how categorization took us away from tradition; how so much of what we get out of these experiences isn’t related to psychedelics at all; why we struggle with connection in the digital age; the power of community as medicine and recognizing a kinship in others; and why we need to integrate our heads and hearts and live more heart-led lives.

They also dive into why cultures have always sought out non-ordinary states of consciousness; how our current state of needing to make sense of a chaotic world is similar to the mindstate of the 60s; psychedelics’ success in palliative care; coaching and why it should be attached to therapy; the creation of the word “psychedelic”; flow states and discovering the intrinsic calling we all have; and the Vital question that starts the podcast out: Are psychedelics the future, or will psychedelics just bring about a different way to think about the future?

Reminder that we’re accepting applications for Vital 2024 now until December 21! Click here to head to the show notes page. 

In this episode, David interviews Alexander Beiner: an Executive Director of Breaking Convention; writer of The Bigger Picture substack; and author of The Bigger Picture: How Psychedelics Can Help Us Make Sense of the World.

He tells his personal story and how his first psychedelic experience felt like a homecoming; discusses his Rebel Wisdom media platform, where, through interviews, he tried to make sense of social upheavals and conflicts through a more flexible, psychedelic way of thinking; and digs deep into the Greek concepts of Moloch and Kairos: how Moloch represents the winner-take-all, race to the bottom, sacrifice-your-values-to-appease-the-system game playing we all get stuck in, and Kairos represents the openness that comes from psychedelics – the transitional, seize-the-moment opportunities we need to take advantage of. And he discusses much more: the power of dialectic inquiry; the corporatization of psychedelics and how we’re really in a psychedelic enlightenment; how the medicalization of psychedelics is like a Trojan horse; and the concept of technology (and specifically the internet) mirroring the switching between realms that we think is so rare in psychedelics – aren’t we doing that every time we look at our phones? 

Beiner was recently part of Imperial College London’s initial trials on intravenous, extended-state DMT, testing correct dosages and speeds for the pump. He describes the details of the study, how he thought they were messing with him at first, and what he saw in his experiences: an outer space-like world of gigantic planet-like entities, and how a massive Spider Queen entity taught him about intimacy and how our metaphysical and personal worlds aren’t separate at all. Click here to head to the show notes page.

In this episode, Alexa interviews Dom Farnan: Founder of DotConnect; author of the best seller, “Now Here: A Journey from Toxic Boss to Conscious Connector”; and Founder and Chief Consciousness Connector of DoseConnect™, a first-of-its-kind company blending organizational strategy, systems thinking, and talent acquisition in the psychedelic space.

Farnan shares her personal journey with psychedelics, discussing her experiences with psilocybin, ayahuasca, and 5-MeO-DMT, and how the last few years of her life have been focused on slowing down and integrating those experiences. She discusses the current state of the psychedelic industry, including downsizing and company closures, but also opportunities from networking, community engagement, and volunteering. She believes that while options may not be clear now, they will be there in the future, and may be jobs we never anticipated. So get to know companies now, and pay close attention with good discernment – not everything is as it appears.

She discusses her experiences with mentors and coaches; how psychedelic journeys and integration build onto each other; the importance of journaling; the need for patience as the industry grows; her book and the concept of conscious leadership over toxic leadership; and the beauty of embracing the openness we experience after a psychedelic experience: Can we use what we’ve learned to reprogram what we’re taught about life, invest in ourselves, let go of dissenting and limiting voices, and truly redefine what success (and happiness) means to us? Click here to head to the show notes page. 

In this episode, Kyle interviews author of Recapture the Rapture: Rethinking God, Sex and Death In a World That’s Lost Its Mind; speaker; and Founder of the Flow Genome Project, which researches and trains on improved human performance.

This episode – the last of the many recorded at Psychedelic Science 2023 – may ruffle some feathers, as Wheal is very outspoken and opinionated, focusing on what he spoke about at the conference: the pitfalls of the psychedelic movement. While his outlook is negative, he speaks with humor, and these shadow aspects are issues we need to be talking about: how the nature of capitalism and returning profits to shareholders affects the concept of set and setting; how easy it is to prescribe ketamine and the puppy mill clinics popping up everywhere; how innovators are racing to the bottom to get ahead; the designer drug epidemic likely leading us to a Prozac Nation 2.0; digital narcissism, Instagram “Shamans,” and the dangers of cults; chemists trying to take the experience out of the drug; the overuse of psychedelics creating super egos; and much more.

While he believes the hype and excitement of the psychedelic renaissance is leading us towards a trough of dissolution and that people aren’t turning their amazing experiences into net positives anywhere near enough, he believes that fewer people using psychedelics less often and more intensely – with initiatory practices, intentions, integration, and honest self-reflection – will help us all climb out of our egos and move towards a healthier society. There is hope, but we need to honestly look at all the shadow aspects in order to move towards it.

Click here to head to the show notes page. 

In this episode, David interviews psychiatrist, main researcher behind the first US Phase II trial of MDMA-assisted psychotherapy, and Senior Medical Director at MAPS Public Benefit Corporation: Dr. Michael Mithoefer; and Research Group Lead at the University of Zurich, and Principal Clinical Biomarker Lead at Boehringer Ingelheim, Katrin Preller, Ph.D.

Mithoefer, Preller (and David) are speakers at the upcoming Psychedelic Medicine – Israel, which will now take place July 28 - 31, 2024, in Tel Aviv. They discuss the conference and their current research: Preller's neuroimaging and work with psilocybin for alcohol use disorder, and Mithoefer (likely) being extremely close to seeing the FDA approve MDMA-assisted psychotherapy. He talks about how the therapeutic protocols for MDMA-assisted psychotherapy were created, what it's like to be so close to legalization, and how the next challenges will be accessibility and not minimizing therapy in favor of faster turnover. 

They discuss neuroplasticity and whether or not it actually translates into something in humans; the concept of performing brain scans before a psychedelic experience to look for trauma biomarkers (and how this could actually result in savings over time); the excitement of seeing clinical work and neuroscience progressing in parallel; why integration frameworks need to be individualized; and the importance of embracing different therapeutic approaches. Click here to head to the show notes page.

In this episode, Melanie Pincus, Ph.D. and Manesh Girn, Ph.D. once again take over hosting duties, this time interviewing Gül Dölen, MD, Ph.D.: Associate professor of Neuroscience and Neurology at the Johns Hopkins University, School of Medicine, and head of the Dölen lab.

Dölen largely researches the neuroscience behind social behaviors and is most known for her work in establishing how psychedelics reopen critical periods of learning, and that the true benefit of psychedelics could be in learning how best to reopen those critical periods, how long they’re open for, and which therapeutic frameworks and integration practices could best take advantage of them. Her most recent research was giving MDMA to otherwise very asocial (and violent) octopuses to prove that a drastically different species would exhibit typical MDMA-inspired prosocial behavior. And, after discovering that all the classic psychedelics worked to reopen critical periods – that psychedelics are apparently the master key to opening these periods – she’s now researching why, through the PHATHOM project (Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability).

You will likely learn a ton in this episode: why critical periods close as we get older and what may impede them from opening more often; how plasticity and metaplasticity relate to each other and why increased neuroplasticity isn’t always a good thing; how the length of different psychedelic experiences relates to efficacy; why the different results of MAPS’ and Compass Pathways’ studies show the importance of therapy; how autism could be related to critical periods; why repeated psychedelic use may make it harder for one’s brain to reset; and how important context is in the ability to reopen critical periods – especially around social learning. Click here to head to the show notes page. 

In this episode, Joe interviews Federico Seragnoli: coordinator of the ALPS Foundation, psychologist who works with patients undergoing compassionate use treatments with psychedelics, and Founder of the ALPS Conference.

This year, the ALPS Conference (which stands for Awareness Lectures on Psychedelic Science) takes place Oct. 27 – 29 at the Bâtiment des Forces Motrices in Geneva – a prime location for a conference due to Switzerland’s legality around psychedelics, where any citizen can apply for psilocybin or LSD therapy if they fall into the category of ‘treatment-resistant.’ Seragnoli discusses how the conference was originally inspired by an article on the MAPS blog about how to be a psychedelic researcher; and talks about its humble beginnings, its new location, and why it’s moved across the country each year. The conference features names like Rick Doblin and Michael Mithoefer, but he’s most excited about the smaller size of the event and the panel discussions, which gives attendees a chance to ask questions and hear some real conversations. 

He discusses the vibrant field of psychedelic therapy and research in Switzerland; the importance of compassionate use and the criteria physicians need to be able to use it; the impact of students creating psychedelic associations at their universities; and Seragnoli’s new research: seeing if there is a link between cognitive science and a conceptualization of science – if you can model consciousness off neuroscience, can you model it off how you feel? Click here to head to the show notes page. 

In this episode, Johanna interviews Jungian analyst-in-training, writer, researcher, 5Rhythms® teacher, and Vital graduate: Mackenzie Amara; and Vital instructor, clinical psychologist, and creator of our new course, “Illuminating the Hidden Self: Navigating the Jungian Shadow with Psychedelics“: Dr. Ido Cohen.

This sequel to their fascinating discussion about shadow work earlier this year focuses on dreams, as Amara, while dreaming that she was having an acid trip and coming to the realization that dreams and LSD may be sending her to the same place, is researching the similarities between the odd worlds of dreams and psychedelic experiences: Is it the same place? Do the dreams we have after psychedelic experiences continue those visions and ‘Aha!’ moments? Can they answer questions for us (the concept of “sleep on it”)? Does dream analysis result in a greater feeling of integration? Can we use the dreams we have before experiences to help guide the experience itself?

The conversation goes a lot of places: the many aspects of Jungian psychology; the fluidity of Indigenous perspectives around visible and invisible worlds; how Jung wrote “The Red Book”; the concept of eros and reclaiming our relationship with aliveness; how nature is in constant equilibrium (as are we); how to build a relationship with your dreams; how to work with symbols in dreams; and much more. Ultimately, this episode is about the clash between the conscious and unconscious, the willed and the incidental, and waking life and other realities, and dream analysis and integration work is really tracking vitality in the human psyche: what is alive in us and how does it want to live out in our beings? What makes us come alive? Can our dreams tell us?

Click here to head to the show notes page.

In this episode, Joe interviews Louie Schwartzberg: renowned filmmaker known for the award-winning documentary, “Fantastic Fungi”; and now, director of the new film, “Gratitude Revealed.”

He talks about his path to photography and filmmaking and how psychedelics were a huge inspiration – how his techniques of slowing down, speeding up, and zooming in were ways to capture the invisible aspects of reality – that which is “too slow, too fast, too small, and too vast for the human eye,” but is always there. He discusses the premiere of “Fantastic Fungi” and the waves it spread through the psychedelic space; The Louie Channel, his new streaming channel that will feature all his work in 4k and the work of other curated artists and friends; and the clinical trial he’s involved in to see if participants have better results in the treatment of their alcohol use disorder by watching his imagery set to music on an 80-inch screen while on psilocybin – research that hopefully leads to the concept of being able to prescribe images and music to people based on specific criteria. 

He discusses his new film, “Gratitude Revealed,” which explores the power of gratitude: making it a daily practice (and especially a post-psychedelic integration practice), how resilience is one of the best benefits from practicing gratitude, and how easy it is to stop a rumination spiral by simply finding something to be grateful for. He also talks about the blessing of being a photographer and always thinking of beauty; how psychedelics make people more environmentally conscious; tripping with parents; how a shared love of nature could be the bridge between opposing sides; and how the best way to deal with the climate crisis is to start in your own yard.  

You can watch “Gratitude Revealed” now, and then, on October 25th, we’re hosting a Q+A with Louie Schwartzberg on our Navigators platform. head to psychedelicstoday.com/events for details. Click here to head to the show notes page.

In this episode, Joe interviews Deborah C. Mash, Ph.D.: neuroscientist; Professor Emerita of Neurology and Molecular and Cellular Pharmacology at the University of Miami Miller School of Medicine; and leading researcher in addiction and brain disorders for over 30 years.

She is also the CEO and Founder of DemeRx Inc., a clinical stage drug development company working to advance ibogaine and its active metabolite, noribogaine, for the treatment of opioid use disorder. She talks about the Federal and state complications behind ibogaine research, the need for partnerships between clinics and researchers, what needs to be done to collect much needed Phase II and III ibogaine data, and why this all has to be in partnership with the FDA. 

And she discusses much more: her story of how studying Cocaethylene led to her finding out about ibogaine; ibogaine and QTc-prolongation; deaths related to iboga and the amount of variables that aren’t considered; how the French were essentially using noribogaine in the 1930s; and, as this was recorded at Psychedelic Science 2023, her thoughts on the event and Rick Doblin’s opening statement. Click here to head to the show notes page.

In this episode, David interviews Madison Margolin: NY-based, psychedelics and Judaism-focused journalist; host of the Set & Setting podcast; co-founder of DoubleBlind Magazine and the Jewish Psychedelic Summit; and author of the soon-to-be released, Exile & Ecstasy: Growing Up With Ram Dass and Coming of Age in the Jewish Psychedelic Underground.

They explore the relationship between Judaism and psychedelics, with Margolin sharing her experiences growing up in a Hindu-Jewish family; her personal journey with her Jewish identity; and how her use of psychedelics has deepened her life. She talks about the significance of Jewish holidays, and how holiday traditions connect them to nature and themselves in a very psychedelic way; the importance of intentionality; the beauty in dancing through an uncomfortable ayahuasca experience; the Jewish Psychedelic Summit; whether or not ancestors were using substances (and does that matter?), and why being in Israel feels so different – and psychedelic. 

Margolin is an instructor in our new course, “Navigating Psychedelics: Jewish Informed Perspectives,” where she will be leading discussions on setting sacred time and space, particularly focusing on the significance of Shabbat and the energetic frequencies that are at play during certain holidays. The 9-week course begins next week – October 10 – so sign up now!  Click here to head to the show notes page. 

In this episode – with the ​2024 edition of Vital​ announced and applications officially open – we’re launching another series of Vital Psychedelic Conversations, with David hosting Jasmine Virdi: Vital instructor, writer, educator, and activist who works at Synergetic Press and volunteers for Fireside Project; and Tabata Gerk: Vital student, psychotherapist, and facilitator.

As always, they discuss what they think the most vital conversation should be right now, largely expressing concerns over the medicalization of psychedelics and the idea of a ‘traumadelic culture,’ where psychedelics are often only seen as healers of trauma and not doorways to mysticism and new ideas. And they point out another concern: the romanization of Indigenous culture and not recognizing that these are contemporary cultures that are affected by the same Western, capitalist paradigms that affect us all.

They also discuss the concept of epistemic injustice and needing to respect other ways of knowing; hyper-individualism and why we became so reductionist as a society; the role of money (who defines the problem and the solution?); concerns over who decides who is allowed to use these substances; the power of small steps of change; and, through talking about Gerk’s recent Amazonian ayahuasca experience, they dig into what it is about these experiences and surrounding communities that make them so special. Could we take some of that and effectively incorporate it into our Western models? Click here to head to the show notes page. 

In this episode, Joe interviews Ethan Nadelmann: author, speaker, Founder and former Executive Director of Drug Policy Alliance, host of the PSYCHOACTIVE podcast, and one of the leading voices in drug policy reform and harm reduction. 

Nadelmann shares his journey from Princeton University to founding Drug Policy Alliance, to working with George Soros, encouraging Gary Johnson to push cannabis legalization, and interacting with prominent figures like Milton Friedman and Grover Norquist. He explores the motivations behind the drug war, the massive growth of incarcerations it led to, why the US spread its war on drugs abroad even when it went against our best interests, and, thankfully, the progress made in fighting the drug war – particularly with cannabis and psychedelics.

And he discusses much more: the banning of drug testing kits; the damages of our slow learning curve against the idea of a safe supply; the risks of under-prescribing opioids for people who actually need them; how libertarians, the right, and left are all starting to become against the drug war for the same reasons; why cigarette smokers should all switch to vaping; the concept of needing to pass a test at the pharmacy to prove you understand (and won't abuse) medication; and some strong arguments for decriminalization as an incremental step. And he asks some pretty important questions that we can all simmer on for a bit: how do we find a balance between helping people and not opening the rest of society up to harm? How do we challenge abuse in a way that doesn't hurt future harm reduction efforts? And how do we incentivize people into acting in their own best interests?  Click here to head to the show notes page. 

In this special episode, Melanie Pincus, Ph.D. and Manesh Girn, Ph.D., who joined David in episode 403 to discuss the launch of their new course, essentially interview each other.

As the 2nd edition of their popular course, Psychedelic Neuroscience Demystified, begins on November 1, we wanted to give them a chance to highlight some of the aspects of neuroscience students can expect to learn in the course, and what so many people who are interested in psychedelics don’t fully understand: What does neuroplasticity actually entail? Can one predict if a patient is more apt to have an experience with ego dissolution? How does the amygdala relate to mood disorders? When are critical periods of greater plasticity and socialization at their most beneficial? How does neuroplasticity relate to chronic stress?

They also discuss lessons they’ve received from their own journeys; why they created the course; serotonin; psychological flexibility; body-based versions of self vs. memory-based versions; psychedelics and re-encoding memories (and the potential for false memories); how psychedelic therapy is different from standard drug treatments; psychedelics and the default mode network (is the story oversimplified?), and much more.  Click here to head to the show notes page. 

In this episode, Kyle interviews Rachel Harris, Ph.D.: Psychologist in private practice for over 40 years, researcher who has published more than 40 peer-reviewed studies, and author of the new book, Swimming in the Sacred: Wisdom from the Psychedelic Underground.

She talks about graduating college and going straight to Esalen, where she had little concern over therapy or integration, and how, after 20 years of ayahuasca experiences, she learned to see psychedelic-assisted therapy and ceremonial, transformational experiences as very different things. She discusses her ayahuasca journeys; a surprising MDMA experience; what having an ongoing relationship with the spirit of ayahuasca means; Ann Shulgin’s concerns over going through death’s door while in a journey; what true integration is; how psychedelics can help prepare for death, and more.

And she talks about her new book, Swimming in the Sacred, which collects the stories, unique perspectives, and wisdom of 15 female elders who have been working in the underground for at least 15 years each, and how their experience has led to a somatic-based intuition and ‘know it in their bones’ feeling that so many new practitioners and facilitators need – and can only come with time.  Click here to head to the show notes page. 

Last year, Joe attended his first Burning Man, and sadly, we didn’t hear much about it. In this episode, recorded just a few days after Joe returned from his second outing of nearly 12 days on the playa, Victoria changes that, asking Joe all the burning questions we all want to know.

He talks about preparing for Burning Man and the numerous obstacles he and his partner, Ali, encountered on their very slow journey there; the media’s interpretation of the rain and mud vs. the reality of being there in the middle of it all; the bogus reports of an ebola outbreak and disaster zone surrounded by FEMA officials (and was that all a prank by Burners?); the debate over the environmental impact of such a massive event, and more.

And he talks about the many joys of Burning Man: how, despite the weather and needing to remain at camp more, the community, abundance, embracing of all that is weird, and passion to share and make the best of it all made this a better year for him in many ways. He learned the importance of patience, avoiding a frantic state, and fighting panic with positive vibes, which was made infinitely more easy with the Big Krab Car: the art car Ali built and they drove around, DJing on all week. Click here to head to the show notes page. 

In this episode, Kyle interviews General Stephen Xenakis, MD: an adult, child, and adolescent psychiatrist who retired from the U.S. Army in 1998 at the rank of Brigadier General and began a career starting up medical technology companies and clinical practice to support human rights and new methodologies of healthcare. 

In June, he became the new Executive Director of the American Psychedelic Practitioners Association (APPA), whose mission is to bring practitioners together as a community; develop the best training programs and practices; shift to a more patient-centered, integrated model of care; eventually accredit practitioners to practice with legal substances; and overall, help to make these new modalities more mainstream. 

He discusses their path to success, which began with their publishing of the first professional practice guidelines for psychedelic-assisted therapy practitioners, and will continue on with ethical guidelines and clinical practice guidelines in the future. And he talks about the idea of a safety net for people who have adverse effects from psychedelic journeys; what clinicians need to know about psychedelics; concerns over accessibility; and the importance of identifying the correct treatments for the correct patients, as each person’s path to healing will likely be drastically different. Click here to head to the show notes page. 

In this episode, David interviews Dr. JoQueta Handy, Ph.D., IMD: speaker, author, educator, Natural Integrative Health Practitioner, and CEO and Chief Visionary of Brilliant Learning, Handy Wellness Center, and Brilliant Blends.

She shares childhood memories of growing up on her Grandparents’ farm, where she developed a deep appreciation for nature, staring at the stars, and the beauty in stillness, and how coming back to that stillness has been key in her life and psychedelic journeys. The conversation then shifts to all that she’s learned through her work with children on the autism spectrum: the problems of putting people into boxes; how autism affects everyone; the different ways people learn; the connection between autism and the gut microbiome; and how she has learned more from some of these children than any book could teach her – culminating in a story of discovering that a very challenged child people were ready to give up on could actually read and comprehend everything he was hearing.

She discusses her favorite adaptogens; the art of stacking adaptogens and different modalities; her multi-day coaching sessions; Internal Family Systems; quantum biofeedback; the use of supplements in microdosing; and Brilliant Blends, which sells blends of supplements designed to provide benefits as close to what psilocybin can provide (but legally) – inspired by the unique needs of autistic individuals. PT listeners can receive 10% off all purchases with code: PT10. Click here to head to the show notes page. 

In the first-ever episode of Hyphae Leaks, Mary and Reggie sit down with Joe Moore and share their backgrounds, impetus for launching a psychedelic tell-all podcast, and what listeners can expect from the first season.

Want to dig in on some of the topics discussed today? Quick links:

• Quick stats on biodiversity and Indigenous communities.
• Excellent reporting on why Indigenous lands protect biodiversity.
• Why we can’t blame the unhoused issue on drug decriminalization.
• Follow Reggie Harris on Instagram
• Follow Mary Carreón on Instagram
• Follow Hyphae Leaks on Instagram
• Subscribe to the Hyphae Leaks Substack.

Catch Season 1 of Hyphae Leaks streaming NOW wherever you get your podcasts. New episodes every third Wednesday until Dec. 20. Rate, review, and subscribe!

In this episode, David interviews the President of the Psychedelic Medicine Association, host of the Psychedelic Medicine Podcast, and Psychedelics Today advisory board member and Vital contributor: Lynn Marie Morski, MD, JD.

She shares her journey with psychedelics and how they enabled her to leave a toxic job and pursue her passion for advocacy with vitality, and how important it is to focus your energy where it's best used. She talks about where we find ourselves in the psychedelic space based on Psychedelic Science 2023, as well as her recent TV appearances and the responsibility of preaching to the non-choir. And she discusses the idea of perfectionism in today's age; the need for psychedelic people to be involved in non-psychedelic conferences; the complications behind requiring physicians to experience psychedelics; the concept of it being malpractice for a physician to not mention psychedelic options; and the Psychedelic Medicine Association's upcoming virtual conference: Sana Symposium 2023, which happens October 26-27. 

Morski talks a lot about the importance of educating healthcare professionals about psychedelics, debunking myths, and the need for standards in training therapists and primary care providers. She highlights how there is still no nationally-recognized certification for even ketamine providers, so how can people make informed decisions on who to trust? The Psychedelic Medicine Association is taking steps to improve this paradigm, offering a new course called "Managing Medical Risk in Patients Seeking Psilocybin Therapy," which will work to help clinicians make risk assessments for patients seeking psilocybin therapy – something that is not really being done today.  Click here to head to the show notes page. 

In this episode, Alexa interviews Chase Hudson: Founder of HempLucid, a premium CBD wellness brand.

Hudson discusses his journey from being a firefighter to becoming involved in the cannabis and hemp industry, the origins of HempLucid, the restrictions they faced, and their current genetics and flagship water soluble tincture. He talks about the benefits of CBD and cannabis used in conjunction with psychedelic therapy - especially ketamine-assisted therapy, which he gives to his employees as a benefit. And he talks about Lamar Odom and the documentary he executive produced, "Lamar Odom Reborn," which chronicles how Odom came back from rock bottom through high dose CBD, iboga, and ketamine therapy.

He also discusses the idea of cannabis as a gateway drug to healing; the need for insurance to cover psychedelic therapy; the changing landscape of Utah from religious ideology to psychedelics; ketamine as the bridge between old and new models of healthcare, and more. And they talk about their own journeys a lot, with Hudson telling the story of his powerful and life-changing ibogaine treatment, and Alexa sharing stories from her tragic car accident and recovery, as well as the ketamine sessions she recently began. The conversation ultimately becomes one about the need for education and conversation to help us all climb out from decades of drug war propaganda.  Click here to head to the show notes page.

In this episode, David interviews East Forest: Portland, OR-based producer, podcaster, ceremony guide, and musician, specializing in ambient, electronic, contemporary classical, and indie pop music largely to guide listeners through deep journeys.  

Forest discusses his live performances and influences; how his music pairs with journeys and specific psychedelics; the difference in the connection and vibe from a live performance vs. a recording; the difference between single-artist music created specifically for sessions vs. Spotify playlists; the inhumanity of generative music; his Journey Space online music and journey platform; and the challenges of making money in a time when music is more prevalent than ever, but also more in-the-background and diluted. 

He talks a lot about sound itself: the role of rhythm and sound in communication and personal transformation; how richer overtones and increased layers of sound increase effects; research into very low pulsating tones, and how more synthesized sound and the growth of AI has created a yearning for more authentic, imperfect sounds.  

His newest album was just released August 18: “Music For The Deck of The Titanic,” an homage to the musicians who spent their last few hours playing songs for passengers amidst the chaos and tragedy – an album Forest sees as an offering to the chaotic moment we’re all in.

Click here to head to the show notes page.

In this episode, Joe interviews Satya Thallam: Policy Advisor at the international law firm, Arnold & Porter; and longtime policy expert based in Washington, D.C. who previously served in senior roles at both the White House and the U.S. Senate.

Thallam was the lead author and negotiator of the Federal Right to Try Act, which grants terminally ill patients access to experimental therapies and substances that have completed Phase I testing but have not yet been approved by the FDA. He discusses its intricacies and benefits, how psychedelics were not a focus but were always obvious, whether or not it allows people to grow their own mushrooms, and more. He talks abut the implementation of the first Federal legalization of hemp under the Farm Bill in 2018, breaking down the history and detail of how it came to be, and why a difference of .3% in weight truly matters when establishing law.

He discusses the changing landscape of politicians and psychedelics; how local action creates a culture of inspiring Washington; the internal fight between different agencies and the endless lobbying it takes to get things done; how one needs to cater their argument by who is listening; risk assessment and judgment-proof operations; the concern over whether or not we got everything wrong with cannabis; and why we will likely begin seeing a lot of coalitions popping up in the psychedelic space. Click here to head to the show notes page. 

In this episode, Kyle interviews Lisa Wessing: Clinical Psychologist and facilitator specializing in harm reduction at Kiyumí retreats in The Netherlands. 

Wessing shares her personal journey and the shift from being uninspired with studying psychology to being a part of space-holding in Mexico and finding her true path. She dives into the world of Kiyumí retreats, discussing their holistic healing approach using psilocybin, somatic movement, dance expression, and other methods supporting their four pillars of embodiment, nature, mindfulness, and art. She discusses their more long-term program with Dr. Gabor Maté integrating his Compassionate Inquiry framework; their Equity Program, which offers partial or full funding for people who may not have the financial resources or who come from marginalized communities (e.g. BIPOC & Queer); and the importance of integration as a continuous process and checking in with people much later to build their “Kiyumíty.”

Much of this discussion covers the challenges of somatic psychology and facilitation in group containers: how most people are somatically illiterate and the journey of becoming more somatic; what to do about someone laughing or singing in a group context; what moving into one’s body really means; and different ways of using art to integrate an experience.

As part of our Vital program, we are running a psilocybin retreat with Kiyumí from September 6-11, and we have some available spots left! If you like what you hear, you’ll be in The Netherlands in September, and want to have an amazing experience with us, click here for more info! Click here to head to the show notes page. 

In this episode, recorded in-person at Psychedelic Science 2023, Kyle interviews Senator for the Mexican Green Party, Alejandra Lagunes.

Lagunes is the first Senator in Mexico to promote the use of psychedelics, and has been organizing open parliaments to foster collaboration between researchers, scientists, politicians, and Indigenous people, culminating in a groundbreaking decriminalization initiative to decriminalize psilocybin and psilocin from list 1 to list 3 (meaning they could be prescribed), create a new chapter for entheogens (and move mushrooms there), build an economically beneficial framework for Indigenous people, protect ancestor knowledge by law, and make big bioconservation moves with changes to environmental laws. 

She discusses her personal journey with depression, anxiety, and a life-saving ayahuasca journey; how Covid uncovered a crisis in meaning and an openness to talk about mental health; the need for accessibility and safety in psychedelics against challenges in politics and policy implementation; our mental health crisis and the need for innovation, education, and overcoming stigma; the influence of US drug control policies on international regulations; the power of storytelling; and why we need to go back to our origins. Click here to head to the show notes page. 

In this episode, Joe interviews Stéphane Lasme, a former professional basketball player from Gabon who is now a partner at SteddeCapital, a private markets investment platform investing long-term capital into U.S.- and Africa-based opportunities across sports ownership, infrastructure, technology and plant medicine.

Lasme speaks of his childhood, growing up in Gabon with more traditional Catholic values while journeying deep into the jungle to visit his Grandmother every summer. It was there that he embraced the cultural aspect of Gabon and community, and first learned of iboga, which he had a profound experience with at age 12, and would later revisit in his basketball days. He discusses the drive and passion that led him to become the first person from Gabon to play in the NBA, and the subsequent pressure, stress, cultural differences, and “ok, what now?” moments that came at the end. He talks about Gabonese traditions; how iboga improved his stress relief and mental focus; how embracing yoga and Buddhist methods of self-discovery improved his life; scientific reductionism vs. the magic of mystery and trying to define an experience; and more. 

While Gabon allows for the export of iboga, Lasme’s goal is to build a lab and treatment center in Gabon and share the power of Gabonese culture with people – so they can experience the medicine in its own country, with its traditional rituals and music. He has begun the fundraising process, and through his investment and facilitation work, is working to get African athletes to invest back into Africa and make Gabon a major destination for iboga. Click here to head to the show notes page. 

In this episode, Kyle interviews The Susan Hill Ward Endowed Professor of Psychedelics and Consciousness Research at Johns Hopkins, and renowned researcher of nearly 20 years: Matthew W. Johnson, Ph.D.

Recorded in-person at MAPS’ Psychedelic Science after running an 8-hour workshop on psychedelic therapy for addiction treatment, Johnson was still happy to sit down with PT to explore a wide range of topics: the under-researched concept of integration; how to best take advantage of optimal neuroplastic windows; why psycholytic therapy used to be more common; how our current protocols and research models are largely arbitrary; and his hopes for new, experimental, and flexible models of psychedelic therapy.

He also discusses his ongoing smoking cessation studies; the Oregon model (are we doing therapy or not?); misrepresentation in psychedelic therapy and knowing your lane; and the role of music in psychedelics: why shouldn’t people pick the music they know will give them goosebumps? Click here to head to the show notes page.

In this episode, Joe interviews Maya Albert: Co-Founder of the Psyched conference, and Director of Operations at Tabula Rasa Ventures and the Synthesis Institute.

She shares her journey of how she became involved in the psychedelic space through her mother, and her personal experience as a patient in a clinical trial on psilocybin for the treatment of anorexia – a much more common and deadly affliction than most people realize. She discusses her involvement with the various psychedelic gatherings surrounding Davos and the World Economic Forum, as well as the work she’s doing with Tabula Rasa and some of their clients seeking to expand insurance coverage to psychedelic-assisted therapy. 

She discusses the Synthesis Institute’s recent struggles that shook up the psychedelic space, what they’re doing to save the company, how Retreat Guru has helped them, and the implications for the wider psychedelic movement. And she talks about much more: the legality and vetting process for training in Oregon and Colorado; truffles in the Netherlands vs. classic psilocybin; the idea of alcohol as poison and ‘Cali sober,’ and how can we all be more collaborative and not sling mud at each other? Click here to head to the show notes page. 

In this episode, Kyle interviews the Founder and CEO of FreshCap Mushrooms and host of The Mushroom Show on YouTube, Tony Shields.

He talks about how an early interest in lucid dreaming sent him down a psychedelic path, and how, as his interest in mushrooms has grown, he’s watched the culture shift from a narrative of mycophobia to one of appreciation and interest. With FreshCap Mushrooms and The Mushroom Show, he aims to provide much needed education around this vast and mysterious world of fungi.

He talks about the thriving psilocybin scene in Jamaica, and how, through filming a documentary there, he learned how much communities still don’t know about mushrooms, how much tourism supports the country, and how much of a special vibe Jamaica has for psilocybin retreats.

And he discusses much more: why lion’s mane should help with concussions and TBIs; indications mushrooms could heal, from long Covid to paralysis; concerns over over-medicalization; why Terence McKennas’ ideas weren’t as crazy as many thought; visiting mushroom shops in Canada; the secret language of mushrooms; where psychedelic people can start to learn about functional mushrooms; and why, if he could embody any mushroom, it’d be cordyceps. Click here to head to the show notes page. 

In this episode, recorded on the eve of MAPS’ Psychedelic Science 2023, Kyle interviews MAPS’ Founder and President, Rick Doblin, Ph.D.

He begins with an overview of the fast-approaching (and largest ever) psychedelics conference, emphasizing its significant growth, many features, and bipartisan opening ceremony, then discusses MAPS’ soon-to-be-released confirmatory Phase III data on MDMA-assisted therapy for PTSD, which should set the stage for legal MDMA and the increasing need for trained psychedelic therapists. 

As the FDA is requiring studies on adolescents, he discusses this sensitive issue and questions why it’s so controversial, since teenage years are often closer to both trauma and a more malleable brain, Indigenous traditions certainly didn’t have age limits, and honest drug education – something that is absolutely necessary to fight the backlash against this quickly growing field – teaches us that it’s not the substance; it’s our relationship to it. Could not having these rites of passage be hurting us?

He also discusses the natural vs. synthetic conflict; breathwork; whether or not cannabis is truly damaging to young minds; Federal rescheduling vs. state rescheduling; why it’s controversial to give therapists MDMA in training; Gul Dolen’s work with reopening critical periods; psychedelics in couples therapy; and much more. Click here to head to the show notes page.

In this episode, Joe interviews Sarko Gergerian, MS, MHC, CARC: a police peer support, community outreach, and health-fitness officer; founding member of the Community and Law Enforcement Assisted Recovery Program (C.L.E.A.R.); and psychotherapist trained in ketamine- and MDMA-assisted psychotherapy.

Any regular listener of the show should be familiar with how passionately Joe is against the drug war and the resulting policing of what many of us feel should be legal, so this in-person conversation with a police officer who seems to mostly be on our side is pretty refreshing to hear. 

Gergerian discusses his entry into the force in his 30s, and what it was like to bring in a healthy “why is this illegal?” viewpoint on drug use and personal agency vs. the slow moving attitudes he saw in much of law enforcement. He talks about how working nightclub security taught him about safe spaces; the problems with officers not proactively moving on actionable information and building relationships with communities; and the very philosophy behind law enforcement: what do they hope to accomplish, do they want to make real change, and do they believe in the laws they’re enforcing? 

And they discuss so much more: the need for diversity, cultural competency, and broadness in perspective; the criminalization of self-directed behavior; the effect critical incidents have on officers; drug war paranoia, legitimate concerns over hotlines and sensitive data, and psychedelic culture’s relationships with police; creating a culture of harm reduction within law enforcement, and what it might look like for police officers to receive psychedelic therapy. Click here to head to the show notes page. 

In this episode, Joe interviews one of the world’s leading experts on human performance: New York Times bestselling author and Executive Director of the Flow Research Collective, Steven Kotler.

Kotler's work explores the neurobiology of peak human performance, flow states, and aging, and the concept of getting our biology to work for us rather than against us in our later years, by using the parts of our brains that expand in our 50s, combined with neuroplasticity, learning by play, and the biggest factor: working toward a very difficult - but not impossible - task. His 30-year exploration of the neurobiology behind people accomplishing 'impossible' feats led him to test his theories by teaching himself to park ski at 53 with resounding success, then using his protocol with people up to 70 years old the next season. The story is told in his newest book about challenging tired concepts of aging, "Gnar Country." 

He discusses the power of flow states and how much flow actually amplifies productivity, motivation, wisdom, empathy, and more; why dynamic motion is a key activity for greater longevity and why skiing and similar action sports are some of the best examples; why dynamic activity in novel environments is even better; why changing one's mindset may be the biggest factor toward change; why corporations are looking at flow training and where these concepts could go in the future; and of course, how this all relates to psychedelics.  Click here to head to the show notes page!

In this episode, David interviews Dr. Gabrielle Lehigh: Co-Founder and Managing Director of Psychedelic Grad, a web-based community serving as an educational and career hub for up-and-coming psychedelic professionals; and the host of the related podcast, “Curious to Serious,” where she speaks with students and professionals about the path they took to land in the psychedelic field. 

Lehigh recently earned her Ph.D. with research on something not many are looking at: the stories behind powerful and transformative psychedelic experiences specifically at music events, based on 38 interviews and over 500 surveys mostly collected at day-long festivals in the southern United States. While the goal was largely data collection in support of the clear potential for therapeutic benefit in using psychedelics in recreational settings (as many of us who have experienced this can attest), she was surprised to learn how many people still blindly trust dealers; how much festival security can affect safety; how the community often makes more of a difference than the music itself; and how many parallels exist between colder clinical models of psychedelic-assisted therapy and the completely open festival experience. 

She discusses how she found her way from environmental justice to psychedelics; what people are most looking for on Psychedelic Grad; why she chose to use the word “transformative” in her research; what music she has had her best experiences with; why psychonauts shouldn’t forget about Pink Floyd; and much more. Click here to head to the show notes page!

In this episode, Kyle interviews the Reverend Dr. Brian Rajcok, Lead Pastor at St. Matthew Lutheran Church in Avon, Connecticut, who recently completed his Ph.D. in pastoral counseling.

Rajcok dives into the intersection of spirituality, religion, mysticism, and how psychedelics bring these topics together, discussing a transformative peyote ceremony and the awe-inspiring moments of surrender, connection, and divine presence that left a lasting impact on him and deepened his connection to God. And he talks about his recently completed dissertation that was inspired by it all: "The Lived Experience of Professional Mental Health Clinicians With Spiritually Significant Psychedelic Experiences," which he created to gauge the relationship between religious spiritual commitment, tolerance, and multicultural counselor competency. He shares stories from the study and reflections on how these experiences have changed the way involved clinicians work. 

And he discusses much more in the realm of psychedelics and religion: why he pursued pastoral counseling and how psychedelics come into play; the balance between tradition and reason and spiritual commitment and tolerance; the legal and regulatory considerations of religious psychedelic use; the concept of a faith quadrilateral; the need for psychedelic experiences in counseling training programs; the big question of 'when is it religion and when is it mental health care?'; and how the future of psychedelic spirituality could be humanity's biggest evolution. Click here to head to the show notes page. 

In this episode, David interviews Dr. Rosalind Watts: famed clinical psychologist, former clinical lead on Imperial College London’s first Psilocybin for Depression trial, and Founder of ACER Integration. 

She discusses the awakening she had after having a child; her work at Imperial College and realizing the importance of staying in touch with patients; the challenges of balancing her work with being a mother; her ACER integration model and the interconnectedness of trees in a forest; how the Watts Connectedness Scale works (and David fills it out); and how much the outside-the-hype surrounding pieces matter – the therapy, the therapeutic relationship, the lessons learned, and the work done to integrate it all. 

And she talks about another moment of awakening, at last year's Psych Summit conference, where capitalism's obsession with profit-over-care frameworks and "magic bullet" and "brain reset" narratives was on full display, which fully enforced what she hopes for in the future: a world where we embrace non-clinical, ceremonial, and nature-based practices; with healing centers (psychedelic and non); supportive communities; infrastructure around conflict resolution and restorative justice; and a shift towards collectivism and collaboration – and how that all starts by finding our psychedelic elders.  Click here to head to the show notes page!

In this episode, Joe interviews Oliver Carlin, Founder of Curative Mushrooms, a grow kit solution company designed to produce mushrooms of one’s choosing within 30 days with little effort and no growing experience. 

Carlin tells his personal story of 20 years in the Navy to a 7g psilocybin journey and the work of perfecting these grow bags; how a grow bag works; how easy it can be to grow your own mushrooms; the advantages of growing your own mushrooms vs. buying them; the legalities of grow kits and how he has been able to do this; steps growers can take to reduce their legal risks; the variety of people benefitting from mushrooms (especially in the veteran community); and how growing your own mushrooms seems to make the experience more curated and special.

Curative Mushrooms recently hired someone to create new strains for them every month, they do bimonthly live Q&As for people interested in growing, and they ship a bonus mycology book with each kit that shows how to study spores. They offer growing kits for Lion’s Mane, Turkey Tail, and Shiitake mushrooms, but his most popular option is the “All-in-One Happy Mushrooms for Sad People” kit. Click here to go to the show notes page. 

In this episode, David interviews Dr. Roberta Murphy: member of the Imperial Centre for Psychedelic Research and training medical psychotherapist.

This is a rare impromptu podcast, recorded about a half hour after David heard Murphy speaking on a panel at UK’s Breaking Convention conference. He asked her if she wanted to be on the podcast sometime, and before they knew it, they were recording. Fastest turnaround ever?

She discusses her past research and what she's doing at Imperial College; her work on a psilocybin for depression trial; a psilocybin versus Escitalopram trial; her hopes for psychedelics treating people with Parkinson's; and her recent co-written paper on the ARC Framework (Access, Reciprocity and Conduct), where she will be focusing strongly on the Conduct aspect through her work at Imperial. 

She mostly talks about her other recent paper exploring the impact of one of the more important aspects of therapy: the therapeutic alliance on the psychedelic experience. How does the treatment dynamic between the therapist and the client impact the outcome (and course) of the therapy, and what determines whether it's neutral, negative, positive, or very positive?

Click here to head to the show notes page.

In this episode, Alexa interviews Rachel Clark: Education Manager for DanceSafe, a public health nonprofit specializing in serving people who use drugs and their communities.

As we move into the prime festival season, more people are going to be doing drugs, and the importance of harm reduction and drug testing becomes even more central to the experience. She discusses the complications of drug testing and how it’s more of an act of ruling substances out rather than determining purity; the fentanyl problem and its surrounding myths; how to identify and treat an overdose (and what not to do); Philadelphia’s struggles with Xylazine highlighting the problem with regional cross contamination; and DanceSafe’s “We Love Consent” and “Healing is Power” campaigns, which aim to open up the dialogue of true harm reduction and safe spaces outside of the substance alone.

Check out DanceSafe.org for more info, and use this link when you’re ready to make a purchase! psychedelicstoday.com

In this episode of Psychedelics Weekly, Joe and Alexa reminisce about last week's Psychedelic Science 2023, dubbed as the largest psychedelic conference in history. 

They discuss Joe's two Psychedelic Morning Shows with Anne Philippi; Court Wing, Bob Wold, and the work of Clusterbusters and the new Psychedelics and Pain Association; Aaron Rogers and athletes' growing interest in psychedelics; the legality of mushroom growing kits; and the overall fun and overwhelming atmosphere of such a massive event. And as Alexa had her first breathwork session with the East Institute, they dig more into breathwork, which serves as somewhat of a follow-up to our breathwork episode a few weeks ago.  

They also talk about a short film they came across called "Open Up," which looks at the party lifestyle of always seeking a new high, the potential of ketamine abuse, and what can happen when people don't talk about their problems.

https://psychedelicstoday.com/2023/06/30/psychedelics-weekly-a-recap-of-psychedelic-science-2023/

In this episode, David interviews Professor Celia Morgan, Ph.D., who holds the Chair of Psychopharmacology and co-leads the Transdisciplinary Psychedelics Group at The University of Exeter.

This was recorded on the dawn of UK's Breaking Convention conference, where Morgan was speaking about the therapeutic potential of ketamine as well as the danger of people developing a dependence on it. She touches on that topic, but largely discusses her current Phase III Trial for ketamine-assisted therapy for the treatment of severe alcohol use disorder (also called the KARE model (Ketamine for reduction of Alcohol Relapse)), a collaboration with Awakn Life Sciences.

She discusses her other research: studies on mindfulness intervention before and after ketamine, epigenetic changes after ayahuasca use, the antidepressant qualities of ayahuasca, and CBD for cannabis dependence. And she talks about the necessary balance for making treatments amazing but affordable; how connecting with nature during integration is key; how the drug is just a tool, yet we focus on it too much; and how we need studies on how different therapies work with different substances.

www.psychedelicstoday.com

In the second episode of our special, two-part series, the Psychedelic Morning Show, Joe Moore and Anne Philippi are live once again bright and early from Psychedelic Science 2023 in Denver.

Listen to this podcast as they interview four guests working on the front lines of psychedelic research, law, and the treatment of chronic pain. 

Guests for this episode include: 

• Tommaso Barba – PhD candidate at Centre for Psychedelic Research, Imperial College London
• Allison Hoots – Attorney at Hoots Law Practice and advocate; President of Sacred Plant Alliance
• Bob Wold - Founder & President, Clusterbusters
• Court Wing – Founder, REMAP Therapeutics 

psychedelicstoday.com

In this limited series, Joe and Anne chat in real-time with guests working in all corners of the psychedelic ecosystem, from advocacy, law and finance, to research and therapy. 

Guests for this episode include: 

• Dr. Julie Holland – Psychiatrist, psychedelic researcher, author and medical advisor for MAPS
• Daniel Goldberg – Co-Founder and Principal at Bridge Investments & Palo Santo
• Hadas Alterman – Director of Government Affairs | American Psychedelic Practitioners Association
• Melissa Lavasani – Founder and Chief Executive Officer at Psychedelic Medicine Coalition, Founder and President of Psychedelic Medicine PAC
• Tracey Tee – Founder of Moms on Mushrooms

psychedelicstoday.com

In this episode, David interviews Frederick Barrett, Ph.D.: cognitive neuroscientist, Associate Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine, and now, Director of the Johns Hopkins Center for Psychedelic & Consciousness Research.

With today’s news, Barrett officially takes over for the legendary Roland Griffiths, who has been in the role since the Center’s launch in 2019, and who will continue on as a member of the leadership team while dealing with the Stage 4 cancer diagnosis he has been remarkably candid about in recent interviews. 

Dr. Barrett has been conducting research at Johns Hopkins for a decade, authoring or co-authoring some of the first studies on psilocybin’s enduring effects, and receiving the first federally funded human psychedelic research grant from the NIH since the 70s. He discusses the work and importance of Roland Griffiths; the history of the Center and current research he’s most excited about; the mystery of consciousness; and the power and sacredness of music: how we all use music to regulate our emotions, and how he wants to explore the brain mechanisms behind that connection. www.psychedelicstoday.com

In this edition of Psychedelics Weekly, Joe and Kyle dedicate the entire episode to one of their biggest passions: breathwork and the power of breath in reaching non-ordinary states of consciousness.

What many listeners may not know is that Psychedelics Today was created because of the lack of attention being paid to breathwork, transpersonal psychology, and the work of Stanislav Grof, so this episode serves as a deep dive into all the facets of our fascinating ability to reach psychedelic states simply by breathing in specific ways.

They discuss the history of breathwork; the various methods (box breathing, alternate nostril breathing, rebirthing breathwork, the Wim Hof method, Holotropic and Transpersonal breathwork, etc.); early and most powerful experiences; why Joe recommends becoming familiar with breathwork before a first psychedelic experience; how a breathwork practice can help enhance psychedelic experiences; and one of the most amazing things about breathwork: that it can give people a sense of agency they may never have felt before – that they can produce these experiences and insights with nothing but their own bodies.

If you've been curious about breathwork, this episode is a great starting point to learn more.  www.psychedelicstoday.com

In this episode, Kyle interviews Liana Gillooly: Strategic Initiatives Officer at MAPS, Board Chair & Founder of the non-profit, North Star, and Advisor to Chacruna’s Indigenous Reciprocity Initiative.

While she talks about updates in MAPS’ world and how to manage and scale a rapidly growing industry while trying to change a system from the inside, she mostly talks about what she, the rest of MAPS, and a lot of the psychedelic space in general are most excited about right now: Psychedelic Science 2023, the largest psychedelic conference in history, beginning next week in Denver. 

She discusses the growth of the conference; why they chose Denver as a location; and how programming has changed over the years to embrace the multiplicity of identities inside the psychedelic space, including much more business content, a culture stage that focuses on how psychedelics interact with the mainstream, various programs put on by community partners, pre- and post- workshops covering an array of topics, and an area they’re calling Deep Space, which was designed to help attendees get out of their heads and more into their bodies. 

If you were thinking of attending, this episode should serve as a great inspiration to finally buy a ticket. When you do, be sure to use code PT15 to get 15% off your purchase, and when you’re there, visit us at booth 834 Wednesday through Friday. Joe is hosting a Psychedelic Morning Show with Anne Philippi on Thursday and Friday, and we’re partnering with Lounge CashoM, an all-inclusive environment designed to be a decompression space from that big conference energy. Email [email protected] for more info, and head to the show notes page for more details about afterparties. www.psychedelicstoday.com

In this episode, David interviews Alex Belser, Ph.D.: clinical scientist; author; licensed psychologist; Co-Investigator for a psilocybin and OCD study at Yale University; and co-creator of the EMBARK approach, a new model of psychedelic-assisted therapy that focuses on six clinical domains that typically arise during psychedelic experiences.

He is also one of the editors of "Queering Psychedelics: From Oppression to Liberation in Psychedelic Medicine," the new anthology from Chacruna featuring 38 essays from queer authors and allies looking at the heteronormative aspects of psychedelic culture and psychedelic-assisted psychotherapy, self-acceptance, psychedelics and pleasure, and ways the queer community can become allies with other groups. As they serendipitously recorded this episode on June 1, it only made sense to celebrate Pride Month by releasing it now, as well as launching a giveaway, where you can win one of five copies of "Queering Psychedelics." 

Belser talks about the concurrent emergence of the psychedelic and queer communities; the need to research the effects of transphobia and homophobia in psychedelic work (as well as the internalized phobias often realized during an experience); why it’s more important than ever to talk about the psychedelic space’s dark past with conversion therapy; why the Mystical Experiences Questionnaire needs to be updated; the idea of queer people being boundary walkers; recreating the Good Friday Experiment, the immense importance of long-form interviews and other forms of qualitative research, the power of love and community, and the question: how does anyone not want to change after a powerful psychedelic experience?

www.psychedelicstoday.com

In this episode of Psychedelics Weekly, Joe and Kyle are once again able to take advantage of Kyle's temporary Colorado residency and record together in Joe's office.

While last week focused on the numerous challenges facing a rapidly growing industry of psychedelic therapists, facilitators, and guides, the topic of therapy itself is put under the microscope this week, as they dissect a New York Times article titled, "Does Therapy Really Work? Let’s Unpack That." They discuss whether or not therapy is right for everyone, the efficacy of different types of therapy, the role of the therapeutic alliance in treatment outcomes, and how (if it's even possible) to measure all of these factors.

They also discuss:

-a study showing that ketamine was more effective than ECT (electroconvulsive therapy) for patients with treatment-resistant depression;

-the potential benefits of the LSD analog, Br-LSD, in treating people with major depressive disorders, cluster headaches, and more;

-Ireland's Health Service Executive launching the Safer Nightlife program, which will partner with music festivals this summer to establish on-site drug testing;

-the U.S. slowly beginning to legalize fentanyl test strips, which, for some reason, are illegal in many parts of the country;

And much more!

See you next week, and if you're in the NYC area, make sure to check out "Tales of Transformation," an in-person event Thursday, June 8 at the Athenæum, moderated by David, and featuring Ifetayo Harvey, Juliana Mulligan, and Raad Seraj. www.psychedelicstoday.com

In this episode, Joe interviews the Co-Founders of Enosis Therapeutics: researcher and scientist, Agnieszka Sekula; and psychiatrist, clinical advisor to the Australian Psychedelic Society, and leading Australian advocate for psychedelic-assisted psychotherapy, Dr. Prash P. 

Enosis Therapeutics is a medtech startup that began with the question: how can we use VR – with or without psychedelics – to improve mental health outcomes? They feel that the biggest problem with powerful psychedelic experiences is that, once you’re back in reality, it’s oddly difficult to remember the insights and new ideas that were so clear during the experience, and even harder to make connections that lead to concrete change. They believe that the immersive nature of VR and the novelty of unique VR environments creates a sense of presence that can’t be recreated otherwise – a liminal, in-between state that’s just different enough to allow the patient to feel like they’re back in that non-ordinary state, and therefore more able to anchor their experience and begin to find connections and more clearly understand newfound insights. 

This all happens by the user essentially creating nonlinear, abstract, multi-sensory VR paintings while describing what they remembered; allowing them to revisit these worlds later, bring in therapists (or anyone else) to work inside these environments, and hear their own voice describing what happened, thereby creating a mental map that can be worked with in completely unique ways. 

They talk about the conflict between new technologies and traditionalists; the problems with moving away from psychoanalysis and not treating psychotherapy as a process; how VR could improve the efficacy of therapy (and improve therapists’ lives); how it could replace models of repeated dosage; how VR could generate analytics to actually quantify success in mental health treatment; and how (whether psychedelics are used or not) culture needs to bring the psychedelic way of thinking to mental health.

www.psychedelicstoday.com

In this episode of Psychedelics Weekly, Kyle and David meet up to talk news, but end up mostly having a discussion about the numerous challenges facing the rapidly growing industry of psychedelic therapists, guides, and facilitators.

That discussion comes from the article, “Psychedelic workers of the world, unite!”, which breaks down the shortcomings and risks of an industry many are flocking to without realizing what they’ll likely have to deal with: unprecedented legal and financial risks, burnout, misalignment with management, transference and countertransference, and what happens when one finds themselves in the middle of a genuine emergency? While these issues could be found in any industry, a big reason why they seem so prevalent and dangerous in the psychedelic world is our lack of elders and passed-down experience – and the faster this all grows, the more we need that guidance. 

And for news, they talk about Ohio State making history as the first U.S. University to receive a license to grow psilocybin mushrooms; a new study showing that LSD enhanced learning, exploratory thinking, and sensitivity to feedback; and the National Institute on Drug Abuse (NIDA) funding $1.5 million to research the efficacy of psychedelics for substance use disorder – which spurs a conversation about research, funding, and the idea that maybe we’re spending too much time and money on neuroscience. www.psychedelicstoday.com

In this episode, Joe interviews Priyanka Wali, MD: board-certified practicing physician in Internal Medicine, MAPS-trained psychedelic facilitator, comedian, and co-host (with Sean Hayes of "Will & Grace" fame) of the HypochondriActor podcast, where they discuss interesting medical issues in a funny (and hopefully uplifting) way. 

She talks about recognizing and protecting the humanity of healthcare professionals, and how medical school is creating a cycle of hurt people trying to help other hurt people. She believes we need to become more holistic, especially in embracing Indigenous ways of thinking, as their frameworks may be the only way to explain phenomena with which Western science can’t come to terms.  

They talk a lot about ancient psychedelic use: the use of a soma described in the Rigveda; Egyptian culture and mushrooms observed in statues; Plato; the work of Brian Muraresku and Graham Hancock; and Vedic chants, Kashmiri Bhajans, and how singing (especially in a group) can be especially healing to the nervous system. And as Wali experienced first-hand the Kashmiri Pandit genocide of 1990, she discusses how much colonialism has changed cultures, and how much our cycles of oppression relate to our collective inability to experience pain and fear.  

They discuss the psychological impact of living through major catastrophes; the special and hard-to-describe feeling of returning to your home (especially in a world changed by colonization and constant conflict); the sad case of Ignaz Semmelweis and hand washing; ghosts of Japan’s 2011 tsunami, the concept of ‘future primitive,’ and more. www.psychedelicstoday.com

In this episode of Psychedelics Weekly, Joe and Kyle are both on the road, so David and Alexa take the helm.

They cover news stories about: 

-a man in Colorado facing a Class 3 drug felony for giving people psilocybin mushrooms in exchange for monetary donations – pointing out the bold (or stupid?) stances some are taking to highlight the absurdity of legislation that allows possession and donation as long as no money changes hands; 

-a study showing what many of us have felt ourselves: that the day after psilocybin-assisted therapy, depressed patients had a stronger brain response to music and saw improvements in the ability to find pleasure in previously empty activities; 

-a trip report from a psychedelically-naive 50-year old, showing the power and beauty of MDMA-assisted therapy; 

-the New Hampshire state Senate continuing to be behind the times and voting down House Bill 639, which would have created a legal recreational cannabis framework for the state;

-a video where people on the street in Oregon were asked how much they thought psilocybin therapy would cost, showing a drastic misalignment between public perception and reality;

and a local TV news feature touring Rose City Laboratories, the first licensed psilocybin testing lab in Oregon.

And in conversation, they talk about some of the lesser-discussed (and often dismissed) tools like CBD, THC patches, and very low-dose edibles; the problem with drug dealers and harm reduction; the power of music in guiding a psychedelic experience (and in living a pleasurable life); and the importance of dosing and listening to your body to know what's right for you.

www.psychedelicstoday.com

In this episode, Joe interviews Nick Kadysh: Founder and CEO of PharmAla Biotech and member of the board of directors for The Canadian Psychedelic Businesses Association. 

PharmAla Biotech is a Toronto-based Life Sciences company with two focuses: contracting with manufacturers to provide researchers with GMP MDMA (created under Good Manufacturing Practice regulations), and creating and researching novel analogs of MDMA. And just today, they announced that Health Canada has authorized them (and their distribution partner, Shaman Pharma) to supply their LaNeo™ MDMA for the treatment of a patient under Canada’s Special Access Program – the first time this has happened in Canada. 

He discusses the creation of PharmAla and why their model changed from primarily researching analogs to manufacturing; why they’re operating out of Canada and using manufacturers instead of running the lab themselves; the excitement around Australia’s recent about-face on MDMA and psilocybin-assisted therapy; the bureaucracy of U.S. drug policy and how much a broken supply chain affects the whole industry; bad IP and companies filing rapid fire patents; why creating new analogs of MDMA is so important; and why the psychedelic space needs to bring culture along with us.

He also talks about Spravato, cannabis and risks of cancer, THC nasal sprays, and research he’s most excited about: that MDMA seems to alleviate dyskinesia caused from Parkinson’s disease, and that MDMA could improve social anxiety in people with autism. He’s aiming to run a clinical trial and believes they have developed a safe MDMA analog that the autistic community will respond to very well.

www.psychedelicstoday.com

In this episode of Psychedelics Weekly, Joe and temporary-Colorado-resident Kyle once again record in-person, discussing how psychedelics could change business, the drug war and safe supply, and more. 

They cover: 

-a Rolling Stone profile on David Bronner, who makes the case for multi-stakeholder capitalism; where businesses are accountable to their workers, customers, the environment, and surrounding Indigenous communities instead of just investors – an idea more people would likely align with after a psychedelic experience; 

-The first psilocybin service center in Oregon (EPIC Healing Eugene) finally receiving their license via the Oregon Health Authority;

-A man who saw his color blindness improve for four months after a 5g mushroom experience;

-Delaware officially legalizing recreational cannabis; 

-The opening of 'The Drugs Store' in Vancouver, British Columbia: a mobile store selling drugs illegally as a response to the opioid epidemic and constant influx of untested and laced drugs – the "inevitable result of the government doing nothing" towards offering a safe supply; 

-and a survey from the CDC showing that cannabis use among teenagers has declined since legal dispensaries began opening, disproving one of the most common prohibitionist arguments that legalization would only increase use. 

And of course, these topics bring on a lot of conversation: how businesses need to be more reflective on how they're operating; concern over if too much regulation is nerfing the world; the human cost of the drug war and the ever-escalating amount of ODs and drug poisoning cases; HPPD and the need for research around psychedelics and vision/perception; why we will always need both clinical access and the recreational underground, and more. www.psychedelicstoday.com

In this episode, Joe interviews Erica Rex: award-winning journalist, past guest and writer, and participant in one of the first ever clinical trials using psilocybin to treat cancer-related depression; and Mona Sobhani, Ph.D.: cognitive neuroscientist and the author of "Proof of Spiritual Phenomena: A Neuroscientist’s Discovery of the Ineffable Mysteries of the Universe."

As Rex discovered the power of psychedelics through a clinical trial, she discusses a huge problem she discovered: that researchers are not preparing participants enough for the ontological shock they may go through in trying to match unexplainable happenings to a rigid framework (or match the normal to a framework that has suddenly shifted) – that while patients have support at the clinic, it all disappears when they return to normal life. She believes that all too often, researchers are doing only what is necessary to be able to continue to receive funding, push drugs through the FDA, and prescribe a pill. 

And as psychedelics changed Sobhani from very constrained scientific thinking to being very open to new ideas about consciousness and spirituality, she learned that many scientists had similar stories, and that coming out of the psychedelic closet is sometimes the best thing to do to normalize these ways of healing. 

They discuss the challenges of newcomers trying to explain their experience without having the necessary language; how we still don't truly understand mental illness; how the DSM just clusters symptoms to fit 'disorders' into a box; how society has started pathologizing anything we find unpleasant (which of course, is a part of being human); Gary Fisher’s research on using LSD and psilocybin for schizophrenic children, why science needs to combine consciousness research and psychedelics research, and more.

www.psychedelicstoday.com

In this episode of Psychedelics Weekly, Joe and Kyle record in-person again, discussing psychedelics and parenthood, sports, music, and more. 

They cover:

-an Elle (!) article about how mushrooms are becoming the new ‘Cali sober,’ with more and more people starting to microdose – including parents; 

-ESPN's documentary, "Peace of Mind," highlighting the rise of psychedelic use among athletes, including retired NHL player, Riley Cote;

-An article discussing how interest in psychedelics has skyrocketed in Oregon since the passing of Measure 109, and how over-regulation and the glacial speed of the government is only driving the growth of the black market; 

-An essay attempting to define what it is that leads people to describe music as psychedelic (with several recommendations from Joe); 

-DMT aficionados using AI to create and catalog depictions of the entities they've seen;

and more!

And they have larger discussions about the drug war, how famous athletes are opening people's minds to psychedelics, how strict regulation in psychedelic legislation can create more harm, how we need to collaborate more in the psychedelic space, the concept of a DMT 'hyper-slap,' and the problem of psychedelic exceptionalism and thinking your drug is good while others are bad.

www.psychedelicstoday.com

In this episode, David interviews two founding members of Fireside Project: activist, healing justice practitioner, musician, and Chief Ambassador, Hanifa Nayo Washington; and lawyer, aspiring researcher, and Executive Director, Joshua White, Esq.

Fireside Project was created after White volunteered for a help line for years and realized a few things: that follow-up calls made a big difference; that the state of mental health in the U.S. was a disaster (he was talking to some of the same people for years); and that while psychedelics were becoming popular, they would likely only be accessible to the wealthy. Alongside Washington, they realized the most effective thing they could do would be creating a free help line where people could call for peer support during a psychedelic experience, and receive support in integrating that experience afterward. They’ve focused on finding volunteers who may be marginalized or who have been persecuted from the war on drugs, but most importantly, have real experience and true compassion (rather than letters after their name proving their credentials). They are on track to receive 10,000 calls over their first two years.

They discuss Fireside’s Burning Man origin story; the serendipity they’ve seen in the organization’s beginnings and so many calls; where the name came from; how they prepare volunteers; what true equity looks like; and how, while it’s a common challenge for therapists and facilitators to hold back and not try to fix a problem, that may be even more important here.

Fireside Project takes calls every day from 11am – 11pm PST, and while there is an app you can download, they recommend saving their number in your phone for when you need it (62-FIRESIDE). And to destroy the notion of being afraid to ask for help, they encourage everyone to share their stories on social media: the times that you’ve used Fireside Project or the times you had a challenging experience and wish you had known about them. Many newcomers have no idea this support exists, and it could truly be life-changing for them.

www.psychedelicstoday.com

In this episode of Psychedelics Weekly, David speaks with Kyle, who recorded at Joe’s place while he was away at Trailblazers in NYC. 

They talk about David’s trip to the UK last week for Breaking Convention, then discuss a recent Vice article about looking outside the binary and confined thinking of Western medicine and embracing the underground – that there are cheaper and more accessible peer support models and affinity groups for everyone, but in going underground, we need to be careful that more accessible models aren’t dangerous or re-traumatizing. While businesses are competing to make headway in the psychedelic space, nobody is controlling all of it, which leads to both possibility and risk. 

They cover SB23-290, the bill Senate President Steve Fenberg created to establish a regulatory framework for psilocybin access and administration in Colorado in lieu of the advisory board that should have been put in place as part of Prop 122. They break down the positives and negatives of this framework, and ask: how much do these committees who are passing legislation really know about psilocybin? 

And they briefly discuss an article on what MDMA therapy may look like when MAPS hopefully gets approval via the FDA early next year, Rick Doblin’s speech at Breaking Convention, and his concept of society eventually having “net zero trauma.” www.psychedelicstoday.com

In this episode, Joe interviews Deborah Parrish Snyder: ecologist, Director and VP of the Institute of Ecotechnics, and Co-owner and CEO of Synergetic Press, which has published over 40 books on ethnobotany, psychedelics, biospherics, and social and ecological justice. 

Straddling the line between ecology, psychedelics, and psyche, she discusses the many projects of the Institute: Biosphere 2, the large-scale closed ecological system she helped design in 1986; London's "October Gallery," a man-made city biome project that could be a model for other cities; their "Eden in Iraq" wastewater project; and the Heraclitus, an 82-foot ship which has sailed 270k miles around the earth, studying different cultures, mapping coral reefs, and more, and will soon be setting sail again after being rebuilt for the last decade.  

She talks about where we're at as a society in regards to the environment: how we're in a period of consequences and it's easy to feel hopeless, but much of the youth are "solutionists" who don't want to hear apologies, and instead, want to do something about it. She believes that while schools don't teach ecology, it's never too late to learn, and non-ordinary states of consciousness could help people remember our connection to nature, care about our planet, and find the others who feel the same way. Consider pairing your self-exploration with improving the world around you: what can you do to turn your perfect, overly fertilized lawn into a regenerative landscape instead? www.psychedelicstoday.com

In this episode of Psychedelics Weekly, Joe and Kyle once again record in person, diving into novel compounds, changing opinions, Bicycle Day, and more. 

They start by dissecting a very recent controversy around The Church of Psilomethoxin and whether the sacrament they label as psilomethoxin – supposedly created by adding 5-MeO-DMT to the substrate of cultivated Psilocybe mushrooms – actually contains any psilomethoxin in it. Usona Institute published a paper last week reporting on their analysis of a sample they allegedly collected from the Church, which only showed what we’d see in a sample of a typical psilocybin-containing mushroom. While the Church has issues with Usona’s data collection, analytical methods, and motives, they also reiterate a main component of the church: that their "claims to the existence of Psilomethoxin, at this time, are solely based on faith," and bolstered by their “own direct experiences with the Sacrament.” It’s a very interesting story that touches on faith, consent, personal safety, and the harms of the drug war, which Joe covered extensively in a Twitter Space last night with Andrew Gallimore and the writer of a very critical article, Mario de la Fuente. 

They also discuss: 

-a Time magazine article about the mystery of Long COVID, and how many believe the anti-inflammatory and neuroplastic benefits of psychedelics could be the answer; 

-how Bicycle Day may soon become more popular than 4/20, likely due to society’s warmer reception to the life-changing effects of psychedelics (as opposed to their propagandized and unmoving beliefs about cannabis); 

-how some analysts believe that seven in 10 ketamine companies will likely face financial challenges as the industry grows too quickly; 

and why Snoop Dogg apparently microwaves blunts before smoking them (and does that actually do anything?).

www.psychedelicstoday.com

In this episode, on the eve of Bicycle Day, Victoria and Kyle interview two long-standing icons of visionary psychedelic art: Alex and Allyson Grey.

They talk about the LSD trip that saved Alex’s life, connected him to Allyson, inspired his art, and even made him change his name; his decades-in-the-making “Sacred Mirrors” project of 21 7-foot tall pieces depicting the complex layers of human existence; the interconnectedness of life; the history of psychedelic art; how imagination and non-ordinary states help us connect with the divine; and the value of art in conveying the mystical experience.

Alex and Allyson are the Co-Founders of the Chapel of Sacred Mirrors, an interspiritual church/retreat center in upstate New York that, after years of work, is debuting Entheon: an art sanctuary and psychedelic reliquary featuring much of their art and work from favorite artists, a shrine to Tool (who Alex has worked with for most of their career), and a collection of relics from psychedelic legends that includes Albert Hofmann’s glasses, art signed by Stan Grof and the Shulgins, and even Timothy Leary’s ashes. Entheon opens on June 3, on the anniversary of the first acid trip the Greys took together, which gave them a framework for understanding life and an inspiration for art they still follow to this day.

And in honor of Bicycle Day, Alex talks about two pieces dedicated to Albert Hofmann, and continues his Bicycle Day tradition of reading a statement Hofmann made a year before he passed about psychedelics being the “absolute highest importance to consciousness change.” In celebration of Albert Hofmann and the gift he gave us, and with inspiration from the incredibly complex and beautiful art Alex and Allyson create, have a happy, safe, and creative Bicycle Day!  www.psychedelicstoday.com

In this episode, Joe interviews Melissa Lavasani: CEO of Washington, DC-based Psychedelic Medicine Coalition and now, President of the brand new Psychedelic Medicine PAC.

She discusses her path to psychedelics, how she ended up running the Initiative 81 campaign (the Entheogenic Plant and Fungus Policy Act of 2020), and how she came to realize that decriminalization efforts can't be the only option we go for – that, like it or not, we live in a system where politics and money are major factors behind any systematic change, and if we want to make any headway, we have to play the game. The Psychedelic Medicine PAC (Political Action Committee) was created to open up federal funding for psychedelic research, as nearly all research today (of which there still isn't enough) is being funded by private companies. They will use donations to support politicians who are on our side and can advance psychedelic progress, who will push for federal funding to get the new and necessary data people who aren't bought in yet need to see. 

They talk about speaking with people from the other side of the aisle at a recent education campaign in DC; how federal funding is neutral money; what she learned from DC's deprioritization of cannabis policing; how personal stories and one-on-one human connection can change minds better than traditional confrontational activism; and the need to get ahead of the inevitable wave of big pharma propaganda they'll bring when they officially step up to the table. She believes the path to helping the most people is advancing science and data through federal funding, and that begins with education and getting more politicians on our side. If you agree, follow them for details about their upcoming event in May, visit their table at Psychedelic Science this June (use PT15 for 15% off tickets), and donate to the PAC or the coalition. 

Also, as a bonus, this episode begins with a mini version of Psychedelics Weekly. Joe and Kyle didn't have enough time to record a full episode, but still wanted to check in and review a few notable stories and highlight our recent Vital graduation ceremony. See you next week!

www.psychedelicstoday.com

In this episode, Joe lets Court Wing take lead in interviewing two of the leaders behind Clusterbusters: Founder and Executive Director, Bob Wold; and President, Eileen Brewer.

A long-time friend of the show, Court Wing has become our resident expert on chronic pain, writing articles about how psilocybin relieved his chronic pain, and hosting Timothy Furnish, MD & Joel Castellanos, MD in their episode about phantom limb pain. Now he speaks with Clusterbusters, a non-profit dedicated to educating people about the horrors of cluster headaches, funding ongoing research into new treatments, and normalizing the miracle that psilocybin has been to so many sufferers in alleviating their headaches. 

Wold and Brewer discuss their past struggles (Wold is a cluster sufferer and Brewer has migraine disease) and discovering the amazing intervention of psychedelics; the battles they've gone through in spreading this knowledge; how using psychedelics is also helping people work through PTSD; the barriers that legal psilocybin is creating; the concept of schools having a drug education program; the research looking at cluster headaches and other headache diseases; their creation of the Pain And Psychedelics Association, and more. While cluster headache sufferers have a lot to be frustrated about; as psilocybin becomes more mainstream and more and more research is funded, they now have a lot of hope.

www.psychedelicstoday.com

In this episode of Psychedelics Weekly, Kyle is back in Colorado and in-person with Joe, and they discuss what stood out to them in the news this week:

-A New York Times interview with Roland Griffths, where he talks about his cancer diagnosis and how meditation and psychedelics have helped him prepare for the inevitable end;

-An article on the rising popularity of psychedelics among mothers, and the benefits and risks of moms rejecting alcohol culture in favor of something new (and largely illegal);

-The NBA removing cannabis from its list of banned substances and allowing players to invest in cannabis companies, which follows years of other sports slowly accepting that cannabis is a part of our culture and there’s no need to play the part of “big brother” anymore;

and an article looking at legalization from the perspectives of people who were against recent measures like Prop 122, and how some towns in Colorado and Oregon are looking for ways to prevent the creation of psilocybin service centers from being built in their backyards.

They also go further into the Psychedelic Medicine Coalition’s recently created Political Action Committee and the work they’re doing to educate lawmakers; Harvard Law School hosting webinars comparing psychedelic legislation and the role of psychedelics in Indigenous groups in Europe, Australia, and North America; Arizona’s HB-2486, which would give $30 million in grants to universities and non-profit organizations to conduct psilocybin research; and Rick Doblin’s recent appearance on The Joe Rogan Experience.

www.psychedelicstoday.com

In this episode, David interviews neuroscientist, artist, and educator, Melanie Pincus, Ph.D.; and Ph.D. candidate in Neuroscience, lead or co-author on over a dozen scientific publications, and regular contributor to PT, Manesh Girn. 

They tell their stories of how they became interested in neuroscience, and stress the importance of staying radically open-minded (or “epistemically naive”) when it comes to how much we can claim we understand about the brain, the mind-body connection, and consciousness itself – that while fMRI and other advances have brought us a long way, there are still a ton of “unknown unknowns,” especially around creativity, decision making, and imagination. They discuss the misconception that we only use 10% of our brains; comparisons between the brain and the universe; society’s misunderstanding of “happy hormones” (dopamine, serotonin, etc.); how chronic stress takes a toll on all parts of the body; how MDMA works with memory processing; and how stacking modalities with the psychedelic experience (like play or activities focused on emotion regulation) can really help with personal goals and growth. 

They have taken their understanding and fascination with neuroscience and applied it to a new course in our Psychedelic Education Center: “Psychedelic Neuroscience Demystified: How Psychedelics Alter Consciousness and Produce Therapeutic Effects“: an 8-week live course with 10 hours of prerecorded material and a built-in community. It was designed with practitioners and clinicians in mind, but with the goal of still being as accessible as possible for anyone who is curious about the neuroscience of psychedelics, and how that knowledge can help with preparation, the journey, integration, and working with a heightened window of neuroplasticity. 

Class begins on May 17, and if you sign up before April 12, you can get $100 off! www.psychedelicstoday.com

In this episode of Psychedelics Weekly, Joe calls in from Los Angeles to cover the week's news with David. 

They review: 

-Dr. Julie Holland's recent appearance on the The Cannabis Investing Podcast, where she discussed the concept of cannabis being a psychedelic;

-Vancouver Island University in British Columbia, Canada, planning to establish a Psychedelic Research Centre, with a focus on the historical and ethical context of psychedelic substances, using a "two eyed seeing" approach that combines Western-style science with Indigenous perspectives;

-A group of investors creating a Real Estate Investment Trust (REIT) to purchase real estate for the purposes of psychedelic therapy, which, if used as the collaborative model we imagine it could be, could solve a lot of problems;

-Diplo completing the Los Angeles Marathon in 3 hours and 35 minutes while under a reported 4-5 drops of LSD, and the dismissive spin mainstream media added to the story; 

and a Rolling Stone article focusing on (and somewhat oversimplifying) the conflicts between the medicalization and decriminalization/legalization camps (can we just do both?).

The articles of course lead to much larger discussions: how cannabis has helped David overcome OCD; the need for more transparency and a review system based on abusive behavior in the psychedelic space; the idea of collectivization in therapy models; why we need to agree on ethical foundations; and our general misunderstanding of IP and IP law: was all the criticism of Compass Pathways unwarranted?

www.psychedelicstoday.com

In this episode, David interviews Sunny Strasburg, LMFT: Clinical Director at TRIPP PsyAssist; psychedelic trainer, consultant, therapist, and writer, specializing in EMDR and Internal Family Systems, and offering ketamine-assisted therapy as well as ketamine therapy retreats (often co-led by Dr. Richard Schwartz). 

She talks about her family history with magic, and how the act of calling energy in and out pairs with psychedelic work; how the human experience is made up of contrasts; why we need to embrace the recreational part of psychedelics; how art can be used more in therapy; and how post-experience group integration is the act of creating mythology, recreating the small-community-sitting-by-the-fire archetype – that community we so desperately need. And she discusses ketamine: different ways she uses it; how it pairs perfectly with Internal Family Systems; and how it’s autobiographical medicine, making us an observer and allowing us to separate ourselves from our story.

While passionate about the mystical, magic, and reconnecting to nature, she is also very involved with virtual reality, and she discusses how VR and meditation apps are easing people into non-ordinary states and familiarizing people with breathwork. With the help of pioneering psychedelic DJ, David Starfire, she created PsyAssist, an app with music playlists and voice integration for people to enhance ketamine experiences that don’t otherwise include therapy or integration work. PsyAssist was acquired by VR company, TRIPP, and they’re running a study on people using VR before a psychedelic experience to see if data proves that VR really does reduce the anxiety so many of us feel before taking that big journey. But she reminds us: as we become more connected to technology, VR, and AI, being connected to other human beings will become more and more important.

www.psychedelicstoday.com

In this episode, Joe interviews Ph.D. student in the Drug Use and Behavior Lab at the University of Alabama Birmingham, Haley Maria Dourron.

She talks mostly about the paper she co-authored last year with Dr. Peter Hendricks and Camilla Strauss: “Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis,” which analyzes the long-standing comparisons between the psychedelic state and psychosis, and points out important distinctions between the two – that science should be looking more at the way one processes information and their level of self-focus rather than similarities in outward behavior. She discusses what she calls entropic processing, which is essentially how one’s brain creates novel ideas, relations, and insights based on very loosened mental schemas: with new information being considered in new ways (with no filter), do the connecting pathways that seem like eureka moments actually make sense? 

She discusses the broaden and build theory and the broadening of intentional scope; entropy; chronic LSD use and risk of psychosis; schizophrenia and psychedelics; why science needs to embrace naturalistic research, and more. As of this release date, there are still a few participatory spots left in her current study on the effect of psychedelic experiences on people who have a history of psychosis, so if you had an episode of psychosis at some point and have gone on to use psychedelics, she wants to hear your story. Head to the show notes for the link. www.psychedelicstoday.com

In this episode of Psychedelics Weekly, Joe and Kyle are back at it, talking about news and what's going on at Psychedelics Today (applications for Vital close this Sunday, March 26, and we've just announced a new neuroscience course!).

Following up on last week's news that Field Trip Health had closed five clinics, they start with more unfortunate news: that Field Trip is laying off a lot of people, Ronan Levy has resigned as the CEO, trading has been suspended, and the company has obtained CCAA Protection (which, through the Companies' Creditors Arrangement Act, essentially allows a struggling company a chance to restructure its finances to avoid bankruptcy, all through a formal Plan of Arrangement). And in similar news, all Ketamine Wellness Centers (an Arizona company recently acquired by Delic Holdings) would be closing immediately, with employees let go with little warning or explanation. These stories (and Synthesis Institute’s downfall) highlight the sad reality many of us in the psychedelic space forget: that just because a business is heart-centered and psychedelic-minded, it's still a business, and businesses need to be profitable to survive. 

Next, they cover Melissa Lavasani and the Psychedelic Medicine Coalition creating the Psychedelic Medicine PAC (Political Action Committee) to get more government funding behind psychedelic research. Members of PMC went to D.C. last week, presenting a psychedelic briefing to begin the process of educating legislators about the realities of plant medicines and psychedelic-assisted therapy (and Joe was there). 

And they discuss more: concerns over Australia's recent about-face on MDMA and psilocybin being used legally; a recent study where researchers used EEG and fMRI together to record what is happening in the brain while under the influence of DMT (and we should probably have Manesh Girn on again to explain it better than we could); and an interview with Eric Andre at SXSW where, in about 2 minutes, he brilliantly shines a light on drug exceptionalism, the lies of the drug war, and the need for more education on psychedelics – all to a bewildered reporter who didn't seem prepared to talk to Eric Andre (we are- please come on the podcast!).

www.psychedelicstoday.com

In this episode, Joe interviews the Co-Founder and CEO of Beckley Retreats, Neil Markey. 

Markey describes Beckley Retreats as comprehensive well-being programs, and talks about the importance of holistic wellness – that, while the retreats are centered around two group psilocybin experiences, the true benefits come from complementary factors: the four weeks of online prep and community building before the retreat, the six days in Jamaica surrounding the experiences, the six weeks of integration work after, and the depth of connections people find in the new community they may not have realized they needed so badly. He breaks down the details of the retreats and what they look for in facilitators, and tells a few success stories that really highlight how trauma, opposing ideas, and an infatuation with material objects and amassing wealth can all get in the way of real relationships and meaning. 

Beckley Retreats is currently working on two new projects: an observational study with Heroic Hearts and Imperial College London on using psilocybin for-traumatic brain injury, and a study with Bennet Zelner and the University of Maryland to bring executives through a retreat to see how it affects leadership and decision-making: can they prove that these types of experiences lead to more heart-centered leaders?

www.psychedelicstoday.com

In this episode of Psychedelics Weekly, Joe and Kyle join up once again to discuss the news and articles they found the most interesting this week. 

They start with the business news everyone is talking about: Field Trip Health & Wellness closing 5 of their clinics due to financial struggles (a deficit of $48.7 million since their inception and a net loss of $6.9 million reported for the last quarter), little confidence they'd be able to receive more funding, and the changing landscape of ketamine telehealth now that the Covid Public Health Emergency should finally come to an end in May. They also highlight an article dissecting the collapse of Synthesis Institute and the lessons to be learned, with both stories really showing just how new and unstable psychedelic business still is, and how the allure of first-mover advantage can be a dangerous gamble.

They also discuss four drug reform bills introduced in Vermont: two of which would decriminalize simple possession of all drugs, making a "personal use supply of drugs” a civil offense with a $50 fine; one removing penalties for using or selling psilocybin; and the last decriminalizing certain psychedelic plants and fungi. 

And they look at a research study aiming to learn more about people's lives after they've been involved in a clinical trial, Time Magazine's article about psychedelics and couples therapy, and a study that found that while 64% of survey respondents said at-home ketamine helped their symptoms, 55% (and 58% of Millennials) said they used more than the recommended dose – either by accident or on purpose.

www.psychedelicstoday.com

In this episode, David hosts another Vital Psychedelic Conversation, this time with Bennet Zelner, Ph.D.: Vital instructor who teaches economics at the University of Maryland Smith School of Business; and Giles Hayward: Vital student and Co-Founder of Woven Science (a company backing and building psychedelic and wellness tech companies) and El Puente, which focuses on Indigenous biocultural preservation.

Zelner believes that the traditional capitalist system we’ve grown accustomed to is an extractive and predatory one directly in opposition to a natural system we should be striving to emulate – one that circulates resources and exits largely in equilibrium with its different parts. His concept of the Pollination Approach (or regenerative economics) is about developing economic structures that are capable of balance: where communities are built to directly benefit each other and where businesses are structured to share resources and capital to all involved. In a hyper-individualistic system where loneliness and never feeling good enough are key drivers of depression, anxiety, and trauma, how could we not benefit from feeling more connected to each other, our communities, and the businesses that exist within them? 

They talk about different ways the pollination approach could be applied; how psychedelics disrupt these broken systems; how we can make these treatments affordable; and why we should be focusing on the delivery and integration of substances rather than creating new ones. And since Hayward is about to graduate from Vital’s inaugural run, he shares his feelings on the program and how it fell into this concept of regenerative economics. 

The application deadline for this year’s Vital has been extended to March 26, but that will be the last extension. So if you’re interested, now is the time to apply! www.psychedelicstoday.com

In this episode, Joe interviews Graham Hancock: legendary bestselling author and writer and presenter of the new Netflix docuseries, "Ancient Apocalypse," where he travels the world looking for evidence of lost civilizations likely much more advanced than historians previously believed.

Hancock talks about his early books and how ayahuasca influenced his writing; the similarities in cave art and the common link of altered states of consciousness; how integral non-ordinary states of consciousness likely were to early religion (especially Christianity); how much the annihilation of religious traditions has hidden history; why his and Rupert Sheldrake's Tedx talks were originally taken offline; new understandings of Neanderthals' intelligence and creativity; the Quetzalcóatl; and the concept of the Younger Dryas impact hypothesis: could there have been an advanced civilization 12,800 years ago that we're just starting to comprehend? Could it have been Atlantis? 

He discusses the conflict with mystery and archaeology's obsession with scientism and materialist reductionism – that we keep trying to force everything into little boxes of approved science and have lost our imaginations and openness to possibility, especially when you realize how often narratives are built based on interpretations of data rather than facts (since the farther back we go, evidence becomes harder to come by). He believes science needs humility, a willingness to listen to Indigenous history, and a much more open mind when it comes to altered states of consciousness: “I'm convinced we're missing something important from our past, and if we don't look for it, we won't find it.” Hancock has just announced that he will be a speaker at UK's Breaking Convention, April 20 - 22 at the University of Exeter, and some of the PT team will be there too! To save 10% off tickets, use code PSYCHTODAYBC10 at checkout.

www.psychedelicstoday.com

In this episode of Psychedelics Weekly, David is joined by Kyle, who is finally home after a lot of traveling, to talk shop and dig into the articles they found the most interesting this week. 

They begin with the news that Paul Stamets now has a species of mushroom named after him (Psilocybe stametsii), then take a look at a recent self-report study called “Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics,” which aimed to collect data on just how many psychedelic users (in this study, anyone who had ever tried a psychedelic) felt that they had had a challenging or difficult experience. They discuss the results and highlight some interesting data: that LSD was the most commonly associated substance, that smoking cannabis was one of the most commonly reported interventions, and of course, the question of whether or not these experiences were beneficial. 

They then talk about Synthesis Institute closing its doors, the possible hope Synthesis could have, and the sadness in this – when businesses fail, it’s easy to look at numbers and profit margins and be dismissive, but we forget the people involved; not just at Synthesis, but the hundreds of would-be students. 

And lastly, they look at an article about a California-based startup called the Reality Center, which uses a combination of pulsing lights, sounds, and vibrations to create a drug-free but seemingly very psychedelic experience, reminding us yet again that you do not need a substance to achieve  non-ordinary states of consciousness. www.psychedelicstoday.com

In this episode of Vital Psychedelic Conversations, David interviews Vital instructor, Dr. Devon Christie: Senior Lead of Psychedelic Programs at Numinus, MAPS-certified MDMA therapist, and now four-time guest; and Vital student, Emefa Boamah: coach, facilitator, and trauma-informed intuitive guide specializing in embodiment. 

We've all heard the trope, "It's all in your mind," but it's also in your heart, soul, community, support system, and body - the focus of this episode. Christie and Boamah dive deep into the various aspects of the relationship between non-ordinary states and our bodies: ways to embody our bodies more; how the body is a fundamental source of truth; the benefit of checking in with one's body after an experience (to validate or disprove what may have come up); the importance of movement and rest; the different bodies we inhabit (physical, emotional, energetic, mental, and spiritual); and ways to accept (and eventually love) our bodies in a society that's always working to make us hate them – is self-love the ultimate act of defiance?

They also discuss the post-experience plasticity in everything, and the challenge of preparing an experiencer for something we can't know; how facilitators and practitioners need to track their own subconscious feelings and reactions; the concept of embodied inquiry; the necessity of remaining curious and humble; and the idea of using integrative practices to find ways to become the person you want to be – the person you may have seen glimpses of in non-ordinary states. 

And as this year's edition comes to an end, Boamah reflects on her experiences with Vital, particularly the communal aspects of the retreat and how healing it was to literally be lifted up by her companions. Head to the show notes to see a video showcasing some of the Vital experience, and if you're curious about whether Vital is right for you, please come to an upcoming Q+A. Applications close March 19! www.psychedelicstoday.com

In this episode, in celebration of International Women’s Day, Victoria interviews Tracey Tee: co-founder and CEO of Band of Mothers Media, co-producer and co-host of the Band of Mothers podcast, and founder of Moms on Mushrooms, an online educational community for psychedelic-curious moms outside the prying eyes of social media.

With similar histories of womb trauma, self discovery, and body reconnection, Victoria and Tracey discuss the complications of motherhood, substance use and embracing psychedelics in a broken culture, in which engaging with small, approved coping mechanisms is fine – where the “wine mom” archetype and numbing yourself with medications is celebrated, but where we don’t often talk about how challenging motherhood can really be, and the lasting mental, physical, and spiritual impacts of birth, loss, and grief. Tracey’s goal with Moms on Mushrooms is to bring mothers together for personal growth, healing, and most of all, for the safe, supportive container that so many women considering plant medicine need.

She tells her story of creating and performing “The Pump and Dump Show” and the psychedelic journeys that led her to creating M.O.M., and discusses much more: how those large dose journeys reconnected her with her body; how microdosing has helped her feel more vulnerable, honest, and in tune with her daughter; how psychedelics can help parents realize where problematic core beliefs came from; how teaching children the ways of the world forces parents to confront and reaffirm what they truly believe; and the challenges mothers face in even talking about wanting to try psychedelics.

If you’re a mother and this episode resonates with you, check out Tee’s Microdosing 101 (for moms) course or join the Moms on Mushrooms community for $4.44 a month.

www.psychedelicstoday.com

In this episode, Psychedelics Weekly is back after a brief hiatus (everyone was either traveling or sick last week!), with the OG PT team: Joe and Kyle. 

With the exception of some commentary on John Oliver's recent piece on psychedelics (which was excellent), they skip the psychedelic news this week in favor of Psychedelics Today news, as a lot has been going on!

In the last few weeks:

Joe sustained a traumatic brain injury and a broken arm;

Joe, Kyle, and Victoria attended PT's first Cannadelic in Miami, where Joe and Kyle moderated or sat on several panels, Kyle and Victoria went and saw Afroman, and we won the Psychedelic Brand of the Year award(!);

Joe experienced a music festival in different ways (completely sober, and somewhat still in a concussion daze) and did some interesting research on psychedelics and post-concussion effects;

Despite Joe and Kyle both getting sick and not being able to attend all of it, the last Vital retreat was an amazing one, capping off a year of incredible content and connection that is only fueling the fire to make this year's Vital even better;

And, due to issues beyond our control with the planned venue and the City of Los Angeles, we had to cancel Convergence.

Phew! As promised, lots going on!

 www.psychedelicstoday.com

In this episode, David interviews Kevin Cannella, LPC: MAPS-trained psychedelic psychotherapist and Co-Founder and Executive Director of Thank You Life, a nonprofit organization working to provide access to psychedelic therapy by eliminating its financial barriers.

Co-Founded by Dr. Dan Engle, Thank You Life is very new and still in the process of officially launching, having just obtained 501(c)(3) status in December and recently gaining its first corporate sponsor in Dr. Bronner's. The nonprofit came from the realization of just how expensive psychedelic-assisted therapy can be, and Cannella wondering: what if there was a fund practitioners could plug into when a patient couldn't pay? While access for the patient is obvious, this model benefits the practitioner as well, which is something not often discussed in the psychedelic space – we focus a lot on how much these services will cost the patient, but rarely on the practitioner deserving to be paid fairly for their time and expertise. 

Cannella tells his story of immersion into a world of ayahuasca, yoga, and vipassana meditation; volunteering at the Temple of the Way of Light, living in Hawaii, then Brazil, and finally, landing at Naropa University, where his passions were finally validated. He discusses looking for signs and learning to trust intuition, ways to increase accessibility outside of a 501(c)(3) model, how it feels to be paid well for your work, and why he only wants to work with practitioners who offer therapy alongside their chosen substance.

Head to their website to donate to the Thank You Life fund, and follow them on socials for details on upcoming launch/fundraising events in April and May.

www.psychedelicstoday.com

In this episode, David interviews Victor Alfonso Cabral, LSW: Director of Policy and Regulatory Affairs at Fluence Training and Licensed Social Worker and practicing psychotherapist in Pennsylvania.

Cabral is currently involved with the film, “We are the Medicine,” which aims to explore the reemergence of plant medicines from the perspective of people of color from all backgrounds and walks of life, with the added factor of a strong hip hop influence. Filmmakers Eric Blackerby and Esteban Serrano want the film to normalize the concept of psychedelics and healing for people of color, but also the notion of men being truly authentic with each other and building each other up with love and support – something that challenges society’s expectations on how men (and more specifically, Black and Brown men) should be in relationships with one another. Head to pictureacolorfulworld.com to donate and sign up for the mailing list for more info on future fundraisers and screenings. 

He begins the episode by reading a powerful poem he read at Horizons NYC, then tells his story: his childhood and his mother’s sacrifices; how trauma caught up to him in college and led to the low point of his life; his subsequent 120-pound weight loss journey and embracing of therapy, how his first psychedelic experience resulted in an awakening of possibility; how he became a social worker and why he felt instantly aligned with the work; how he ended up working for PA Governor Tom Wolf; and how he came to be interviewed by Sway Calloway (who is also an Executive Producer of the film). His story and all of the organizations and efforts he’s been involved with prove that being authentic, following your heart, and building relationships with the right people can lead to growth and positive change in whatever path you choose in this space. 

www.psychedelicstoday.com

In this episode, Joe interviews Greg Lake, Esq.: Co-Founder of the Church of Psilomethoxin, author, and attorney specializing in working with entheogen-based religious practitioners in establishing their right to consume their sacraments under existing religious freedom laws.

Psilomethoxin (4-Hydroxy-5-methoxydimethyltryptamine or 4-Hydroxy-5-MeO-DMT) was first synthesized in 2021 by mixing 5-MeO-DMT with psilocybin substrate, and after initial tests and months of user reports, it was deemed safe to use.* Lake co-founded the Church of Psilomethoxin in 2022 with the goal of shifting the paradigm of religion to primary direct experiences and individual beliefs rather than a dogma everyone must follow, with a big focus on community and discussing the ultimate questions of life together – with Psilomethoxin as the sacrament of choice. While he prefers member-to-member referrals, there is an application on the site, and he hopes to grow the church through linking people up regionally, (eventually) training people to facilitate, and partnering with a data collection company to gather real-world data on both Psilomethoxin and on why people are seeking out psychedelic churches in the first place. 

He discusses several cases that brought us here and inspired his work; why he believes Psilomethoxin won't be a target of the Federal Analogue Act; the Religious Freedom Restoration Act (RFRA) and the need for states to establish similar state legislation; the importance of new churches establishing evidence in the public record; how much courts take sincerity into consideration; and the concept that, while we're quick to think of the law as the enemy, courts often don’t want to go after churches – religion is a sacred and intimate thing, so who is the victim if a court brings a church to court that hasn't harmed anyone?

www.psychedelicstoday.com

*Update, April 17, 2023: Results from analytical testing released on April 12, 2023, reveal that there is no evidence to suggest the compound psilomethoxin is present in the samples of sacrament material the Church of Psilomethoxin is offering to their members online. The report, prepared by Samuel Williamson and Alexander Sherwood of the Usona Institute, states, “Psilocybin, baeocystin, and psilocin, were, however, unambiguously identified in the sample, suggesting that the claims regarding the biosynthesis of psilomethoxin may be misguided. The implications of these findings should be critically considered within the context of public health and safety.”

We are following this story at Psychedelics Today and are working to update our community with commentary from the researchers. Stay tuned to our social media channels for more on this topic.

In this episode of Vital Psychedelic Conversations, Kyle interviews Carla Kieffer: psychedelic educator, Certified Psychedelic Facilitator, Community Liaison at Maya Health, and Founder of Kairos Integration, a company offering psychedelic training, preparation, facilitation, integration, and microdosing support.

This episode was recorded in-person, in between the first and second psilocybin retreats at Atman Retreat in Jamaica, where Kyle, Johanna, and a large group of Vital students just worked with Carla last month. Many participants that attend retreats are new to psychedelics, and often don’t know each other, so it was powerful to have a group of classmates follow the breathwork model of having sitters and journeyers take turns (which is the same model she uses for her Psychedelic Guide Training and Certificate Program), and demonstrates how much one can learn when taking the role of the sitter and how the journey becomes the teacher. They talk about how big the therapy part of psychedelic-assisted therapy is, in how rare it is to have someone attending to your every need for hours on end, and wonder: How can we take that aspect of holding space for each other and apply it to everyday life? 

She discusses the importance of data collection and how her Internal Family Systems training has helped her balance her love for the mystical with her more science and data-based mind; the importance in facilitators meeting some sort of baseline harm reduction and safety training (and the need to establish an agreed-upon set of standards); the need for increased accessibility; how important it is to further educate about and normalize conversations about psychedelics; and how integration isn’t just a box you check off as part of the experience, but a continuous process and part of our lives, where checking in on ourselves should be a regular practice.

www.psychedelicstoday.com

In this episode, Joe interviews Dr. Devon Christie: Senior Lead of Psychedelic Programs at Numinus, educator at CIIS and Vital, and MAPS-certified MDMA therapist; and Dr. Pamela Kryskow, MD: founding board member of the Psychedelic Association of Canada and Medical Lead of the nonprofit, Roots To Thrive.

Christie and Kryskow recently co-authored one of the first papers looking at MDMA for chronic pain, “MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorder,” which came about after they received access to MAPS’ Phase 2 data from a lead-in PTSD study and noticed significant improvements in pain measurements – something the study was not looking for at all. They’re looking into where chronic pain fits within the frameworks of Western medicine and psychedelic-assisted therapy, and discuss the many reasons why MDMA should be tremendously helpful for chronic pain and other conditions that fall under the large umbrella of central sensitivity syndromes and nociplastic pain. They are currently working on a new study following the MAPS protocol that will research MDMA-assisted psychotherapy specifically for people with fibromyalgia, which some believe might be physicalized PTSD. If you’d like to contribute a tax-deductible donation, visit giving.viu.ca, select “other” from the dropdown, and type in “MDMA for Fibromyalgia.”

They talk about how research trials focus too much on the molecule while ignoring what the patient is saying; how a large percentage of physicians and patients don’t at all like the psychometrics used in measuring data; how physicians regularly use expectancy bias but research trials don’t (and how that affects results); why everyone needs to place higher importance on the biopsychosocial model; the idea of being more humble with science and using “theoretical” more often; the problems with microdosing trials; and the issues with evidence: If there isn’t sufficient evidence, why isn’t there? And what exactly would be sufficient?

www.psychedelicstoday.com

In this episode of Psychedelics Weekly, Kyle is joined by another new voice from the PT team: one of the main instructors and facilitators from our Vital program, Diego Pinzon. 

Originally from Colombia, Diego has been living in Australia since 2008 and has been involved in the Australian psychedelic scene, playing roles in the charity sector, research with Psychae Institute, and is one of the researchers in the St. Vincent’s Melbourne trial, Australia’s first trial using psilocybin for end-of-life depression and anxiety. Diego gives his insight into the recent TGA re-scheduling of psilocybin and MDMA for treatment-resistant depression and post-traumatic stress disorder, respectively.

They cover the details, unknowns, and concerns: Is there enough time to train enough people? Do they have the infrastructure for this? What are the substances actually going to be? What percentage of people who apply will be granted access? What will it cost? And while psychiatrists will be able to prescribe, how much will the program really focus on therapy? 

And they discuss Vancouver’s Filament Health creating the world’s first ayahuasca pill, which is close to FDA authorization to begin a Phase 1 trial. Of course this news begs some questions as well, mainly: with psychedelic use being such an active experience, how much does something like this change our relationship to ayahuasca? And with a consistent, more predictable experience, does that kill the magic?

www.psychedelicstoday.com

In this episode of Vital Psychedelic Conversations, Johanna takes the helm for the first time, hosting a conversation with Jungian analyst-in-training, writer, researcher, 5Rhythms® teacher, and Vital student: Mackenzie Amara; and clinical psychologist, long time PT collaborator, and Vital instructor: Dr. Ido Cohen.

As this episode features three huge fans of Jung (Johanna wrote her Master’s dissertation on The Red Book and teaches a course through PT), they focus less on education and the future of psychedelic therapy, and instead get pretty deep; shining a light on an integral part of psychedelia (and life) we often avoid: the shadow. What is the shadow and what is true shadow work? What did Jung give us, and why is Jungian psychology so relevant for integrating psychedelic experiences? 

They discuss the notion of the unconscious as a place you can develop a relationship with and access by very different means; the idea of the healer as the container; the problematic binary of good vs. evil; the flawed concept of ego death; the differences between authentic and neurotic suffering and personal and collective consciousness; the archetype of the wounded healer and why facilitators should both be wounded and in the process of healing; and how wonderful it is that society is beginning to embrace the weird and what makes us unique. 

There are no shortcuts in life and there is no “cure” for the parts of the human condition we aren’t comfortable with, but in the capitalist, efficiency-above-all-else West, we aren’t raised to sit with the unpleasant, and instead learn to seek a quick fix, which has created an environment where we’ve lost the ability to feel in the ways that we need to. Can you be with someone else’s pain if you’re running from your own? Can you have real compassion if you’ve never suffered? Can you be complete without knowing your shadow?

www.psychedelicstoday.com

In this episode, Joe interviews artist Rupert Alexander Scriven, who, under his brand, Vintage Disco Biscuit, recently released “The Art of Ecstasy”: a coffee table book of images of ecstasy tablets he collected for 25 years.

www.psychedelicstoday.com

In this episode, David is joined by Director of Advocacy at the National Psychedelics Association, Kathryn L. Tucker, JD, who updates us on the 3 AIMS vs. the DEA cases, discussing what their outcome could mean for the future.

www.psychedelicstoday.com

In this episode, Vital Psychedelic Conversations switches it up, with Kyle interviewing our Coordinator of Education and Training, Johanna Hilla, about 2022's inaugural edition of Vital. And what can students expect this year?

www.psychedelicstoday.com

In this episode, Joe interviews Jessica "Jaz" Cadoch & Sovereign Oshumare: Co-Founders of ALKEMI, a consulting firm for psychedelic ethics and accountability. They discuss the Prop 122 conflict, what true access means, and more.

www.psychedelicstoday.com

In this episode, Ph.D. candidate in Neuroscience, Manesh Girn joins new podcast voice, Julian Bost, to explain recent research we found confusing, and to discuss schizophrenia, inflammation and depression, and the ways we learn.

www.psychedelicstoday.com

In this episode, David interviews Grof-certified Holotropic Breathwork® practitioner, author, developer of InnerEthics®, and Vital instructor: Kylea Taylor: M.S., LMFT; and therapist and Vital student: Shabina Hale. 

www.psychedelicstoday.com

In this episode, Joe interviews Gina Gratza, MS, LMFT: Portland, OR-based research therapist and educator at InnerTrek, a psilocybin facilitator training program. She discusses MDMA, Burning Man, therapy, psilocybin, and more.

www.psychedelicstoday.com

In this episode, David interviews clinical psychologist and Vital instructor, Dr. Dominique Morisano, and facilitator and Vital student, Jessika Lagarde, about their perspectives on psychedelic education, and of course, Vital. 

www.psychedelicstoday.com

In this episode, David interviews Raad Seraj: host of Minority Trip Report, a podcast for underrepresented views in psychedelics/mental health, and founder of Mission Club, an education & investment platform.

www.psychedelicstoday.com

In this episode, Joe is joined by Kyle, calling in from a retreat in Jamaica. They discuss data Concerns in Oregon, hopeful legalization in NH and Missouri, and Vital: the retreats, what students are saying, and the 5 elements.

www.psychedelicstoday.com

In this episode, Kyle interviews researcher, writer, and one of the world’s leading experts on 5-MeO-DMT, Dr. Malin Vedøy Uthaug. She discusses Heron’s theory of catharsis, dietas, freediving, the mind-body connection, and more.

www.psychedelicstoday.com

In this episode, Joe covers Prince Harry coming out of the psychedelic closet, Virginia lawmakers proposing the legalization of psilocybin, psychedelic legislation already in plans for nearly a dozen states in 2023, and more.

www.psychedelicstoday.com

In this episode, Joe interviews neurobiologist, researcher, & author, Dr. Andrew R. Gallimore, who discusses his newest book: "Reality Switch Technologies", DMT, intravenous infusion pumps, John Mack, Terence McKenna, and more!

www.psychedelicstoday.com

In this episode, David and Joe discuss Tryp Therapeutics researching psilocybin-assisted psychotherapy for I.B.S.; NY lawmakers pre-filing a bill to legalize natural psychedelics; and British Columbia decriminalizing drugs. 

www.psychedelicstoday.com

In this episode, Kyle interviews author and board-certified psychiatric-mental health nurse practitioner, C.J. Spotswood. They discuss microdosing and why nurses could be the answer to the psychedelics and scalability problem.

www.psychedelicstoday.com

In this episode, Joe and Kyle cover a study where psilocybin improved stress response; The Economist highlighting psychedelic medicine as a main story for 2023; and the Minnesota Medical Association endorsing decriminalization.

www.psychedelicstoday.com

In this episode, David interviews internationally recognized Indigenous rights activist: Sutton King, MPH. She discusses the challenges Indigenous people continue to face from intergenerational trauma, and their resiliency.

www.psychedelicstoday.com

In this episode, Joe and Kyle discuss concerns over Prop 122 and data privacy, the hopeful end to the sentencing disparity between crack cocaine and powder; and the cost vs. value problem of psychedelic therapy: is it worth it? 

www.psychedelicstoday.com

In this episode, Joe interviews Zach Leary: author, facilitator, trainer, host of the MAPS podcast, and of course, son of psychedelic legend: Timothy Leary. They discuss Ram Dass, Michael Pollan, flotation tanks, and more.

www.psychedelicstoday.com

In this episode, Joe & David discuss the DA dropping a felony drug charge against a Denver mushroom rabbi, the economics of psychedelic-assisted therapies, and the belief that most US states will legalize psychedelics by 2037. 

www.psychedelicstoday.com

In this episode, Joe interviews New York Times best-selling author, pioneer in the field of integrative medicine, legend in the health and wellness space, and (somewhat surprising to us) psychedelic advocate, Andrew Weil, M.D. 

www.psychedelicstoday.com

In this episode of Psychedelics Weekly, Joe and David discuss methylation and genetic memory; why the term, “The Psychedelic Renaissance” is problematic; and the importance of harm reduction – especially at music festivals.

www.psychedelicstoday.com

In this episode, David interviews Sherry Rais: CEO/Co-Founder of Enthea, a benefit plan administrator offering psychedelic-assisted therapy as a benefit to interested employers.

www.psychedelicstoday.com

In this episode, Joe and Alexa discuss our first conference-meets-festival, Convergence; a study looking at the potentiality of 5-MeO-DMT reactivation; and the story of a woman using cannabis as an adjunct treatment for cancer.

www.psychedelicstoday.com

In this episode, Victoria interviews James Fadiman, Ph.D., Adam Bramlage, and Conor Murray, Ph.D, who discuss the benefits of microdosing and the first-ever take-home wireless EEG microdosing study (which you can be a part of). 

www.psychedelicstoday.com

In this episode, David, Joe, (and in her first appearance) Alexa Jesse discuss The PACT Caucus and Breakthrough Therapies Act, Jim Harris overcoming paralyzation through psilocybin, and research on chronic pain and Alzheimer's.

In this episode, Kyle interviews Marc Aixalà, writer of "Psychedelic Integration: Psychotherapy for Non-Ordinary States of Consciousness." They discuss what integration truly is, and how it should be more personalized. 

www.psychedelicstoday.com

In this episode of Psychedelics Weekly, David welcomes Jon Dennis, Esq. They discuss Colorado Prop 122 and Jon gives an update on Oregon's legal psilocybin as the Oregon Health Authority finalizes its proposed rules.

www.psychedelicstoday.com

In this episode, David interviews Co-Medical Director of Nue Life, Dr. Ben Medrano. He discusses the risks, safety, and efficacy of at-home ketamine, Nue Life's recent study in Frontiers, and Nue Life's Nue Care program. 

www.psychedelicstoday.com

In this inaugural episode of Psychedelics Weekly, Joe and Kyle are back together again to kick off a new weekly show. In this episode, they discuss the recent Wonderland controversy and Colorado Proposition 122.

www.psychedelicstoday.com

In this Veteran's Day episode, Joe interviews two members of the Heroic Hearts Project: Founder/President, Jesse Gould, and Chief of Operations, Zach Riggle. They discuss their current studies, their new documentary, and more.

www.psychedelicstoday.com

In this episode, Victoria interviews podcaster and comedian, Dennis Walker. He sees his platform, Mycopreneur, as "The Onion of the psychedelic space," and talks about the need for more satire in our increasingly serious lives.

www.psychedelicstoday.com

In this episode, Joe interviews Canadian cannabis policy reform legend and long-time anti-drug war activist, Dana Larsen. They discuss prohibition, civil disobedience, and his Coca Leaf Cafe, where he sells coca tea and peyote. 

www.psychedelicstoday.com

In this episode, Court Wing (Founder of REMAP Therapeutics) joins Joe in interviewing Joel Castellanos, MD, and Timothy Furnish, MD, of UC San Diego's Psychedelics and Health Research Initiative (PHRI). 

www.psychedelicstoday.com

In this episode, Kyle interviews Dr. Steven Radowitz: Medical Director at Nushama, a wellness center in New York City primarily offering IV ketamine, with a strong focus on allowing an undisturbed, explorational journey.

www.psychedelicstoday.com

In this episode, Joe interviews David Bronner, CEO of Dr. Bronner’s, a top-selling natural soap brand. They discuss Colorado Proposition 122, a ballot initiative that would decriminalize several natural medicines in the state. 

www.psychedelicstoday.com

In this episode, Joe interviews Dr. Rochelle Hines, Ph.D. and Dr. Dustin Hines, Ph.D.: Co-Founders of Tesselate Therapeutics, which is focused on the development and testing of novel psychedelic molecules. 

www.psychedelicstoday.com

In this episode, Kyle interviews Dr. Jennifer Montjoy: psychiatric nurse practitioner specializing in ketamine-assisted psychotherapy, and Medical & Research Director at TRIPP; a 501(c)(3) psychedelic training organization.

www.psychedelicstoday.com

In this episode, David interviews Jamie Wheal: author of Recapture the Rapture: Rethinking God, Sex and Death In a World That's Lost Its Mind, and Founder of performance research/training organization: the Flow Genome Project.

www.psychedelicstoday.com

In this episode, Joe interviews Reggie Harris: Founder of Oakland Hyphae, which organizes events like the Hyphae Cup (previously the Psilocybin Cup), and performs psilocybin potency testing through Hyphae Labs. 

www.psychedelicstoday.com

In this episode, Victoria interviews Cory Firth: Chief Storyteller at the Nikean Foundation, a non-profit passionate about storytelling, and aiming to build the largest collection of transformational psychedelic stories online.

www.psychedelicstoday.com

In this episode, Joe interviews Jason Slot, Ph.D.: Associate Professor of Mycology and Evolutionary Genomics at Ohio State University. Slot discusses mushroom reproduction and what the science of evolutionary genomics entails.

www.psychedelicstoday.com

In this episode, Joe interviews Stephanie Wang: Founder and CEO of KA! Empathogenics, which has created the first-ever supplement chew with the primary ingredient of kanna, a natural succulent plant with effects similar to MDMA.

www.psychedelicstoday.com

In this episode, Joe interviews Sawyer Hurwitz: filmmaker and augmented reality collage artist who releases art under the name, Psychotronic Solutions. He also directed our new TV show, "Psychedelics Tonight" airing on ALTRD.TV.

www.psychedelicstoday.com

In this episode, Kyle interviews Clinical Psychologist and Founder of the Psychedelic Society of Vermont, Dr. Rick Barnett, from a live event in Burlington, VT this past June. They discuss psychedelics' various contexts of use.

www.psychedelicstoday.com

In this episode, David interviews Dr. Hans Eriksson: clinical psychiatrist and Chief Medical Officer at HMNC Brain Health, which is currently in Phase 2 trials for Ketabon, a non-dissociative, prolonged-release oral capsule. 

www.psychedelicstoday.com

In this episode, Joe interviews Brom Rector: podcaster and founder of Empath Ventures, a venture capital fund that invests in psychedelic medicine startups. They discuss investment, IP, the psychedelic crash, ibogaine, and more.

www.psychedelicstoday.com

In this episode, David interviews Founder of the People of Color Psychedelic Collective: Ifetayo Harvey. She talks about the racism of the drug war, the importance of caregiving, and what we can do collectively to make change.

www.psychedelicstoday.com

In this episode, Joe interviews Laura Guzmán-Dávalos: 40-year veteran mycologist at the University of Guadalajara, Mexico; and daughter of Gaston Guzman, who most consider the world authority on the genus, Psilocybe. 

www.psychedelicstoday.com

In this episode, Kyle interviews Doctors James Fadiman, Sam Gandy; and David Luke. They discuss Fadiman's past research and Gandy and Luke's new paper, "Psychedelics as potential catalysts of scientific creativity and insight."

www.psychedelicstoday.com

In this episode, Joe interviews Alex Enchin & Ian-Michael Hébert, MA; Co-Founders of HOLOS, a company building hospitality wellness centers with a strong focus on community, reconnection to nature, and a return to wholeness.

www.psychedelicstoday.com

In this episode, Joe interviews Seth Rosenberg: Washington DC-based mycologist and anti-drug war advocate who worked on DC's decriminalization Initiative 81, and who was presumably arrested for purchasing legal plants online. 

www.psychedelicstoday.com

In this episode, David interviews Jim Gilligan: Interim CEO and Chief Scientific Officer of Tryp Therapeutics, a biotech company researching psychedelics for the treatment of eating disorders and nociplastic pain. 

www.psychedelicstoday.com

In this episode, Joe interviews transformational coach and guide, Brenna Gebauer; in-person from her parents' RV at this year's Lightning in a Bottle festival, with facilitator and past guest, Mark Haberstroh stopping in too. 

www.psychedelicstoday.com

In this episode, David interviews globally-recognized cannabis activist, author, entrepreneur, speaker, podcaster, and “Father of the Legal Cannabis Industry,” Steve DeAngelo; discussing industry, decriminalization, and more!

www.psychedelicstoday.com

In this episode, Joe interviews Christopher Koddermann: Co-Founder of the International Therapeutic Psilocybin Rescheduling Initiative (ITPRI). He discusses patents, IP, and what needs to be done to reschedule psilocybin. 

www.psychedelicstoday.com

In this episode, David interviews Kevin Balktick: Founder & Director of Horizons; one of the world's longest-running psychedelic media and education communities, which is expanding to Portland, Oregon this year with Horizons NW.

www.psychedelicstoday.com

In this episode, "Vital Psychedelic Conversations" returns with Kyle interviewing Steve Thayer: psychologist, Clinical Director of Education & Training at Novamind, and co-host of the Psychedelic Therapy Frontiers podcast. 

www.psychedelicstoday.com

In this episode, David interviews Susan Beaulieu: Extension Educator at the University of Minnesota Extension, who works with her community (the Anishinaabe people) around intergenerational trauma and community resilience. 

www.psychedelicstoday.com

In this episode, Joe interviews Soren Shade: producer of the third season of “Hamilton’s Pharmacopeia" and Co-Founder of Top Tree Herbs, a kratom tea company dedicated to educating people about kratom and normalizing its use.

www.psychedelicstoday.com

In this episode, Victoria Dekker debuts, interviewing the CEO of TheraPsil, Spencer Hawkswell, about the charter challenge that effectively sues the Canadian government for ending psilocybin exemptions for end-of-life patients.

www.psychedelicstoday.com

In this episode, David interviews Monnica Williams, Ph.D. She discusses the mental health impact communities of color face as a result of racism; and what therapists, clinicians, and researchers can do to improve this paradigm.

www.psychedelicstoday.com

In this episode, David interviews Joost Breeksema: Executive Director of the OPEN Foundation, which manages the Interdisciplinary Conference on Psychedelic Research (ICPR) which returns to Amsterdam this September 21-24.

www.psychedelicstoday.com

In this episode, Joe interviews Kim Dudine: Chief of Staff at OpenNest Labs and Director of Membership and Strategy at Trailblazers Presents. She discusses the benefits, psychedelic nature, and unifying aspects of cannabis.

www.psychedelicstoday.com

In this episode, Joe interviews Melissa Lavasani: Founder and Executive Director of the Psychedelic Medicine Coalition, proposer of DC's Initiative 81, and interviewee in Michael Pollan's "How to Change Your Mind" docuseries. 

www.psychedelicstoday.com

In this episode, David interviews Lauren Katalinich & Anya Oleksiuk of the Psychedelic Society, a website/community that runs events and works to build the community so many people need after having a psychedelic experience.

www.psychedelicstoday.com

In this episode, David interviews Sisi Li, Ph.D.: Data Architect for Porta Sophia; a non-profit online library collecting relevant prior art in the world of psychedelics for innovators and patent reviewers around the world. 

www.psychedelicstoday.com

In this episode, Joe interviews Christopher Dawson & Andrew Galloway: Co-Founders and CEO/COO, respectively, of Dimensions; a company creating retreats blending traditional plant ceremony with modern science and 5-star luxury. 

www.psychedelicstoday.com

In this episode, David interviews David Nutt: Psychiatrist, Founder/Chief Scientific Officer at Drug Science, Chief Research Officer at Awakn Life Sciences, and Professor of Neuropsychopharmacology at Imperial College London.

www.psychedelicstoday.com

In this episode, Joe interviews T. Cody Swift, MFT, and Miriam Volat, MS; Co-Directors of The Riverstyx Foundation. They discuss plant medicine bioculture; peyote conservation, and working for the survival of Indigenous culture.

www.psychedelicstoday.com

In this episode of the podcast, Joe interviews James Lanthier, the CEO of Mindset Pharma; a biotechnology company discovering and developing new (and hopefully safer, more predictable, and more palatable) psychedelic compounds.

www.psychedelicstoday.com

In this episode, Joe interviews Julie Zukof: Head of Strategic Partnerships for Nue Life and the creator of Psychedelic Women, and Michelle Weiner: a double board-certified Doctor specializing in integrative pain management.

www.psychedelicstoday.com

In this episode, Joe interviews Dick Simon: Co-Founder and CEO of Sensorium Therapeutics, an organization created to research plants we already know are effective and synthesize new ones. How can we best optimize what we know? 

www.psychedelicstoday.com

In this bonus episode, Kyle interviews Dr. Scott Shannon: Co-Founder and CEO of the Board of Psychedelic Medicine and Therapies; a non-profit created to certify healthcare professionals in psychedelic-assisted psychotherapy. 

www.psychedelicstoday.com

In this episode, Joe interviews Licensed Marriage & Family Therapist and Founder of Access To Doorways, Courtney Watson. Watson talks about ancestral practices, Diasporic religions, & trauma healing for QTBIPOC communities.

www.psychedelicstoday.com

In this episode, David interviews Founder and Executive Director of MAPS, Rick Doblin, Ph.D. He discusses the abuse allegations unearthed in the recent “Cover Story” podcast series, real-world evidence, and MAPS' future goals. 

www.psychedelicstoday.com

In this episode, David interviews clinical psychologist and Founder of the Psychedelic Society of Vermont, Dr. Rick Barnett. He discusses addiction, recovery, spirituality, and the Psychedelic Science & Spirituality Summit.

www.psychedelicstoday.com

In this episode of the podcast, Joe interviews Philip Wolf: Founder of the "elevated dining" company, Cultivating Spirits. His new project is CashoM; an education platform for cannabis consumers, from beginners to connoisseurs.

www.psychedelicstoday.com

In this episode of the podcast, Joe interviews the Founder of Personal Plants: Amanda Reiman, Ph.D., MSW. She discusses our connection to plants and the endless possibilities of cryptocurrencies, NFTs, and other Web3 projects. 

www.psychedelicstoday.com

In this episode of the podcast, Kyle interviews Dr. Reid Robison and Steve Thayer, Ph.D.: CMO (Robison) and Clinical Director of Education & Training (Thayer) at Novamind, and hosts of the Psychedelic Therapy Frontiers podcast.

www.psychedelicstoday.com

In this episode of the podcast, Joe interviews retired Nurse Practitioner, Midwife, and Air Force Captain, Kimberly Juroviesky. She discusses ketamine, Complex Regional Pain Syndrome, and her goals with her Ketamine Task Force.

www.psychedelicstoday.com

In this episode of the podcast, Joe interviews Lyle Maxson: Co-Founder and Chief Strategy Officer of Entheo Digital, a “technodelic” company working with VR and digital therapeutics to explore how technology can help us.

www.psychedelicstoday.com

In this episode of the podcast, David interviews former journalist and Founder/CEO of The New Health Club, Anne Philippi. She discusses non-linear healing, intergenerational trauma, and how psychedelics can heal the workforce.

www.psychedelicstoday.com

In this episode of the podcast, Joe interviews Kole, who was famously arrested for growing mushrooms in Denver back in 2020 – shortly after psilocybin had been decriminalized there. He talks about his arrest and trust. 

www.psychedelicstoday.com

In this episode of the podcast, Joe sat down for a live recording with the team from Umbo Mushrooms: Unlimited Sciences founder, Del Jolly; Former UFC champion, Rashad Evans; and 10-year NFL veteran quarterback, Jake Plummer.

www.psychedelicstoday.com

In this episode of the podcast, Joe interviews Jason Grechanik; a tabaquero running plant dietas, ayahuasca ceremony facilitator, and host of "The Universe Within" podcast. They discuss shamanism, dietas, breathwork, and more!

www.psychedelicstoday.com

In this episode of Vital Psychedelic Conversations, David interviews philosopher, clinical psychologist, and Co-Founder of Dreamshadow Group: Lenny Gibson, Ph.D. They discuss shamanism, Greek mythology, Whitehead, and more!

www.psychedelicstoday.com

In this episode of the podcast, David interviews Dr. Dominique Morisano: clinical psychologist and Co-Founder of the upcoming conference, "From Research to Reality: Global Summit on Psychedelic-Assisted Therapies and Medicine."

www.psychedelicstoday.com

In this episode of Vital Psychedelic Conversations, Kyle interviews Daniel McQueen, MA: author of “Psychedelic Cannabis” and Executive Director of the Center for Medicinal Mindfulness. They discuss self-care, cannabis, and more!

www.psychedelicstoday.com

In this episode of the podcast, Joe interviews Holotropic Breathwork® facilitator, Christine Calvert, LCDC. They discuss the many facets of the holotropic paradigm, the nuance of touch, the ethics of spaceholding, and more. 

www.psychedelicstoday.com